0001224608us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2023-06-30

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q


☑			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~June 30, ~~2022~~2023


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___ to ___

Commission File Number 001-31792

CNO Financial Group, Inc.

Delaware

75-3108137

State of Incorporation

IRS Employer Identification No.

11825 N. Pennsylvania Street

Carmel,

Indiana

46032

(317)

817-6100

Address of principal executive offices

Telephone

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

Common Stock, par value $0.01 per share

CNO

New York Stock Exchange

Rights to purchase Series E Junior Participating Preferred Stock

New York Stock Exchange

5.125% Subordinated Debentures due 2060

CNOpA

New York Stock Exchange

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes ☒ No ☐

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act. Large accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☐ No ☒

Shares of common stock outstanding as of ~~October 24, 2022: 114,403,320~~July 25, 2023: 112,996,712

TABLE OF CONTENTS


PART I - FINANCIAL INFORMATION		Page

Item 1.	Financial Statements (unaudited)

	Consolidated Balance Sheet as of SJune 30 ~~eptember~~ ~~30, 2022~~, 2023 and December 31, ~~2021~~2022	3
	Consolidated Statement of Operations for the three and six ~~nine~~months ended ~~September~~June 30 ~~30,~~, 2023 and 2022 ~~and 2021~~	5
	Consolidated Statement of Comprehensive Income (Loss) for the three and six ~~nine~~months ended ~~September~~June 30 ~~30,~~, 2023 and 2022 ~~and 2021~~	6
	Consolidated Statement of Shareholders' Equity for the three and ~~nine~~six months ended ~~September~~June 30 ~~30,~~, 2023 and 2022 ~~and 2021~~	7
	Consolidated Statement of Cash Flows for the ~~nine~~six months ended ~~September~~June 30 ~~30,~~, 2023 and 2022 ~~and 2021~~	9
	Notes to Consolidated Financial Statements	10

Item 2.	Management's Discussion and Analysis of Consolidated Financial Condition and Results of Operations	5776
	Cautionary Statement Regarding Forward-Looking Statements	5776
	Overview	5978
	Critical Accounting ~~Policies~~Estimates	6281
	Results of Operations	6384
	Liquidity and Capital Resources	7495
	Investments	80101
	Investments in Variable Interest Entities	87108
	New Accounting Standards	90111

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	90111

Item 4.	Controls and Procedures	90111


PART II - OTHER INFORMATION

Item 1.	Legal Proceedings	91112

Item 1A.	Risk Factors	91112

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	91112

Item 5.	Other Information	113

Item 6.	Exhibits	92114

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEET

(Dollars in millions)

(unaudited)

ASSETS


		September 30, 2022		December 31, 2021			June 30, 2023		December 31, 2022
									(As recast)
Investments:	Investments:					Investments:
Fixed maturities, available for sale, at fair value (net of allowance for credit losses: September 30, 2022 - $52.0 and December 31, 2021 - $7.6; amortized cost: September 30, 2022 - $23,442.5 and December 31, 2021 - $21,867.6)		$	20,301.1	$	24,805.4
Fixed maturities, available for sale, at fair value (net of allowance for credit losses: June 30, 2023 - $66.1 and December 31, 2022 - $56.0; amortized cost: June 30, 2023 - $23,630.5 and December 31, 2022 - $23,384.2)						Fixed maturities, available for sale, at fair value (net of allowance for credit losses: June 30, 2023 - $66.1 and December 31, 2022 - $56.0; amortized cost: June 30, 2023 - $23,630.5 and December 31, 2022 - $23,384.2)	$	20,959.7	$	20,353.4
Equity securities at fair value	Equity securities at fair value	135.8		131.1		Equity securities at fair value	96.4		135.3
Mortgage loans (net of allowance for credit losses: September 30, 2022 - $5.3 and December 31, 2021 - $5.6)		1,227.3		1,218.6
Mortgage loans (net of allowance for credit losses: June 30, 2023 - $10.3 and December 31, 2022 - $8.0)						Mortgage loans (net of allowance for credit losses: June 30, 2023 - $10.3 and December 31, 2022 - $8.0)	1,825.9		1,411.9
Policy loans	Policy loans	120.2		120.2		Policy loans	124.2		121.6
Trading securities	Trading securities	223.3		227.2		Trading securities	218.9		207.9
Investments held by variable interest entities (net of allowance for credit losses: September 30, 2022 - $6.5 and December 31, 2021 - $3.7; amortized cost: September 30, 2022 - $1,166.7 and December 31, 2021 - $1,206.8)		1,099.2		1,199.6
Investments held by variable interest entities (net of allowance for credit losses: June 30, 2023 - $4.5 and December 31, 2022 - $5.5; amortized cost: June 30, 2023 - $982.2 and December 31, 2022 - $1,134.2)						Investments held by variable interest entities (net of allowance for credit losses: June 30, 2023 - $4.5 and December 31, 2022 - $5.5; amortized cost: June 30, 2023 - $982.2 and December 31, 2022 - $1,134.2)	948.2		1,077.6
Other invested assets	Other invested assets	1,028.6		1,224.0		Other invested assets	1,176.7		1,034.7
Total investments	Total investments	24,135.5		28,926.1		Total investments	25,350.0		24,342.4
Cash and cash equivalents - unrestricted	Cash and cash equivalents - unrestricted	498.0		632.1		Cash and cash equivalents - unrestricted	457.7		575.7
Cash and cash equivalents held by variable interest entities	Cash and cash equivalents held by variable interest entities	55.5		99.6		Cash and cash equivalents held by variable interest entities	104.2		69.2
Accrued investment income	Accrued investment income	236.0		216.4		Accrued investment income	242.1		235.6
Present value of future profits	Present value of future profits	218.9		222.6		Present value of future profits	191.8		203.7
Deferred acquisition costs	Deferred acquisition costs	1,886.4		1,112.0		Deferred acquisition costs	1,857.7		1,770.9
Reinsurance receivables (net of allowance for credit losses: September 30, 2022 - $2.0 and December 31, 2021 - $3.0)		4,271.9		4,354.3
Reinsurance receivables (net of allowance for credit losses: June 30, 2023 - $2.0 and December 31, 2022 - $2.0)						Reinsurance receivables (net of allowance for credit losses: June 30, 2023 - $2.0 and December 31, 2022 - $2.0)	4,029.2		4,223.4
Market risk benefit asset						Market risk benefit asset	66.0		65.3
Income tax assets, net	Income tax assets, net	1,180.2		118.3		Income tax assets, net	1,007.1		1,063.4
Assets held in separate accounts	Assets held in separate accounts	2.7		3.9		Assets held in separate accounts	3.0		2.7
Other assets	Other assets	552.2		519.1		Other assets	745.1		580.8
Total assets	Total assets	$	33,037.3	$	36,204.4	Total assets	$	34,053.9	$	33,133.1

(continued on next page)

The accompanying notes are an integral part

of the consolidated financial statements.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEET, continued

(Dollars in millions)

(unaudited)

LIABILITIES AND SHAREHOLDERS' EQUITY

September 30,
2022 December 31,
2021

Liabilities:
Liabilities for insurance products:
Policyholder account liabilities $ 14,653.7 $ 13,689.7
Future policy benefits 11,747.5 11,670.7
Liability for policy and contract claims 454.3 501.8
Unearned and advanced premiums 238.2 246.7
Liabilities related to separate accounts 2.7 3.9
Other liabilities 749.4 830.9
Investment borrowings 1,639.9 1,715.8
Borrowings related to variable interest entities 1,115.3 1,147.9
Notes payable – direct corporate obligations 1,138.4 1,137.3
Total liabilities 31,739.4 30,944.7
Commitments and Contingencies
Shareholders' equity:
Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: September 30, 2022 – 114,367,345; December 31, 2021 – 120,377,152) 1.1 1.2
Additional paid-in capital 2,030.6 2,184.2
Accumulated other comprehensive income (loss) (2,165.7) 1,947.1
Retained earnings 1,431.9 1,127.2
Total shareholders' equity 1,297.9 5,259.7
Total liabilities and shareholders' equity $ 33,037.3 $ 36,204.4


	June 30, 2023		December 31, 2022
			(As recast)
Liabilities:
Liabilities for insurance products:
Policyholder account balances	$	15,387.7	$	15,234.2
Future policy benefits	11,479.6		11,240.2
Market risk benefit liability	10.5		11.3
Liability for life insurance policy claims	64.6		64.1
Unearned and advanced premiums	233.6		235.0
Liabilities related to separate accounts	3.0		2.7
Other liabilities	898.9		693.9
Investment borrowings	1,839.5		1,639.5
Borrowings related to variable interest entities	1,001.0		1,104.6
Notes payable – direct corporate obligations	1,139.7		1,138.8
Total liabilities	32,058.1		31,364.3
Commitments and Contingencies
Shareholders' equity:
Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: June 30, 2023 – 113,673,882; December 31, 2022 – 114,343,070)	1.1		1.1
Additional paid-in capital	1,997.9		2,033.8
Accumulated other comprehensive loss	(1,733.5)		(1,957.3)
Retained earnings	1,730.3		1,691.2
Total shareholders' equity	1,995.8		1,768.8
Total liabilities and shareholders' equity	$	34,053.9	$	33,133.1

The accompanying notes are an integral part

of the consolidated financial statements.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF OPERATIONS

(Dollars in millions, except per share data)

(unaudited)

Three months ended Nine months ended
September 30, September 30,
2022 2021 2022 2021
Revenues:
Insurance policy income $ 623.2 $ 630.6 $ 1,873.8 $ 1,893.5
Net investment income:
General account assets 289.0 289.5 884.2 854.3
Policyholder and other special-purpose portfolios (20.9) 18.7 (184.0) 171.3
Investment gains (losses):
Realized investment gains (losses) (8.2) 3.7 3.6 14.8
Other investment gains (losses) (9.5) (6.0) (102.8) 11.4
Total investment gains (losses) (17.7) (2.3) (99.2) 26.2
Fee revenue and other income 31.7 31.8 128.4 102.1
Total revenues 905.3 968.3 2,603.2 3,047.4
Benefits and expenses:
Insurance policy benefits 412.2 524.8 1,099.1 1,641.3
Interest expense 37.6 23.7 89.2 71.8
Amortization 87.5 57.9 279.5 200.2
Other operating costs and expenses 230.8 233.9 673.5 714.5
Total benefits and expenses 768.1 840.3 2,141.3 2,627.8
Income before income taxes 137.2 128.0 461.9 419.6
Income tax expense on period income 32.2 28.2 108.5 94.4
Net income $ 105.0 $ 99.8 $ 353.4 $ 325.2
Earnings per common share:
Basic:
Weighted average shares outstanding 114,354,000 126,429,000 116,170,000 130,528,000
Net income $ .92 $ .79 $ 3.04 $ 2.49
Diluted:
Weighted average shares outstanding 115,928,000 129,018,000 118,072,000 133,162,000
Net income $ .91 $ .77 $ 2.99 $ 2.44


	Three months ended				Six months ended
	June 30,				June 30,
	2023		2022		2023		2022
			(As recast)				(As recast)
Revenues:
Insurance policy income	$	628.3	$	625.6	$	1,253.8	$	1,250.6
Net investment income:
General account assets	308.1		317.7		600.3		595.2
Policyholder and other special-purpose portfolios	91.6		(93.8)		142.4		(163.1)
Investment gains (losses):
Realized investment gains (losses)	(21.8)		(7.0)		(36.4)		11.8
Other investment losses	(13.5)		(41.8)		(13.5)		(93.3)

Total investment losses	(35.3)		(48.8)		(49.9)		(81.5)
Fee revenue and other income	30.1		54.3		82.2		96.7
Total revenues	1,022.8		855.0		2,028.8		1,697.9
Benefits and expenses:
Insurance policy benefits	565.9		302.2		1,175.6		636.1
Liability for future policy benefits remeasurement loss	8.3		.3		8.9		7.3
Change in fair value of market risk benefits	(17.6)		(50.3)		(2.8)		(83.0)
Interest expense	57.6		27.8		112.3		51.6
Amortization	56.0		52.7		111.5		105.0


Other operating costs and expenses	256.5		222.5		528.2		440.8
Total benefits and expenses	926.7		555.2		1,933.7		1,157.8
Income before income taxes	96.1		299.8		95.1		540.1

Income tax expense on period income	22.4		66.5		22.2		123.4

Net income	$	73.7	$	233.3	$	72.9	$	416.7
Earnings per common share:
Basic:
Weighted average shares outstanding	114,273,000		115,533,000		114,409,000		117,078,000
Net income	$	.64	$	2.02	$	.64	$	3.56
Diluted:
Weighted average shares outstanding	115,650,000		117,286,000		116,189,000		119,144,000
Net income	$	.64	$	1.99	$	.63	$	3.50

The accompanying notes are an integral part

of the consolidated financial statements.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS)

(Dollars in millions)

(unaudited)

Three months ended Nine months ended
September 30, September 30,
2022 2021 2022 2021
Net income $ 105.0 $ 99.8 $ 353.4 $ 325.2
Other comprehensive loss, before tax:
Unrealized losses on investments (1,407.2) (112.9) (6,128.2) (436.6)
Adjustment to present value of future profits and deferred acquisition costs 126.2 13.4 666.5 21.6
Amount related to premium deficiencies assuming the net unrealized gains had been realized — 16.5 165.0 114.0
Reclassification adjustments:
For net realized investment (gains) losses included in net income 1.0 (.9) 36.0 (26.4)
For amortization of the present value of future profits and deferred acquisition costs related to net realized investment (gains) losses included in net income (.6) .1 (1.7) 1.4
Other comprehensive loss before tax (1,280.6) (83.8) (5,262.4) (326.0)
Income tax benefit related to items of accumulated other comprehensive loss 279.9 18.0 1,149.6 69.6
Other comprehensive loss, net of tax (1,000.7) (65.8) (4,112.8) (256.4)
Comprehensive income (loss) $ (895.7) $ 34.0 $ (3,759.4) $ 68.8


	Three months ended				Six months ended
	June 30,				June 30,
	2023		2022		2023		2022
			(As recast)				(As recast)

Net income	$	73.7	$	233.3	$	72.9	$	416.7
Other comprehensive income (loss), before tax:
Unrealized gains (losses) on investments	(272.8)		(2,285.9)		353.3		(4,721.0)
Adjustment to discount rate for liability for future policy benefits	157.2		1,158.4		(106.1)		2,378.8
Adjustment to instrument-specific credit risk for market risk benefits	(2.3)		4.1		(1.4)		10.7
Reclassification adjustments:
For net realized investment losses included in net income	29.2		27.2		40.1		35.0
Other comprehensive income (loss) before tax	(88.7)		(1,096.2)		285.9		(2,296.5)
Income tax (expense) benefit related to items of accumulated other comprehensive income (loss)	19.6		241.9		(62.1)		507.0
Other comprehensive income (loss), net of tax	(69.1)		(854.3)		223.8		(1,789.5)
Comprehensive income (loss)	$	4.6	$	(621.0)	$	296.7	$	(1,372.8)

The accompanying notes are an integral part

of the consolidated financial statements.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY

(Dollars in millions, shares in thousands)

(unaudited)


		Common stock			Additional paid-in		Accumulated other comprehensive		Retained					Common stock			Additional paid-in		Accumulated other comprehensive		Retained
		Shares	Amount		capital		income (loss)		earnings		Total			Shares	Amount		capital		income (loss)		earnings		Total
Balance, June 30, 2021		129,105	$	1.3	$	2,383.0	$	1,995.5	$	944.2	$	5,324.0
Balance, March 31, 2022 (as recast)													Balance, March 31, 2022 (as recast)	117,241	$	1.2	$	2,085.7	$	(561.5)	$	1,293.0	$	2,818.4

Net income	Net income	—	—		—		—		99.8		99.8		Net income	—	—		—		—		233.3		233.3
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax benefit of $18.0)		—	—		—		(65.8)		—		(65.8)
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax benefit of $241.9)													Change in unrealized appreciation (depreciation) of investments (net of applicable income tax benefit of $241.9)	—	—		—		(854.3)		—		(854.3)
Common stock repurchased	Common stock repurchased	(4,911)	(.1)		(114.9)		—		—		(115.0)		Common stock repurchased	(2,550)	(.1)		(59.9)		—		—		(60.0)
Dividends on common stock	Dividends on common stock	—	—		—		—		(16.6)		(16.6)		Dividends on common stock	—	—		—		—		(16.4)		(16.4)
Employee benefit plans, net of shares used to pay tax withholdings	Employee benefit plans, net of shares used to pay tax withholdings	76	—		6.5		—		—		6.5		Employee benefit plans, net of shares used to pay tax withholdings	104	—		6.9		—		—		6.9
Balance, September 30, 2021		124,270	$	1.2	$	2,274.6	$	1,929.7	$	1,027.4	$	5,232.9
Balance, June 30, 2022 (as recast)													Balance, June 30, 2022 (as recast)	114,795	$	1.1	$	2,032.7	$	(1,415.8)	$	1,509.9	$	2,127.9

Balance, June 30, 2022		114,795	$	1.1	$	2,032.7	$	(1,165.0)	$	1,343.2	$	2,212.0
Balance, March 31, 2023													Balance, March 31, 2023	114,905	$	1.1	$	2,021.1	$	(1,664.4)	$	1,674.0	$	2,031.8

Net income	Net income	—	—		—		—		105.0		105.0		Net income	—	—		—		—		73.7		73.7
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax benefit of $279.9)		—	—		—		(1,000.7)		—		(1,000.7)
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax benefit of $19.6)													Change in unrealized appreciation (depreciation) of investments (net of applicable income tax benefit of $19.6)	—	—		—		(69.1)		—		(69.1)
Common stock repurchased	Common stock repurchased	(561)	—		(10.0)		—		—		(10.0)		Common stock repurchased	(1,346)	—		(30.0)		—		—		(30.0)
Dividends on common stock	Dividends on common stock	—	—		—		—		(16.3)		(16.3)		Dividends on common stock	—	—		—		—		(17.4)		(17.4)
Employee benefit plans, net of shares used to pay tax withholdings	Employee benefit plans, net of shares used to pay tax withholdings	133	—		7.9		—		—		7.9		Employee benefit plans, net of shares used to pay tax withholdings	115	—		6.8		—		—		6.8
Balance, September 30, 2022		114,367	$	1.1	$	2,030.6	$	(2,165.7)	$	1,431.9	$	1,297.9
Balance, June 30, 2023													Balance, June 30, 2023	113,674	$	1.1	$	1,997.9	$	(1,733.5)	$	1,730.3	$	1,995.8

The accompanying notes are an integral part

of the consolidated financial statements.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY, continued

(Dollars in millions, shares in thousands)

(unaudited)

Common stock
Additional
paid-in Accumulated other comprehensive Retained
Shares Amount capital income (loss) earnings Total
Balance, December 31, 2020 135,279 $ 1.3 $ 2,544.5 $ 2,186.1 $ 752.3 $ 5,484.2
Net income — — — — 325.2 325.2
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax benefit of $69.6) — — — (256.4) — (256.4)
Common stock repurchased (12,511) (.1) (302.3) — — (302.4)
Dividends on common stock — — — — (50.1) (50.1)
Employee benefit plans, net of shares used to pay tax withholdings 1,502 — 32.4 — — 32.4
Balance, September 30, 2021 124,270 $ 1.2 $ 2,274.6 $ 1,929.7 $ 1,027.4 $ 5,232.9
Balance, December 31, 2021 120,377 $ 1.2 $ 2,184.2 $ 1,947.1 $ 1,127.2 $ 5,259.7
Net income — — — — 353.4 353.4
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax benefit of $1,149.6) — — — (4,112.8) — (4,112.8)
Common stock repurchased (7,168) (.1) (169.9) — — (170.0)
Dividends on common stock — — — — (48.7) (48.7)
Employee benefit plans, net of shares used to pay tax withholdings 1,158 — 16.3 — — 16.3
Balance, September 30, 2022 114,367 $ 1.1 $ 2,030.6 $ (2,165.7) $ 1,431.9 $ 1,297.9


	Common stock			Additional paid-in		Accumulated other comprehensive		Retained
	Shares	Amount		capital		income (loss)		earnings		Total
Balance, December 31, 2021 (as recast)	120,377	$	1.2	$	2,184.2	$	373.7	$	1,125.6	$	3,684.7


Net income	—	—		—		—		416.7		416.7
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax benefit of $507.0)	—	—		—		(1,789.5)		—		(1,789.5)
Common stock repurchased	(6,607)	(.1)		(159.9)		—		—		(160.0)
Dividends on common stock	—	—		—		—		(32.4)		(32.4)
Employee benefit plans, net of shares used to pay tax withholdings	1,025	—		8.4		—		—		8.4
Balance, June 30, 2022 (as recast)	114,795	$	1.1	$	2,032.7	$	(1,415.8)	$	1,509.9	$	2,127.9

Balance, December 31, 2022 (as recast)	114,343	$	1.1	$	2,033.8	$	(1,957.3)	$	1,691.2	$	1,768.8


Net income	—	—		—		—		72.9		72.9
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax expense of $62.1)	—	—		—		223.8		—		223.8
Common stock repurchased	(1,979)	—		(45.1)		—		—		(45.1)
Dividends on common stock	—	—		—		—		(33.8)		(33.8)
Employee benefit plans, net of shares used to pay tax withholdings	1,310	—		9.2		—		—		9.2
Balance, June 30, 2023	113,674	$	1.1	$	1,997.9	$	(1,733.5)	$	1,730.3	$	1,995.8

The accompanying notes are an integral part

of the consolidated financial statements.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF CASH FLOWS

(Dollars in millions)

(unaudited)


		Nine months ended					Six months ended
		September 30,					June 30,
		2022		2021			2023		2022
Cash flows from operating activities:	Cash flows from operating activities:					Cash flows from operating activities:
Insurance policy income	Insurance policy income	$	1,724.9	$	1,756.4	Insurance policy income	$	1,150.4	$	1,153.7
Net investment income	Net investment income	832.2		793.1		Net investment income	648.3		547.5
Fee revenue and other income	Fee revenue and other income	110.4		104.3		Fee revenue and other income	105.3		80.3
Insurance policy benefits	Insurance policy benefits	(1,243.4)		(1,247.3)		Insurance policy benefits	(821.4)		(834.3)
Interest expense	Interest expense	(65.8)		(57.4)		Interest expense	(108.1)		(47.3)
Deferrable policy acquisition costs	Deferrable policy acquisition costs	(245.7)		(213.3)		Deferrable policy acquisition costs	(186.4)		(167.4)
Other operating costs	Other operating costs	(757.4)		(685.7)		Other operating costs	(537.0)		(547.5)
Income taxes	Income taxes	(20.7)		28.9		Income taxes	(27.7)		(18.0)
Net cash from operating activities	Net cash from operating activities	334.5		479.0		Net cash from operating activities	223.4		167.0
Cash flows from investing activities:	Cash flows from investing activities:					Cash flows from investing activities:
Sales of investments	Sales of investments	2,764.9		1,419.7		Sales of investments	747.3		2,226.1
Maturities and redemptions of investments	Maturities and redemptions of investments	1,265.1		2,237.8		Maturities and redemptions of investments	660.3		923.4
Purchases of investments	Purchases of investments	(5,521.1)		(4,363.8)		Purchases of investments	(1,906.1)		(4,353.1)
Net purchases of trading securities	Net purchases of trading securities	(37.4)		(21.1)		Net purchases of trading securities	(30.8)		(1.9)
Other	Other	(39.4)		(68.0)		Other	(22.6)		(24.8)
Net cash used by investing activities	Net cash used by investing activities	(1,567.9)		(795.4)		Net cash used by investing activities	(551.9)		(1,230.3)
Cash flows from financing activities:	Cash flows from financing activities:					Cash flows from financing activities:

Issuance of common stock	Issuance of common stock	6.6		18.6		Issuance of common stock	8.6		4.7
Payments to repurchase common stock	Payments to repurchase common stock	(180.2)		(307.8)		Payments to repurchase common stock	(55.6)		(170.1)
Common stock dividends paid	Common stock dividends paid	(48.7)		(49.9)		Common stock dividends paid	(34.5)		(32.6)
Proceeds from financing arrangements						Proceeds from financing arrangements	43.0		—
Amounts received for deposit products	Amounts received for deposit products	2,457.8		1,379.3		Amounts received for deposit products	1,035.7		1,958.7
Withdrawals from deposit products	Withdrawals from deposit products	(1,071.0)		(999.3)		Withdrawals from deposit products	(847.6)		(711.6)
Issuance of investment borrowings:	Issuance of investment borrowings:					Issuance of investment borrowings:
Federal Home Loan Bank	Federal Home Loan Bank	210.0		720.8		Federal Home Loan Bank	645.5		210.0

Payments on investment borrowings:	Payments on investment borrowings:					Payments on investment borrowings:
Federal Home Loan Bank	Federal Home Loan Bank	(285.9)		(622.1)		Federal Home Loan Bank	(445.5)		(285.6)
Related to variable interest entities	Related to variable interest entities	(33.4)		(1.6)		Related to variable interest entities	(104.1)		(22.5)
Debt issuance costs		—		(.9)

Net cash provided by financing activities	Net cash provided by financing activities	1,055.2		137.1		Net cash provided by financing activities	245.5		951.0
Net decrease in cash and cash equivalents	Net decrease in cash and cash equivalents	(178.2)		(179.3)		Net decrease in cash and cash equivalents	(83.0)		(112.3)
Cash and cash equivalents - unrestricted and held by variable interest entities, beginning of period	Cash and cash equivalents - unrestricted and held by variable interest entities, beginning of period	731.7		991.9		Cash and cash equivalents - unrestricted and held by variable interest entities, beginning of period	644.9		731.7
Cash and cash equivalents - unrestricted and held by variable interest entities, end of period	Cash and cash equivalents - unrestricted and held by variable interest entities, end of period	$	553.5	$	812.6	Cash and cash equivalents - unrestricted and held by variable interest entities, end of period	$	561.9	$	619.4

The accompanying notes are an integral part

of the consolidated financial statements.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

BUSINESS AND BASIS OF PRESENTATION

~~The following notes should be read together with the notes to the consolidated financial statements included in our 2021 Annual Report on Form 10-K.~~

CNO Financial Group, Inc., a Delaware corporation ("CNO"), is a holding company for a group of insurance companies operating throughout the United States that develop, market and administer health insurance, annuity, individual life insurance and other insurance products. The terms "CNO Financial Group, Inc.", "CNO", the "Company", "we", "us", and "our" as used in these financial statements refer to CNO and its subsidiaries. Such terms, when used to describe insurance business and products, refer to the insurance business and products of CNO's insurance subsidiaries.

We focus on serving middle-income pre-retiree and retired Americans, which we believe are attractive, underserved, high growth markets. We sell our products through exclusive agents, independent producers (some of whom sell one or more of our product lines exclusively) and direct marketing.

Our unaudited consolidated financial statements reflect normal recurring adjustments that, in the opinion of management, are necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. As permitted by rules and regulations of the Securities and Exchange Commission (the "SEC") applicable to quarterly reports on Form 10-Q, we have condensed or omitted certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). ~~We have reclassified certain amounts from the prior periods to conform to the 2022 presentation. These reclassifications have no effect on net income or shareholders' equity.~~ Results for interim periods are not necessarily indicative of the results that may be expected for a full year.

Effective January 1, 2023, we adopted Accounting Standards Update 2018-12 ("ASU 2018-12") related to targeted improvements to the accounting for long-duration insurance contracts, with a transition date of January 1, 2021 (the "Transition Date"). The adoption of ASU 2018-12 impacted accounting and presentation related to long-duration insurance contracts and certain related balances for the years ended December 31, 2022 and 2021. Amounts within these interim financial statements, which were previously presented, have been recast to conform with the current accounting and presentation under ASU 2018-12. Disclosures of the impacts of ASU 2018-12 as of the Transition Date are included within the tables in the note to the consolidated financial statements entitled "Recently Adopted Accounting Standards."

Except for balances affected by the adoption of ASU 2018-12, the December 31, 2022 consolidated balance sheet ~~at December 31, 2021, presented herein, has been~~data was derived from the audited consolidated financial statements ~~at that date but does not include all of~~included in our 2022 Annual Report on Form 10-K. Accordingly, these interim consolidated financial statements should be read together with the ~~information and footnotes required by GAAP for complete~~consolidated financial ~~statements.~~statements included in our 2022 Annual Report on Form 10-K.

When we prepare financial statements in conformity with GAAP, we are required to make estimates and assumptions that significantly affect reported amounts of various assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting periods. For example, we use significant estimates and assumptions to calculate values for deferred acquisition costs, the present value of future profits, fair value measurements of certain investments (including derivatives), allowance for credit losses and other-than-temporary impairments of investments, assets and liabilities related to income taxes, liabilities for insurance products, liabilities related to litigation and guaranty fund assessment accruals. If our future experience differs from these estimates and assumptions, our financial statements could be materially affected.

The accompanying financial statements are unaudited and include the accounts of the Company and its subsidiaries. Our consolidated financial statements exclude transactions between us and our consolidated affiliates, or among our consolidated affiliates.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The following summarizes the significant accounting policies that have been added or updated as a result of the adoption of ASU 2018-12:

Deferred acquisition costs, present value of future profits and sales inducements

Deferred acquisition costs represent policy acquisition costs that have been capitalized and are subject to amortization. Capitalized costs are incremental costs directly related to the successful acquisition of new or renewal insurance contracts.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

Such costs consist primarily of commissions, underwriting, sales and contract issuance and processing expenses. Contracts are grouped by contract type and issue year into cohorts consistent with the grouping used in estimating the associated liability. Deferred acquisition costs are amortized on a constant level basis for the grouped contracts over the expected term of the related contracts to approximate straight-line amortization. For life and health insurance products, the constant level basis used is policy counts. For all annuity products, the constant level basis used is the initial deposit in force. The constant level bases used for amortization are projected using mortality and lapse assumptions that are based on our experience, industry data, and other factors and are consistent with those used for the liability for future policy benefits. If those projected assumptions change in future periods, they will be reflected in the cohort level amortization basis at the time. Unexpected lapses, due to higher mortality and lapse experience than expected, are recognized in the current period as a reduction of the capitalized balances. Changes in future estimates are recognized prospectively over the remaining expected contract term. The carrying amount of deferred acquisition costs is not subject to recovery testing upon the adoption of ASU 2018-12.

The present value of future profits is the value assigned to the right to receive future cash flows from policyholder insurance contracts existing at September 10, 2003 (the effective date of the bankruptcy reorganization of Conseco, Inc. (the "Predecessor")). The present value of future profits is amortized in the same manner as described above for deferred acquisition costs, although such balances are subject to periodic recovery testing.

Certain of our annuity products offer sales inducements to contract holders in the form of enhanced crediting rates or bonus payments in the initial period of the contract. Certain of our life insurance products offer persistency bonuses credited to the contract holder's balance after the policy has been outstanding for a specified period of time. These enhanced rates and persistency bonuses are considered sales inducements in accordance with GAAP. Such amounts are deferred and amortized in the same manner as deferred acquisition costs (and are classified as deferred acquisition costs in the consolidated balance sheet). Unlike deferred acquisition costs, such amounts are considered contractual cash flows and, as a result, are subject to periodic recovery testing.

Market risk benefits

Market risk benefits ("MRBs") are contracts or contract features that both provide protection to the contract holder from other-than-nominal capital market risk and expose the Company to other-than-nominal capital market risk. Many of our fixed indexed annuity products include a guaranteed living withdrawal benefit ("GLWB") that is considered a MRB. MRBs are measured at fair value using an option-based valuation model based on amount of exposure, market data, Company experience and other factors. Changes in fair value are recognized in earnings each period with the exception of the portion of the change in fair value due to a change in the instrument-specific credit risk, which is recognized in accumulated other comprehensive income (loss). MRBs in an asset position are presented separately from those in a liability position as there is no legal right of offset between contracts.

Policyholder account balances

Policyholder account balances represent the contract value that has accrued to the benefit of the policyholder as of the balance sheet date. It includes the accumulated account deposits, plus interest credited, less policyholder withdrawals and, if applicable, charges assessed. This balance also includes liabilities for the funding agreement-backed notes ("FABN").

Liability for future policy benefits

The liability for future policy benefits is the present value of estimated future policy benefits to be paid to or on behalf of policyholders and certain related expenses (where the timing and amount of payment depends on policyholder mortality or morbidity), less the present value of estimated future net premiums to be collected from policyholders (where net premiums are gross premiums multiplied by the net-to-gross ratio discussed below). The liability for future policy benefits is accrued over time as premium revenue is recognized. The liability is estimated using current assumptions that include discount rates, mortality, morbidity, lapse/withdrawal rates and expenses. Such assumptions are based on our historical experience, industry data, and other factors that are inherently uncertain.

This liability also includes the amount of total reserves above (below) policyholder account balances for our fixed indexed annuity products due to the valuation of the related embedded derivative.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The liability for future policy benefits is established using a net premium ratio approach where net premiums (the portion of gross premiums required to fund expected insurance benefits and claims settlement expenses) under the contract are accrued each period as the liability for future policy benefits. The net premium ratio used to accrue the liability for future policy benefits in each period is determined by using the historical and present value of expected future benefits and claim adjustment expenses for the cohort divided by the historical and present value of expected future gross premiums for the cohort.

Our long duration insurance contracts are grouped into annual calendar-year cohorts primarily based on the contractual issue date, marketing distribution channel, legal entity and product type. Single premium contracts are grouped into separate cohorts from other traditional products. Riders are generally combined with the base policy. Insurance contracts which were issued prior to September 10, 2003 (the effective date of the bankruptcy reorganization of our Predecessor) are grouped by marketing distribution channel, legal entity and product type in a single issue year cohort. The liability is adjusted for differences between actual and expected experience. We review our historical and future cash flow assumptions quarterly and update the net premium ratio used to calculate the liability each time the assumptions are changed. Each quarter, we update our estimates of cash flows expected over the entire life of a group of contracts using actual historical experience and current future cash flow assumptions. These updated cash flows are used to calculate the revised net premiums and net premium ratio, which are used to derive an updated liability for future policy benefits as of the beginning of the current reporting period, discounted at the original contract issuance discount rate. This amount is then compared to the carrying amount of the liability as of that same date, before the updating of cash flow assumptions, to determine the current period change in liability estimate. This current period change in the liability is the liability remeasurement gain or loss and is presented as a separate component of benefit expense in the consolidated statement of operations. In subsequent periods, the revised net premiums are used to measure the liability for future policy benefits, subject to future revisions.

If a cohort is in a loss position where the liability for future policy benefits plus the present value of expected future gross premiums is determined to be insufficient to provide for expected future policy benefits and claim settlement costs, the net to gross ratio is capped at 100 percent. When this occurs, all changes in expected benefits resulting from both actual experience deviations and changes in future assumptions are recognized immediately.

The locked-in discount rate is generally based on expected investment returns at contract inception for contracts issued prior to January 1, 2021 and the upper medium grade fixed income corporate instrument yield ("A" credit rated corporate bond yield) at contract inception for contracts issued after January 1, 2021. The contract inception date for contracts issued by the Predecessor is September 10, 2003. The discount rate in effect at contract inception is locked-in for the calculation of the net to gross ratio and accretion of interest cost on the liability is recorded through net income. However, for balance sheet remeasurement purposes, the discount rate is updated using the current rate at each reporting period with the impact resulting from such updates recorded in other comprehensive income.

We develop discount rate curves for discounting cash flows to calculate the liability for future policy benefits based on the duration characteristics of the underlying liabilities. For liability cash flows that are projected beyond the duration of market-observable A-credit-rated fixed-income instruments, we use the last market-observable yield level and use linear interpolation to determine yield assumptions for durations that do not have market-observable yields.

Liability for life insurance policy claims

The liability for life insurance policy claims include life policy and contract claims, including incurred but not reported claims. The liability for these claims is based on our estimated ultimate cost to settle all claims that have been incurred as of the reporting date. Such amounts are estimated based on an analysis of historical patterns of claims, which are continually reviewed and updated. Adjustments resulting from differences between our estimates and actual payments are recognized in the period the estimates are made or claims are paid.

Deferred profit liability

For limited-payment products, gross premiums received in excess of net premiums are deferred at initial recognition as a deferred profit liability ("DPL"). Gross premiums are measured using assumptions consistent with those used in the measurement of the liability for future policy benefits, including discount rate, mortality, lapses and expenses.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The DPL is amortized and recognized in insurance policy benefits in proportion to insurance in force for life insurance contracts and expected future benefit payments for annuity contracts. Interest is accreted on the balance of the DPL using the discount rate determined at contract issuance. We review and update the estimate of cash flows for the DPL at the same time as the estimate of cash flows for the liability for future policy benefits. When cash flows are updated, the updated estimates are used to recalculate the DPL at contract issuance. The recalculated DPL as of the beginning of the current reporting period is compared to the carrying amount of the DPL as of the beginning of the current reporting period and any difference is recognized as either a charge or credit to insurance policy benefits.

Reinsurance

We have determined that each of our reinsurance agreements provide indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. Such reinsurance permits recovery of the reinsured losses from reinsurers, although it does not discharge our primary liability as the direct insurer of the risks reinsured.

The reinsurance recoverable for traditional and limited-payment contracts is generally measured using a net premium ratio approach to accrue the projected net gain or loss on reinsurance in proportion to the gross premiums of the underlying reinsured cohorts. Such amount is adjusted on a quarterly basis for actual experience and at least once a year for any changes in cash flow assumptions.

RECENTLY ADOPTED ACCOUNTING STANDARDS

We adopted ASU 2018-12 effective January 1, 2023. The new guidance: (i) improves the timeliness of recognizing changes in the liability for future benefits and modifies the rate used to discount future cash flows; (ii) simplifies and improves the accounting for certain market-based options or guarantees associated with deposit (or account balance) contracts; (iii) simplifies the amortization of deferred acquisition costs; and (iv) requires enhanced disclosures, including disaggregated rollforwards of the liability for future policy benefits, policyholder account liabilities, MRBs and deferred acquisition costs. Additionally, qualitative and quantitative information about expected cash flows, estimates and assumptions is required. The new measurement guidance for traditional and limited-payment contract liabilities and the new guidance for the amortization of deferred acquisition costs was adopted on a modified retrospective transition approach. For contracts in-force at the Transition Date, we continue to use the existing locked-in investment yield interest rate assumption to calculate the net premium ratio, rather than the upper-medium grade fixed-income corporate instrument yield. However, for balance sheet remeasurement purposes, the current upper-medium grade fixed-income corporate instrument yield is used at transition through accumulated other comprehensive income (loss) and subsequently through other comprehensive income. For MRBs, we use the required retrospective application and were able to use hindsight to measure fair value components to the extent assumptions in a prior period are unobservable or otherwise unavailable.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

We selected the modified retrospective transition method, except for MRBs where we are required to use the full retrospective approach. Pursuant to ASU 2018-12, the account balances subject to the guidance were recast on the Transition Date. The following summarizes the impact of adoption on the Transition Date (dollars in millions):


	January 1, 2021
	Amounts prior
	to adoption of		Effect of
	ASU 2018-12		adoption			As recast
Present value of future profits	$	249.4	$	10.2		$	259.6
Deferred acquisition costs	1,027.8		458.0			1,485.8
Reinsurance receivables	4,584.3		144.1			4,728.4
Market risk benefit asset	—		2.5			2.5
Income tax assets, net	199.4		607.0			806.4
Total assets	35,339.9		1,221.8			36,561.7

Policyholder account balances	12,540.6		(172.9)			12,367.7
Future policy benefits	11,744.2		3,960.7			15,704.9
Market risk benefit liability	—		114.8			114.8
Liability for policy and contract claims	561.8		(470.1)			91.7
Total liabilities	29,855.7		3,432.5			33,288.2

Retained earnings	752.3		(130.9)		(a)	621.4
Accumulated other comprehensive income	2,186.1		(2,079.8)			106.3
Total shareholders' equity	5,484.2		(2,210.7)			3,273.5

_____________________

(a) The impact to retained earnings was primarily related to certain long-term care product cohorts where the present value of expected benefits exceeded the reserve at the Transition Date plus the present value of future gross premiums. As a result, the net premium ratio was capped at 100 percent with an immediate increase in the reserve for such cohorts.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following summarizes the impact of adoption on previously reported balances as of December 31, 2022 and as of and for the three and six months ended June 30, 2022 (dollars in millions, except per share data):


	December 31, 2022
	As previously		Effect of
	reported		adoption		As recast
Present value of future profits	$	212.2	$	(8.5)	$	203.7
Deferred acquisition costs	1,913.4		(142.5)		1,770.9
Reinsurance receivables	4,241.7		(18.3)		4,223.4
Market risk benefit asset	—		65.3		65.3
Income tax assets, net	1,165.5		(102.1)		1,063.4
Total assets	33,339.2		(206.1)		33,133.1

Policyholder account balances	14,858.3		375.9		15,234.2
Future policy benefits	11,809.1		(568.9)		11,240.2
Market risk benefit liability	—		11.3		11.3
Liability for policy and contract claims	456.5		(392.4)		64.1
Total liabilities	31,938.4		(574.1)		31,364.3

Retained earnings	1,459.0		232.2		1,691.2
Accumulated other comprehensive income (loss)	(2,093.1)		135.8		(1,957.3)
Total shareholders' equity	1,400.8		368.0		1,768.8


	Three months ended
	June 30, 2022
	As previously		Effect of
	reported		adoption		As recast
Insurance policy benefits	$	340.2	$	(38.0)	$	302.2
Liability for future policy benefits remeasurement loss	—		0.3		0.3
Change in fair value of market risk benefits	—		(50.3)		(50.3)
Amortization	88.1		(35.4)		52.7
Other operating costs and expenses	223.5		(1.0)		222.5
Total benefits and expenses	679.6		(124.4)		555.2
Income before income taxes	175.4		124.4		299.8
Income tax expense	39.3		27.2		66.5
Net income	136.1		97.2		233.3
Earnings per common share - basic	$	1.18	$	0.84	$	2.02
Earnings per common share - diluted	1.16		0.83		1.99

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________


	Six months ended
	June 30, 2022
	As previously		Effect of
	reported		adoption		As recast
Insurance policy benefits	$	686.9	$	(50.8)	$	636.1
Liability for future policy benefits remeasurement loss	—		7.3		7.3
Change in fair value of market risk benefits	—		(83.0)		(83.0)
Amortization	192.0		(87.0)		105.0
Other operating costs and expenses	442.7		(1.9)		440.8
Total benefits and expenses	1,373.2		(215.4)		1,157.8
Income before income taxes	324.7		215.4		540.1
Income tax expense	76.3		47.1		123.4
Net income	248.4		168.3		416.7
Earnings per common share - basic	$	2.12	$	1.44	$	3.56
Earnings per common share - diluted	2.08		1.42		3.50


	As of June 30, 2022
	As previously		Effect of
	reported		adoption		As recast
Retained earnings	$	1,343.2	$	166.7	1,509.9
Accumulated other comprehensive loss	(1,165.0)		(250.8)		(1,415.8)
Total shareholders' equity	2,212.0		(84.1)		2,127.9

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following tables detail the January 1, 2021 transition adjustments by providing a rollforward of the ending reported balances as of December 31, 2020 to the opening balances as of January 1, 2021 for insurance-related balances, accumulated other comprehensive income and retained earnings (dollars in millions):


	January 1, 2021
	Asset accounts
	Present value of future profits		Deferred acquisition costs		Reinsurance receivables		Market risk benefit asset		Income tax assets, net
Amounts prior to adoption of ASU 2018-12	$	249.4	$	1,027.8	$	4,584.3	$	—	$	199.4
Unwinding amounts related to unrealized gains (losses)	10.2		458.0		—		—		—
Changes in measurement of assets	—		—		(81.6)		—		—
Change in discount rates	—		—		225.7		—		—
Changes in market benefit reserve basis	—		—		—		2.5		—
Tax impacts of changes recognized in accumulated other comprehensive income	—		—		—		—		570.3
Tax impacts of changes recognized in retained earnings	—		—		—		—		36.7
Amounts, as recast	$	259.6	$	1,485.8	$	4,728.4	$	2.5	$	806.4


	January 1, 2021
	Liability accounts
	Policyholder account balances		Future policy benefits		Market risk benefit liability		Liability for policy and contract claims
Amounts prior to adoption of ASU 2018-12	$	12,540.6	$	11,744.2	$	—	$	561.8
Unwinding amounts related to unrealized gains (losses)	—		(197.5)		—		—
Changes in remeasurement of future policy benefits	—		31.1		—		—
Changes in classification of liabilities (1)	(172.9)		643.0		—		(470.1)
Reclass to market risk benefit liability	—		(66.6)		66.6		—
Changes in market risk benefit reserve basis	—		—		48.2		—
Change in discount rates	—		3,550.7		—		—
Amounts, as recast	$	12,367.7	$	15,704.9	$	114.8	$	91.7

_____________________

(1) Amount includes certain reclassifications to conform with the revised presentation of ASU 2018-12, such as reclassifying claims and benefits payable on long-duration health contracts to the liability for future policy benefits.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________


	January 1, 2021
	Shareholders' equity accounts
	Accumulated other comprehensive income		Retained earnings
Amounts prior to adoption of ASU 2018-12	$	2,186.1	$	752.3
Unwinding amounts related to unrealized gains (losses)	665.7		—
Changes in measurement of assets and liabilities	—		(112.7)
Change in market risk benefit reserve basis	9.2		(54.9)
Tax impacts of changes recognized in retained earnings	—		36.7
Change in discount rates	(3,325.0)		—
Tax impacts of changes recognized in accumulated other comprehensive income	570.3		—
Amounts, as recast	$	106.3	$	621.4

INVESTMENTS

We classify our fixed maturity securities into one of two categories: (i) "available for sale" (which we carry at estimated fair value with any unrealized gain or loss, net of tax and related adjustments, recorded as a component of shareholders' equity); or (ii) "trading" (which we carry at estimated fair value with changes in such value recognized as either net investment income (classified as investment income from policyholder and other special-purpose portfolios) or investment gains (losses)).

Trading securities include: (i) investments purchased with the intent of selling in the near term to generate income; and (ii) certain fixed maturity securities containing embedded derivatives for which we have elected the fair value option. The change in fair value of the income generating investments is recognized in income from policyholder and other special-purpose portfolios (a component of net investment income). The change in fair value of securities with embedded derivatives is recognized in other investment gains (losses).

We review our available for sale fixed maturity securities with unrealized losses to determine whether such impairments are the result of credit losses. We analyze various factors to make such determinations including, but not limited to: (i) actions

~~Table of Contents~~

~~CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES~~

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~

~~___________________~~

taken by rating agencies; (ii) default by the issuer; (iii) the significance of the decline; (iv) an assessment of our intent to sell the security before recovering the security's amortized cost; (v) an economic analysis of the issuer's industry; and (vi) the financial strength, liquidity, and recoverability of the issuer. We perform a security by security review each quarter to evaluate whether a credit loss has occurred.

In determining the credit loss component, we discount the estimated cash flows on a security by security basis. We consider the impact of macroeconomic conditions on inputs used to measure the amount of credit loss. For most structured securities, cash flow estimates are based on bond-specific facts and circumstances that may include collateral characteristics, expectations of delinquency and default rates, loss severity, prepayment speeds and structural support, including overcollateralization, excess spread, subordination and guarantees. For corporate bonds, cash flow estimates are derived by considering asset type, rating, time to maturity, and applying an expected loss rate.

If a portion of the decline is due to credit-related factors, we separate the credit loss component of the impairment from the amount related to all other factors. The credit loss component is recorded as an allowance and reported in other investment gains (losses) (limited to the difference between estimated fair value and amortized cost). The impairment related to all other factors (non-credit factors) is reported in accumulated other comprehensive income (loss) along with unrealized gains (losses) related to fixed maturity investments, available for sale, net of tax and related adjustments. The allowance is adjusted for any additional credit losses and subsequent recoveries. When recognizing an allowance associated with a credit loss, the cost basis is not adjusted. When we determine a security is uncollectable, the remaining amortized cost will be written off.

If we intend to sell an impaired fixed maturity security, available for sale, or identify an impaired fixed maturity security, available for sale, for which it is more likely than not we will be required to sell before anticipated recovery, the

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

difference between the fair value and the amortized cost is included in other investment gains (losses) and the fair value becomes the new amortized cost. The new cost basis is not adjusted for any subsequent recoveries in fair value.

The Company reports accrued investment income separately from fixed maturities, available for sale, and has elected not to measure an allowance for credit losses for accrued investment income. Accrued investment income is written off through net investment income at the time the issuer of the bond defaults or is expected to default on payments.

Accumulated other comprehensive income (loss) ~~is primarily comprised of the net effect of unrealized appreciation (depreciation) on our investments. These amounts,~~, included in shareholders' equity as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, is comprised of the following (dollars in millions):


	June 30, 2023		December 31, 2022
Net unrealized losses on investments having no allowance for credit losses	$	(1,048.5)	$	(1,247.0)
Unrealized losses on investments with an allowance for credit losses	(1,585.8)		(1,780.7)
Change in discount rates for liability for future policy benefits	394.6		500.7
Change in instrument-specific credit risk for market risk benefits	10.8		12.2
Deferred income tax assets	495.4		557.5
Accumulated other comprehensive loss	$	(1,733.5)	$	(1,957.3)

At June 30, 2023, the amortized cost, gross unrealized gains, gross unrealized losses, allowance for credit losses and estimated fair value of fixed maturities, available for sale, were as follows (dollars in millions):

September 30,
2022 December 31,
2021
Net unrealized gains (losses) on investments having no allowance for credit losses $ (1,222.1) $ 2,963.3
Unrealized losses on investments with an allowance for credit losses (1,929.9) (23.1)
Adjustment to present value of future profits (a) 8.7 (8.3)
Adjustment to deferred acquisition costs 367.1 (420.2)
Adjustment to insurance liabilities — (25.5)
Deferred income tax assets (liabilities) 610.5 (539.1)
Accumulated other comprehensive income (loss) $ (2,165.7) $ 1,947.1

~~________~~


	Amortized cost		Gross unrealized gains		Gross unrealized losses		Allowance for credit losses		Estimated fair value
Corporate securities	$	13,436.3	$	37.5	$	(1,670.1)	$	(64.4)	$	11,739.3
United States Treasury securities and obligations of United States government corporations and agencies	174.2		—		(10.1)		—		164.1
States and political subdivisions	2,815.2		27.6		(388.2)		(1.0)		2,453.6
Foreign governments	93.9		.6		(10.2)		(.5)		83.8
Asset-backed securities	1,485.5		1.0		(136.8)		(.2)		1,349.5
Agency residential mortgage-backed securities	351.4		.4		(3.0)		—		348.8
Non-agency residential mortgage-backed securities	1,758.1		37.8		(178.3)		—		1,617.6
Collateralized loan obligations	961.1		.9		(28.1)		—		933.9
Commercial mortgage-backed securities	2,554.8		.3		(286.0)		—		2,269.1
Total fixed maturities, available for sale	$	23,630.5	$	106.1	$	(2,710.8)	$	(66.1)	$	20,959.7

~~(a)~~The present value of future profits is the value assigned to the right to receive future cash flows from contracts existing at September 10, 2003, the date Conseco, Inc., an Indiana corporation, emerged from bankruptcy.

At December 31, 2021, adjustments to the present value of future profits, deferred acquisition costs, insurance liabilities and deferred tax assets included $(7.3) million, $(132.2) million, $(25.5) million and $35.8 million, respectively, for premium deficiencies that would exist on certain blocks of business if unrealized gains on the assets backing such products had been realized and the proceeds from the sales of such assets were invested at then current yields. There were no such adjustments at September 30, 2022.

1119

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

At ~~September 30,~~December 31, 2022, the amortized cost, gross unrealized gains, gross unrealized losses, allowance for credit losses and estimated fair value of fixed maturities, available for sale, were as follows (dollars in millions):


		Amortized cost		Gross unrealized gains		Gross unrealized losses		Allowance for credit losses		Estimated fair value			Amortized cost		Gross unrealized gains		Gross unrealized losses		Allowance for credit losses		Estimated fair value
Corporate securities	Corporate securities	$	13,942.2	$	22.2	$	(2,136.6)	$	(49.2)	$	11,778.6	Corporate securities	$	13,649.1	$	29.9	$	(1,911.9)	$	(54.4)	$	11,712.7
United States Treasury securities and obligations of United States government corporations and agencies	United States Treasury securities and obligations of United States government corporations and agencies	169.5		—		(11.7)		—		157.8		United States Treasury securities and obligations of United States government corporations and agencies	171.7		—		(13.0)		—		158.7
States and political subdivisions	States and political subdivisions	2,818.8		20.9		(437.8)		(1.7)		2,400.2		States and political subdivisions	2,846.9		19.3		(476.8)		(.9)		2,388.5
Foreign governments	Foreign governments	84.5		—		(14.4)		(.8)		69.3		Foreign governments	86.3		.1		(11.3)		(.4)		74.7
Asset-backed securities	Asset-backed securities	1,402.0		.2		(131.8)		(.3)		1,270.1		Asset-backed securities	1,435.7		1.0		(149.4)		(.3)		1,287.0
Agency residential mortgage-backed securities	Agency residential mortgage-backed securities	39.0		—		(.5)		—		38.5		Agency residential mortgage-backed securities	174.3		1.4		(.7)		—		175.0
Non-agency residential mortgage-backed securities	Non-agency residential mortgage-backed securities	1,755.5		50.7		(167.3)		—		1,638.9		Non-agency residential mortgage-backed securities	1,700.4		40.0		(191.9)		—		1,548.5
Collateralized loan obligations	Collateralized loan obligations	778.3		—		(45.1)		—		733.2		Collateralized loan obligations	825.2		.3		(39.6)		—		785.9
Commercial mortgage-backed securities	Commercial mortgage-backed securities	2,452.7		—		(238.2)		—		2,214.5		Commercial mortgage-backed securities	2,494.6		.1		(272.3)		—		2,222.4
Total fixed maturities, available for sale	Total fixed maturities, available for sale	$	23,442.5	$	94.0	$	(3,183.4)	$	(52.0)	$	20,301.1	Total fixed maturities, available for sale	$	23,384.2	$	92.1	$	(3,066.9)	$	(56.0)	$	20,353.4

At December 31, 2021, the amortized cost, gross unrealized gains, gross unrealized losses, allowance for credit losses and estimated fair value of fixed maturities, available for sale, were as follows (dollars in millions):

Amortized cost Gross unrealized gains Gross unrealized losses Allowance for credit losses Estimated fair value
Corporate securities $ 13,195.4 $ 2,284.5 $ (21.7) $ (7.4) $ 15,450.8
United States Treasury securities and obligations of United States government corporations and agencies 166.2 54.3 (.9) — 219.6
States and political subdivisions 2,649.0 356.7 (1.5) — 3,004.2
Foreign governments 85.4 13.6 (.3) (.2) 98.5
Asset-backed securities 1,129.0 37.0 (3.1) — 1,162.9
Agency residential mortgage-backed securities 36.7 3.7 — — 40.4
Non-agency residential mortgage-backed securities 1,870.4 156.5 (3.1) — 2,023.8
Collateralized loan obligations 587.3 2.3 (1.3) — 588.3
Commercial mortgage-backed securities 2,148.2 77.9 (9.2) — 2,216.9
Total fixed maturities, available for sale $ 21,867.6 $ 2,986.5 $ (41.1) $ (7.6) $ 24,805.4

~~Table of Contents~~

~~CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES~~

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~

~~___________________~~

The following table sets forth the amortized cost and estimated fair value of fixed maturities, available for sale, at ~~September~~June 30, ~~2022,~~2023, by contractual maturity. Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties. Structured securities (such as asset-backed securities, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, collateralized loan obligations and commercial mortgage-backed securities, collectively referred to as "structured securities") frequently include provisions for periodic principal payments and permit periodic unscheduled payments.


		Amortized cost		Estimated fair value			Amortized cost		Estimated fair value
		(Dollars in millions)					(Dollars in millions)
Due in one year or less	Due in one year or less	$	123.4	$	122.6	Due in one year or less	$	132.7	$	130.7
Due after one year through five years	Due after one year through five years	1,935.7		1,805.1		Due after one year through five years	2,260.6		2,113.0
Due after five years through ten years	Due after five years through ten years	2,125.3		1,894.4		Due after five years through ten years	1,793.8		1,643.8
Due after ten years	Due after ten years	12,830.6		10,583.8		Due after ten years	12,332.5		10,553.3
Subtotal	Subtotal	17,015.0		14,405.9		Subtotal	16,519.6		14,440.8
Structured securities	Structured securities	6,427.5		5,895.2		Structured securities	7,110.9		6,518.9
Total fixed maturities, available for sale	Total fixed maturities, available for sale	$	23,442.5	$	20,301.1	Total fixed maturities, available for sale	$	23,630.5	$	20,959.7

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table sets forth the amortized cost and estimated fair value of fixed maturities, available for sale, at December 31, ~~2021,~~2022, by contractual maturity.


		Amortized cost		Estimated fair value			Amortized cost		Estimated fair value
		(Dollars in millions)					(Dollars in millions)
Due in one year or less	Due in one year or less	$	80.3	$	80.5	Due in one year or less	$	112.0	$	110.8
Due after one year through five years	Due after one year through five years	1,147.4		1,205.6		Due after one year through five years	1,913.7		1,790.2
Due after five years through ten years	Due after five years through ten years	1,458.4		1,573.7		Due after five years through ten years	2,098.9		1,910.4
Due after ten years	Due after ten years	13,409.9		15,913.3		Due after ten years	12,629.4		10,523.2
Subtotal	Subtotal	16,096.0		18,773.1		Subtotal	16,754.0		14,334.6
Structured securities	Structured securities	5,771.6		6,032.3		Structured securities	6,630.2		6,018.8
Total fixed maturities, available for sale	Total fixed maturities, available for sale	$	21,867.6	$	24,805.4	Total fixed maturities, available for sale	$	23,384.2	$	20,353.4

Gross Unrealized Investment Losses

Our investment strategy is to maximize, over a sustained period and within acceptable parameters of quality and risk, investment income and total investment return through active strategic asset allocation and investment management. Accordingly, we may sell securities at a gain or a loss to enhance the projected total return of the portfolio as market opportunities change, to reflect changing perceptions of risk, or to better match certain characteristics of our investment portfolio with the corresponding characteristics of our insurance liabilities.

The following table summarizes the gross unrealized losses and fair values of our investments with unrealized losses for which an allowance for credit losses has not been recorded, aggregated by investment category and length of time that such securities have been in a continuous unrealized loss position, at June 30, 2023 (dollars in millions):


	Less than 12 months				12 months or greater				Total
Description of securities	Fair value		Unrealized losses		Fair value		Unrealized losses		Fair value		Unrealized losses
Corporate securities	$	710.1	$	(29.4)	$	2,146.4	$	(358.3)	$	2,856.5	$	(387.7)
United States Treasury securities and obligations of United States government corporations and agencies	130.7		(6.3)		33.4		(3.9)		164.1		(10.2)
States and political subdivisions	193.5		(5.8)		437.6		(106.4)		631.1		(112.2)
Foreign governments	16.3		(.5)		12.7		(1.1)		29.0		(1.6)
Asset-backed securities	339.2		(11.3)		886.5		(121.9)		1,225.7		(133.2)
Agency residential mortgage-backed securities	271.4		(3.0)		.5		—		271.9		(3.0)
Non-agency residential mortgage-backed securities	418.5		(14.3)		870.7		(164.0)		1,289.2		(178.3)
Collateralized loan obligations	141.8		(.9)		640.3		(27.2)		782.1		(28.1)
Commercial mortgage-backed securities	315.4		(10.2)		1,882.8		(275.8)		2,198.2		(286.0)
Total fixed maturities, available for sale	$	2,536.9	$	(81.7)	$	6,910.9	$	(1,058.6)	$	9,447.8	$	(1,140.3)

1321

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

Less than 12 months 12 months or greater Total
Description of securities Fair
value Unrealized
losses Fair
value Unrealized
losses Fair
value Unrealized
losses
Corporate securities $ 3,134.3 $ (495.7) $ 31.4 $ (11.4) $ 3,165.7 $ (507.1)
United States Treasury securities and obligations of United States government corporations and agencies 134.8 (8.0) 21.7 (3.6) 156.5 (11.6)
States and political subdivisions 827.3 (176.7) 4.2 (1.8) 831.5 (178.5)
Foreign governments 10.8 (.4) — — 10.8 (.4)
Asset-backed securities 1,122.5 (115.4) 82.5 (11.6) 1,205.0 (127.0)
Agency residential mortgage-backed securities 33.1 (.5) — — 33.1 (.5)
Non-agency residential mortgage-backed securities 1,053.8 (140.0) 93.4 (27.4) 1,147.2 (167.4)
Collateralized loan obligations 595.6 (36.6) 120.4 (8.5) 716.0 (45.1)
Commercial mortgage-backed securities 1,812.6 (181.4) 394.0 (56.7) 2,206.6 (238.1)
Total fixed maturities, available for sale $ 8,724.8 $ (1,154.7) $ 747.6 $ (121.0) $ 9,472.4 $ (1,275.7)


		Less than 12 months				12 months or greater				Total					Less than 12 months				12 months or greater				Total
Description of securities	Description of securities	Fair value		Unrealized losses		Fair value		Unrealized losses		Fair value		Unrealized losses		Description of securities	Fair value		Unrealized losses		Fair value		Unrealized losses		Fair value		Unrealized losses
Corporate securities	Corporate securities	$	87.8	$	(.4)	$	9.2	$	(.1)	$	97.0	$	(.5)	Corporate securities	$	2,830.8	$	(329.4)	$	370.4	$	(129.3)	$	3,201.2	$	(458.7)
United States Treasury securities and obligations of United States government corporations and agencies	United States Treasury securities and obligations of United States government corporations and agencies	5.7		—		18.7		(.9)		24.4		(.9)		United States Treasury securities and obligations of United States government corporations and agencies	134.4		(9.6)		21.9		(3.4)		156.3		(13.0)
States and political subdivisions	States and political subdivisions	47.3		(.4)		—		—		47.3		(.4)		States and political subdivisions	667.0		(124.8)		132.1		(58.5)		799.1		(183.3)

Foreign governments														Foreign governments	35.0		(3.5)		2.1		(.3)		37.1		(3.8)
Asset-backed securities	Asset-backed securities	210.8		(2.4)		17.8		(.7)		228.6		(3.1)		Asset-backed securities	914.0		(90.1)		258.1		(53.4)		1,172.1		(143.5)

Agency residential mortgage-backed securities														Agency residential mortgage-backed securities	59.7		(.7)		—		—		59.7		(.7)
Non-agency residential mortgage-backed securities	Non-agency residential mortgage-backed securities	380.8		(3.1)		2.3		—		383.1		(3.1)		Non-agency residential mortgage-backed securities	861.6		(89.7)		335.4		(102.2)		1,197.0		(191.9)
Collateralized loan obligations	Collateralized loan obligations	271.5		(1.2)		32.8		(.1)		304.3		(1.3)		Collateralized loan obligations	553.0		(27.4)		184.2		(12.2)		737.2		(39.6)
Commercial mortgage-backed securities	Commercial mortgage-backed securities	694.7		(7.6)		41.4		(1.6)		736.1		(9.2)		Commercial mortgage-backed securities	1,581.4		(160.0)		593.3		(112.3)		2,174.7		(272.3)
Total fixed maturities, available for sale	Total fixed maturities, available for sale	$	1,698.6	$	(15.1)	$	122.2	$	(3.4)	$	1,820.8	$	(18.5)	Total fixed maturities, available for sale	$	7,636.9	$	(835.2)	$	1,897.5	$	(471.6)	$	9,534.4	$	(1,306.8)

Based on management's current assessment of investments with unrealized losses at ~~September~~June 30, ~~2022,~~2023, the Company believes the issuers of the securities will continue to meet their obligations. While we do not have the intent to sell securities with unrealized losses and it is not more likely than not that we will be required to sell securities with unrealized losses prior to their anticipated recovery, our intent on an individual security may change, based upon market or other unforeseen

~~Table of Contents~~

~~CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES~~

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~

~~___________________~~

developments. In such instances, if a loss is recognized from a sale subsequent to a balance sheet date due to these unexpected developments, the loss is recognized in the period in which we had the intent to sell the security before its anticipated recovery.

~~The following table summarizes changes in the allowance for credit losses related to fixed maturities, available for sale, for the three months ended September 30, 2022 (dollars in millions):~~

Corporate securities States and political subdivisions Foreign governments Asset-backed securities Total
Allowance at June 30, 2022 $ 52.2 $ 1.1 $ .7 $ .2 $ 54.2
Additions for securities for which credit losses were not previously recorded 7.2 .2 .1 .1 7.6
Additions for purchased securities with deteriorated credit — — — — —
Additions (reductions) for securities where an allowance was previously recorded (6.9) .5 — — (6.4)
Reduction for securities sold during the period (3.3) (.1) — — (3.4)
Reduction for securities for which the Company made the decision to sell where an allowance was previously recorded — — — — —
Write-offs — — — — —
Recoveries of previously written-off amount — — — — —
Allowance at September 30, 2022 $ 49.2 $ 1.7 $ .8 $ .3 $ 52.0

~~The following table summarizes changes in the allowance for credit losses related to fixed maturities, available for sale, for the nine months ended September 30, 2022 (dollars in millions):~~

Corporate securities States and political subdivisions Foreign governments Asset-backed securities Total
Allowance at December 31, 2021 $ 7.4 $ — $ .2 $ — $ 7.6
Additions for securities for which credit losses were not previously recorded 39.8 .7 .5 .2 41.2
Additions for purchased securities with deteriorated credit — — — — —
Additions (reductions) for securities where an allowance was previously recorded 11.8 1.1 .1 .1 13.1
Reduction for securities sold during the period (9.8) (.1) — — (9.9)
Reduction for securities for which the Company made the decision to sell where an allowance was previously recorded — — — — —
Write-offs — — — — —
Recoveries of previously written-off amount — — — — —
Allowance at September 30, 2022 $ 49.2 $ 1.7 $ .8 $ .3 $ 52.0

1522

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table summarizes changes in the allowance for credit losses related to fixed maturities, available for sale, for the three months ended ~~September~~June 30, ~~2021~~2023 (dollars in millions):


		Corporate securities		Foreign governments		Total			Corporate securities		States and political subdivisions		Foreign governments		Asset-backed securities		Total
Allowance at June 30, 2021		$	2.3	$	—	$	2.3
Allowance at March 31, 2023								Allowance at March 31, 2023	$	57.2	$	.8	$	.5	$	.6	$	59.1
Additions for securities for which credit losses were not previously recorded	Additions for securities for which credit losses were not previously recorded	2.4		.1		2.5		Additions for securities for which credit losses were not previously recorded	1.7		.2		—		—		1.9
Additions for purchased securities with deteriorated credit	Additions for purchased securities with deteriorated credit	—		—		—		Additions for purchased securities with deteriorated credit	—		—		—		—		—
Additions (reductions) for securities where an allowance was previously recorded	Additions (reductions) for securities where an allowance was previously recorded	.7		—		.7		Additions (reductions) for securities where an allowance was previously recorded	7.1		—		—		(.4)		6.7
Reduction for securities sold during the period	Reduction for securities sold during the period	(.1)		—		(.1)		Reduction for securities sold during the period	(1.6)		—		—		—		(1.6)
Reduction for securities for which the Company made the decision to sell where an allowance was previously recorded	Reduction for securities for which the Company made the decision to sell where an allowance was previously recorded	—		—		—		Reduction for securities for which the Company made the decision to sell where an allowance was previously recorded	—		—		—		—		—
Write-offs	Write-offs	—		—		—		Write-offs	—		—		—		—		—
Recoveries of previously written-off amount	Recoveries of previously written-off amount	—		—		—		Recoveries of previously written-off amount	—		—		—		—		—
Allowance at September 30, 2021		$	5.3	$	.1	$	5.4
Allowance at June 30, 2023								Allowance at June 30, 2023	$	64.4	$	1.0	$	.5	$	.2	$	66.1

The following table summarizes changes in the allowance for credit losses related to fixed maturities, available for sale, for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2023 (dollars in millions):


		Corporate securities		States and political subdivisions		Foreign governments		Total			Corporate securities		States and political subdivisions		Foreign governments		Asset-backed securities		Total
Allowance at December 31, 2020		$	1.9	$	.3	$	—	$	2.2
Allowance at December 31, 2022										Allowance at December 31, 2022	$	54.4	$	.9	$	.4	$	.3	$	56.0
Additions for securities for which credit losses were not previously recorded	Additions for securities for which credit losses were not previously recorded	4.3		.1		.1		4.5		Additions for securities for which credit losses were not previously recorded	4.7		.2		—		—		4.9
Additions for purchased securities with deteriorated credit	Additions for purchased securities with deteriorated credit	—		—		—		—		Additions for purchased securities with deteriorated credit	—		—		—		—		—
Additions (reductions) for securities where an allowance was previously recorded	Additions (reductions) for securities where an allowance was previously recorded	(.3)		(.4)		—		(.7)		Additions (reductions) for securities where an allowance was previously recorded	7.6		(.1)		.1		(.1)		7.5
Reduction for securities sold during the period	Reduction for securities sold during the period	(.6)		—		—		(.6)		Reduction for securities sold during the period	(2.3)		—		—		—		(2.3)
Reduction for securities for which the Company made the decision to sell where an allowance was previously recorded	Reduction for securities for which the Company made the decision to sell where an allowance was previously recorded	—		—		—		—		Reduction for securities for which the Company made the decision to sell where an allowance was previously recorded	—		—		—		—		—
Write-offs	Write-offs	—		—		—		—		Write-offs	—		—		—		—		—
Recoveries of previously written-off amount	Recoveries of previously written-off amount	—		—		—		—		Recoveries of previously written-off amount	—		—		—		—		—
Allowance at September 30, 2021		$	5.3	$	—	$	.1	$	5.4
Allowance at March 31, 2023										Allowance at March 31, 2023	$	64.4	$	1.0	$	.5	$	.2	$	66.1

1623

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table summarizes changes in the allowance for credit losses related to fixed maturities, available for sale, for the three months ended June 30, 2022 (dollars in millions):


	Corporate securities		States and political subdivisions		Foreign governments		Asset-backed securities		Total
Allowance at March 31, 2022	$	35.6	$	.8	$	.1	$	.1	$	36.6
Additions for securities for which credit losses were not previously recorded	18.6		.2		.3		.1		19.2
Additions for purchased securities with deteriorated credit	—		—		—		—		—
Additions (reductions) for securities where an allowance was previously recorded	4.1		.1		.3		—		4.5
Reduction for securities sold during the period	(6.1)		—		—		—		(6.1)
Reduction for securities for which the Company made the decision to sell where an allowance was previously recorded	—		—		—		—		—
Write-offs	—		—		—		—		—
Recoveries of previously written-off amount	—		—		—		—		—
Allowance at June 30, 2022	$	52.2	$	1.1	$	.7	$	.2	$	54.2

The following table summarizes changes in the allowance for credit losses related to fixed maturities, available for sale, for the six months ended June 30, 2022 (dollars in millions):


	Corporate securities		States and political subdivisions		Foreign governments		Asset-backed securities		Total
Allowance at December 31, 2021	$	7.4	$	—	$	.2	$	—	$	7.6
Additions for securities for which credit losses were not previously recorded	32.6		.5		.4		.1		33.6
Additions for purchased securities with deteriorated credit	—		—		—		—		—
Additions (reductions) for securities where an allowance was previously recorded	18.7		.6		.1		.1		19.5
Reduction for securities sold during the period	(6.5)		—		—		—		(6.5)
Reduction for securities for which the Company made the decision to sell where an allowance was previously recorded	—		—		—		—		—
Write-offs	—		—		—		—		—
Recoveries of previously written-off amount	—		—		—		—		—
Allowance at June 30, 2022	$	52.2	$	1.1	$	.7	$	.2	$	54.2

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

Mortgage Loans

Mortgage loans are carried at amortized unpaid balance, net of allowance for estimated credit losses. Interest income is accrued on the principal amount of the loan based on the loan's contractual interest rate. Payment terms specified for mortgage loans may include a prepayment penalty for unscheduled payoff of the investment. Prepayment penalties are recognized as investment income when received.

The allowance for estimated credit losses is measured using a loss-rate method on an individual asset basis. Inputs used include asset-specific characteristics, current economic conditions, historical loss information and reasonable and supportable forecasts about future economic conditions.

~~At September 30, 2022, the~~The mortgage loan balance was ~~primarily~~ comprised of commercial and residential mortgage ~~loans~~loans. At June 30, 2023, we held commercial mortgage loan investments with an amortized cost and ~~there~~fair value of $1,338.3 million and $1,190.6 million, respectively. There were no commercial mortgage loans in process of foreclosure. At ~~September~~June 30, ~~2022,~~2023, we held residential mortgage loan investments with an amortized cost and fair value of ~~$63.6~~$497.9 million and ~~$61.6~~$501.9 million, respectively. At ~~September~~June 30, ~~2022,~~2023, there were two residential mortgage loans that were noncurrent with a carrying value of ~~$0.5~~$0.3 million ~~that were~~(of which, one loan with a carrying value of $0.1 million was in ~~foreclosure. There were no other mortgage loans that were noncurrent at September 30, 2022.~~foreclosure).

The following table provides the amortized cost by year of origination and estimated fair value of our outstanding commercial mortgage loans and the underlying collateral as of ~~September~~June 30, ~~2022~~2023 (dollars in millions):


																Estimated fair value																			Estimated fair value
Loan-to-value ratio (a)	Loan-to-value ratio (a)	2022		2021		2020		2019		2018		Prior		Total amortized cost		Mortgage loans		Collateral		Loan-to-value ratio (a)	2023		2022		2021		2020		2019		Prior		Total amortized cost		Mortgage loans		Collateral
Less than 60%	Less than 60%	$	149.3	$	127.6	$	43.9	$	75.8	$	67.1	$	470.2	$	933.9	$	824.5	$	3,790.3	Less than 60%	$	101.0	$	148.1	$	126.5	$	37.1	$	74.7	$	497.4	$	984.8	$	874.7	$	3,656.1
60% to less than 70%	60% to less than 70%	47.3		12.9		—		—		8.2		43.4		111.8		103.3		170.6		60% to less than 70%	47.1		87.3		—		5.6		—		54.5		194.5		179.5		296.4
70% to less than 80%	70% to less than 80%	33.0		22.4		—		—		—		15.1		70.5		60.8		93.7		70% to less than 80%	—		77.8		24.5		—		—		32.2		134.5		118.0		184.4
80% to less than 90%	80% to less than 90%	—		—		—		—		—		42.8		42.8		34.9		52.0		80% to less than 90%	—		—		—		—		—		—		—		—		—
90% or greater	90% or greater	—		—		—		—		—		10.0		10.0		6.9		10.7		90% or greater	—		—		—		—		—		24.5		24.5		18.4		26.0
Total	Total	$	229.6	$	162.9	$	43.9	$	75.8	$	75.3	$	581.5	$	1,169.0	$	1,030.4	$	4,117.3	Total	$	148.1	$	313.2	$	151.0	$	42.7	$	74.7	$	608.6	$	1,338.3	$	1,190.6	$	4,162.9

________________

(a)Loan-to-value ratios are calculated as the ratio of: (i) the amortized cost of the commercial mortgage loans; to (ii) the estimated fair value of the underlying collateral.

The following table summarizes changes in the allowance for credit losses related to mortgage loans for the three months ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022 (dollars in millions):


		Three months ended					Three months ended
		September 30,					June 30,
		2022		2021			2023		2022
Allowance at the beginning of the period	Allowance at the beginning of the period	$	4.9	$	8.3	Allowance at the beginning of the period	$	8.4	$	5.1
Current period provision for expected credit losses	Current period provision for expected credit losses	.4		(1.0)		Current period provision for expected credit losses	1.9		(.2)
Initial allowance recognized for purchased financial assets with credit deterioration	Initial allowance recognized for purchased financial assets with credit deterioration	—		—		Initial allowance recognized for purchased financial assets with credit deterioration	—		—
Write-offs charged against the allowance	Write-offs charged against the allowance	—		—		Write-offs charged against the allowance	—		—
Recoveries of amounts previously written off	Recoveries of amounts previously written off	—		—		Recoveries of amounts previously written off	—		—
Allowance at the end of the period	Allowance at the end of the period	$	5.3	$	7.3	Allowance at the end of the period	$	10.3	$	4.9

1725

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table summarizes changes in the allowance for credit losses related to mortgage loans for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022 (dollars in millions):


		Nine months ended					Six months ended
		September 30,					June 30,
		2022		2021			2023		2022
Allowance at the beginning of the period	Allowance at the beginning of the period	$	5.6	$	11.8	Allowance at the beginning of the period	$	8.0	$	5.6
Current period provision for expected credit losses	Current period provision for expected credit losses	(.3)		(4.5)		Current period provision for expected credit losses	2.3		(.7)
Initial allowance recognized for purchased financial assets with credit deterioration	Initial allowance recognized for purchased financial assets with credit deterioration	—		—		Initial allowance recognized for purchased financial assets with credit deterioration	—		—
Write-offs charged against the allowance	Write-offs charged against the allowance	—		—		Write-offs charged against the allowance	—		—
Recoveries of amounts previously written off	Recoveries of amounts previously written off	—		—		Recoveries of amounts previously written off	—		—
Allowance at the end of the period	Allowance at the end of the period	$	5.3	$	7.3	Allowance at the end of the period	$	10.3	$	4.9

Total Investment Gains (Losses)

The following table sets forth the total investment gains (losses) for the periods indicated (dollars in millions):


		Three months ended				Nine months ended					Three months ended				Six months ended
		September 30,				September 30,					June 30,				June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Realized investment gains (losses):	Realized investment gains (losses):									Realized investment gains (losses):
Gross realized gains on sales of fixed maturities, available for sale	Gross realized gains on sales of fixed maturities, available for sale	$	18.1	$	4.1	$	96.4	$	42.8	Gross realized gains on sales of fixed maturities, available for sale	$	2.8	$	23.5	$	10.1	$	78.3
Gross realized losses on sales of fixed maturities, available for sale	Gross realized losses on sales of fixed maturities, available for sale	(24.4)		(.2)		(81.3)		(18.4)		Gross realized losses on sales of fixed maturities, available for sale	(21.6)		(26.3)		(36.0)		(56.9)
Equity securities, net	Equity securities, net	—		—		(8.3)		(2.8)		Equity securities, net	(.4)		(3.6)		(.6)		(8.3)
Other, net	Other, net	(1.9)		(.2)		(3.2)		(6.8)		Other, net	(2.6)		(.6)		(9.9)		(1.3)
Total realized investment gains (losses)	Total realized investment gains (losses)	(8.2)		3.7		3.6		14.8		Total realized investment gains (losses)	(21.8)		(7.0)		(36.4)		11.8
Change in allowance for credit losses (a)	Change in allowance for credit losses (a)	7.5		(1.4)		(46.9)		13.9		Change in allowance for credit losses (a)	(9.9)		(23.7)		(11.4)		(54.4)
Change in fair value of equity securities (b)	Change in fair value of equity securities (b)	(.7)		(3.0)		(2.4)		(.4)		Change in fair value of equity securities (b)	—		(.5)		.4		(1.7)
Other changes in fair value (c)	Other changes in fair value (c)	(16.3)		(1.6)		(53.5)		(2.1)		Other changes in fair value (c)	(3.6)		(17.6)		(2.5)		(37.2)

Other investment gains (losses)		(9.5)		(6.0)		(102.8)		11.4
Total investment gains (losses)		$	(17.7)	$	(2.3)	$	(99.2)	$	26.2
Other investment losses										Other investment losses	(13.5)		(41.8)		(13.5)		(93.3)
Total investment losses										Total investment losses	$	(35.3)	$	(48.8)	$	(49.9)	$	(81.5)

_________________

(a) Changes in the allowance for credit losses includes ~~$5.7~~$(1.0) million and ~~$(2.8)~~$(6.3) million in the three ~~and nine~~ months ended ~~September~~June 30, 2023 and 2022, respectively, and ~~$0.7~~$1.0 million and ~~$12.6~~$(8.5) million in the ~~three and nine~~six months ended ~~September~~June 30, ~~2021,~~2023 and 2022, respectively, related to investments held by variable interest entities ("VIEs").

(b) Changes in the estimated fair value of equity securities (that are still held as of the end of the respective periods) were ~~$(6.9)~~$0.1 million and ~~$(2.6)~~$(5.8) million for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, respectively.

(c) Changes in the estimated fair value of trading securities that we have elected the fair value option (that are still held as of the end of the respective periods) were ~~$(36.6)~~$(5.6) million and ~~$(0.2)~~$(25.2) million in the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, respectively.

During the first ~~nine~~six months of ~~2022,~~2023, we recognized net investment losses of ~~$99.2~~$49.9 million, which were comprised of: (i) ~~$11.9~~$31.0 million of net ~~gains~~losses from the sales of investments; (ii) ~~$10.7~~$0.2 million of losses related to equity securities, including the change in fair value; (iii) ~~the decrease in fair value~~$7.0 million of losses related to certain fixed maturity investments with embedded derivatives, ~~of $37.4 million;~~including the change in fair value; (iv) the decrease in fair value of embedded derivatives related to a modified coinsurance agreement of ~~$16.1~~$0.3 million; and (v) an increase in the allowance for credit losses of ~~$46.9~~$11.4 million.

During the first ~~nine~~six months of ~~2021,~~2022, we recognized net investment ~~gains~~losses of ~~$26.2~~$81.5 million, which were comprised of: (i) ~~$17.6~~$20.1 million of net gains from the sales of investments; (ii) ~~$3.2~~$10.0 million of losses related to equity securities, including the

1826

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

change in fair value; (iii) the decrease in fair value of certain fixed maturity investments with embedded derivatives of ~~$0.2~~$25.5 million; (iv) the decrease in fair value of embedded derivatives related to a modified coinsurance agreement of ~~$1.9~~$11.7 million; and (v) ~~a decrease~~an increase in the allowance for credit losses of ~~$13.9~~$54.4 million.

Our fixed maturity investments are generally purchased in the context of various long-term strategies, including funding insurance liabilities, so we do not generally seek to generate short-term realized gains through the purchase and sale of such securities. In certain circumstances, including those in which securities are selling at prices which exceed our view of their underlying economic value, or when it is possible to reinvest the proceeds to better meet our long-term asset-liability objectives, we may sell certain securities.

At ~~September~~June 30, ~~2022,~~2023, there were no fixed maturity investments in default.

During the first ~~nine~~six months of ~~2022,~~2023, the ~~$81.3~~$36.0 million of gross realized losses on sales of ~~$1,321.7~~$388.8 million of fixed maturity securities, available for sale, included: (i) ~~$54.3~~$29.8 million related to various corporate securities; (ii) ~~$14.0~~$4.3 million related to ~~non-agency residential~~commercial mortgage-backed securities; and (iii) ~~$7.3 million related to states and political subdivisions; and (iv) $5.7~~$1.9 million related to various other investments. Securities are generally sold at a loss following unforeseen issuer-specific events or conditions or shifts in perceived relative values. These reasons include but are not limited to: (i) changes in the investment environment; (ii) expectation that the market value could deteriorate; (iii) our desire to reduce our exposure to an asset class, an issuer or an industry; (iv) prospective or actual changes in credit quality; (v) better match certain characteristics of our investment portfolio with the corresponding characteristics of our insurance liabilities; or ~~(v)~~(vi) changes in expected portfolio cash flows.

During the first ~~nine~~six months of ~~2021,~~2022, the ~~$18.4~~$56.9 million of gross realized losses on sales of ~~$350.3~~$1,106.0 million of fixed maturity securities, available for sale, ~~primarily~~included: (i) $37.6 million related to various corporate ~~securities.~~securities; (ii) $10.2 million related to non-agency residential mortgage-backed securities; (iii) $4.2 million related to states and political subdivisions; and (iv) $4.9 million related to various other investments.

Future events may occur, or additional information may become available, which may necessitate future realized losses in our portfolio. Significant losses could have a material adverse effect on our consolidated financial statements in future periods.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

LIABILITIES FOR INSURANCE PRODUCTS

The liability for future policy benefits is determined based on numerous assumptions. The most significant assumptions for our life and annuity business are mortality and lapse/withdrawal rates which are based on our experience and, in cases of limited experience, industry experience. Mortality and lapse/withdrawal rates also take into consideration future expectations in policyholder behavior that may vary from past experience. For our health business, mortality rates, lapse rates, morbidity assumptions and future rate increases are based on our experience and, in cases of limited experience, industry experience. Such assumptions also consider future expectations in policyholder behavior that may vary from past experience.

In the first six months of 2023, we reviewed the actual mortality, lapse, and morbidity experience and determined that no changes to assumptions for future cash flows were necessary. This is consistent with the impact in the "Effect of actual variances from expected experience" line items in the tables below, which indicate our actual experience did not deviate significantly from our expectations.

The following tables summarize balances and changes in the liability for future policy benefits for traditional and limited-payment contracts for the six months ended June 30, 2023 (dollars in millions):


	Six months ended
	June 30, 2023
	Supplemental health		Medicare supplement		Long-term care		Traditional life		Other annuities
Present value of expected net premiums ("PVENP"), beginning of period	$	2,781.3	$	2,800.6	$	1,034.1	$	2,175.0	$	—
Effect of changes in discount rate assumptions, beginning of period	188.4		196.4		23.2		137.1		—
Beginning PVENP at original discount rate	2,969.7		2,997.0		1,057.3		2,312.1		—
Effect of changes in cash flow assumptions	—		—		—		—		—
Effect of actual variances from expected experience	(26.8)		17.3		12.1		(25.5)		—
Adjusted beginning of period PVENP	2,942.9		3,014.3		1,069.4		2,286.6		—
Issuances	140.8		166.5		30.0		209.4		3.1
Interest accrual	64.3		60.9		24.6		46.4		—
Net premiums collected	(178.9)		(219.5)		(81.0)		(202.1)		(3.1)
Ending PVENP at original discount rate	2,969.1		3,022.2		1,043.0		2,340.3		—
Effect of changes in discount rate assumptions, end of period	(162.4)		(177.0)		(19.6)		(120.7)		—
PVENP, end of period	$	2,806.7	$	2,845.2	$	1,023.4	$	2,219.6	$	—


Present value of expected future policy benefits ("PVEFPB"), beginning of period	$	5,886.8	$	3,033.1	$	4,158.1	$	4,417.9	$	310.9
Effect of changes in discount rate assumptions, beginning of period	483.3		212.0		28.5		336.6		15.4
Beginning PVEFPB at original discount rate	6,370.1		3,245.1		4,186.6		4,754.5		326.3
Effect of changes in cash flow assumptions	—		—		—		—		—
Effect of actual variances from expected experience	(31.5)		28.2		19.5		(30.8)		1.0
Adjusted beginning of period PVEFPB	6,338.6		3,273.3		4,206.1		4,723.7		327.3
Issuances	141.2		166.5		30.0		212.7		3.2
Interest accrual	148.1		66.3		111.3		102.5		7.4
Benefit payments	(210.3)		(247.2)		(142.8)		(222.9)		(17.3)
Ending PVEFPB at original discount rate	6,417.6		3,258.9		4,204.6		4,816.0		320.6
Effect of changes in discount rate assumptions, end of period	(408.0)		(190.9)		10.3		(290.8)		(11.6)
PVEFPB, end of period	$	6,009.6	$	3,068.0	$	4,214.9	$	4,525.2	$	309.0


Net liability for future policy benefits	$	3,202.9	$	222.8	$	3,191.5	$	2,305.6	$	309.0
Flooring impact	—		.2		—		—		—
Adjusted net liability for future policy benefits	3,202.9		223.0		3,191.5		2,305.6		309.0
Related reinsurance recoverable	(2.3)		—		(356.6)		(194.3)		—
Net liability for future policy benefits, net of reinsurance recoverable	$	3,200.6	$	223.0	$	2,834.9	$	2,111.3	$	309.0

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________


	Six months ended
	June 30, 2022
	Supplemental health		Medicare supplement		Long-term care		Traditional life		Other annuities
PVENP, beginning of period	$	3,496.8	$	3,454.0	$	1,313.4	$	2,483.7	$	—
Effect of changes in discount rate assumptions, beginning of period	(525.6)		(341.8)		(183.2)		(239.4)		—
Beginning PVENP at original discount rate	2,971.2		3,112.2		1,130.2		2,244.3		—
Effect of changes in cash flow assumptions	—		—		—		—		—
Effect of actual variances from expected experience	(7.0)		6.6		(12.5)		(19.0)		—
Adjusted beginning of period PVENP	2,964.2		3,118.8		1,117.7		2,225.3		—
Issuances	152.9		118.3		49.5		284.0		3.3
Interest accrual	62.1		59.8		25.9		41.5		—
Net premiums collected	(177.2)		(232.8)		(85.0)		(201.5)		(3.3)
Ending PVENP at original discount rate	3,002.0		3,064.1		1,108.1		2,349.3		—
Effect of changes in discount rate assumptions, end of period	(54.1)		(82.3)		22.1		(72.7)		—
PVENP, end of period	$	2,947.9	$	2,981.8	$	1,130.2	$	2,276.6	$	—


PVEFPB, beginning of period	$	7,688.0	$	3,750.5	$	5,501.6	$	5,395.7	$	431.9
Effect of changes in discount rate assumptions, beginning of period	(1,414.8)		(373.8)		(1,291.2)		(767.3)		(88.4)
Beginning PVEFPB at original discount rate	6,273.2		3,376.7		4,210.4		4,628.4		343.5
Effect of changes in cash flow assumptions	—		—		—		—		—
Effect of actual variances from expected experience	(7.7)		5.7		(19.1)		(18.9)		(3.5)
Adjusted beginning of period PVEFPB	6,265.5		3,382.4		4,191.3		4,609.5		340.0
Issuances	153.2		117.6		49.5		289.0		3.9
Interest accrual	144.6		65.5		112.0		96.8		7.7
Benefit payments	(206.6)		(244.8)		(130.0)		(247.6)		(17.9)
Ending PVEFPB at original discount rate	6,356.7		3,320.7		4,222.8		4,747.7		333.7
Effect of changes in discount rate assumptions, end of period	(125.9)		(87.2)		235.3		(142.2)		3.9
PVEFPB, end of period	$	6,230.8	$	3,233.5	$	4,458.1	$	4,605.5	$	337.6


Net liability for future policy benefits	$	3,282.9	$	251.7	$	3,327.9	$	2,328.9	$	337.6
Flooring impact	20.0		—		10.2		5.7		—
Adjusted net liability for future policy benefits	3,302.9		251.7		3,338.1		2,334.6		337.6
Related reinsurance recoverable	(3.2)		—		(354.5)		(216.7)		—
Net liability for future policy benefits, net of reinsurance recoverable	$	3,299.7	$	251.7	$	2,983.6	$	2,117.9	$	337.6

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table reconciles the net liability for future policy benefits to the amount presented in the consolidated balance sheet (dollars in millions):


	June 30, 2023		June 30, 2022
Balances included in the future policy benefits rollforwards:
Supplemental health	$	3,202.9	$	3,302.9
Medicare supplement	223.0		251.7
Long-term care	3,191.5		3,338.1
Traditional life	2,305.6		2,334.6
Other annuities	309.0		337.6
Reserves excluded from rollforward (1)	2,601.7		2,609.8
Deferred profit liability	59.9		51.2
Amount of reserves above (below) policyholder account balances (2)	(448.7)		(475.0)
Future loss reserves (3)	34.7		34.0
Future policy benefits	$	11,479.6	$	11,784.9

_______________

(1) Primarily comprised of blocks of business that are 100% ceded.

(2) Such amount represents the difference between: (i) the total insurance liabilities for our fixed indexed annuities (including the host contract and the related embedded derivative); and (ii) the policyholder account balances for these products. The accounting requirement to bifurcate the embedded derivative and value it at the current estimated fair value results in this amount.

(3) In certain instances, the total insurance liabilities for a particular line of business may not be deficient in the aggregate to trigger loss recognition, but the pattern of earnings may be such that profits are expected to be recognized in earlier years followed by losses in later years. In these situations, accounting standards require that an additional liability (the "future loss reserve") be recognized by an amount necessary to sufficiently offset the losses that would be recognized in later years.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

Many of our fixed indexed annuity products include a GLWB that is considered a MRB. The calculation of MRBs includes market assumptions (interest rate, equity returns, volatility and dividend yields) and nonmarket assumptions (mortality rates, surrender and withdrawal rates, GLWB utilization and spreads). Market assumptions are updated quarterly to reflect current market conditions. During the first quarter of 2023, we reviewed the nonmarket assumptions used to calculate MRBs and determined that such assumptions were appropriate.

The following table presents the balance of and changes in MRBs associated with our fixed indexed annuities (dollars in millions):


	Six months ended
	June 30,
	2023		2022
Net liability (asset), beginning of period	$	(54.0)	$	86.2
Effect of changes in the instrument-specific credit risk, beginning of period	12.2		12.1
Balance, beginning of period, before effect of changes in the instrument-specific credit risk	(41.8)		98.3
Issuances	(.1)		(1.0)
Interest accrual	10.7		7.2
Attributed fees collected	—		—
Benefit payments	—		—
Effect of changes in interest rates	4.2		(101.6)
Effect of changes in equity markets	9.7		(8.1)
Effect of changes in equity index volatility	(25.3)		18.9
Actual policyholder behavior different from expected behavior	1.8		(.2)
Effect of changes in future expected policyholder behavior - other	—		—
Effect of changes in future expected policyholder behavior - risk margin	—		—
Effect of changes in assumptions	(3.9)		1.9
Net liability (asset), end of period, before effect of changes in the instrument-specific credit risk	(44.7)		15.4
Effect of changes in the instrument-specific credit risk, end of period	(10.8)		(22.8)
Net asset, end of period	(55.5)		(7.4)
Reinsurance recoverable, end of period	—		—
Net asset, end of period, net of reinsurance	$	(55.5)	$	(7.4)

Balance reported as an asset	$	66.0	$	37.3
Balance reported as a liability	10.5		29.9
Net asset	$	(55.5)	$	(7.4)

Net amount at risk	$	52.0	$	65.7
Weighted average attained age of contract holders	69		68

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table summarizes the amount of revenue and interest related to traditional and limited-payment contracts recognized in the consolidated statement of operations (dollars in millions):


	Gross premiums (a)				Interest accretion (b)
	Six months ended				Six months ended
	June 30,				June 30,
	2023		2022		2023		2022
Other annuities	$	3.8	$	4.1	$	7.4	$	7.7
Supplemental health	355.0		347.4		83.8		82.5
Medicare supplement	307.2		327.9		5.4		5.7
Long-term care	163.6		164.1		86.7		86.1
Traditional life	357.3		346.8		56.1		55.3
Total	$	1,186.9	$	1,190.3	$	239.4	$	237.3

_____________________

(a) Such amounts are included in insurance policy income in the consolidated statement of operations.

(b) Such amounts are included in insurance policy benefits in the consolidated statement of operations.

The following table provides the amount of undiscounted and discounted expected gross premiums and expected future benefits and expenses for traditional and limited-payment contracts (dollars in millions):


	June 30, 2023				June 30, 2022
	Undiscounted		Discounted (a)		Undiscounted		Discounted (a)
Other annuities
Expected future gross premiums	$	—	$	—	$	—	$	—
Expected future benefits and expenses	391.4		309.0		416.7		337.6
Supplemental health
Expected future gross premiums	8,991.5		5,531.8		8,846.0		5,707.1
Expected future benefits and expenses	11,128.9		6,009.6		10,942.6		6,230.8
Medicare supplement
Expected future gross premiums	5,610.2		3,931.0		5,590.3		4,155.8
Expected future benefits and expenses	4,401.0		3,068.0		4,373.0		3,233.5
Long-term care
Expected future gross premiums	2,938.2		2,109.2		3,004.0		2,245.5
Expected future benefits and expenses	7,446.7		4,214.9		7,577.2		4,458.1
Traditional life
Expected future gross premiums	5,509.5		3,947.9		5,447.7		4,062.3
Expected future benefits and expenses	7,443.2		4,525.2		7,244.4		4,605.5

_____________________

(a) Calculated at the discount rates at period end.

Loss expense as a result of net premium ratio capping was not material in both the six months ended June 30, 2023 and 2022.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table provides the weighted average durations (under locked-in rates) of the liability for future policy benefits in years:


	June 30, 2023	June 30, 2022
Other annuities	9.7	9.7
Supplemental health	11.8	12.0
Medicare supplement	6.1	6.0
Long-term care	10.4	10.8
Traditional life	10.5	10.9

The following table provides the weighted average interest rates for the liability for future policy benefits:


	June 30, 2023		June 30, 2022
Other annuities
Interest accretion rate	4.74	%	4.71	%
Current discount rate	5.26	%	4.75	%
Supplemental health
Interest accretion rate	5.03	%	5.08	%
Current discount rate	5.36	%	4.72	%
Medicare supplement
Interest accretion rate	4.27	%	4.22	%
Current discount rate	5.25	%	4.41	%
Long-term care
Interest accretion rate	5.65	%	5.70	%
Current discount rate	5.32	%	4.82	%
Traditional life
Interest accretion rate	4.77	%	4.79	%
Current discount rate	5.37	%	4.74	%

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following tables present the balances of and changes in the liability for policyholder account balances (dollars in millions):


	Six months ended
	June 30, 2023
	Fixed indexed annuities		Fixed interest annuities		Other annuities		Interest-sensitive life		Funding agreements		Other (a)
Balance, beginning of period excluding contracts 100% ceded	$	9,490.4	$	1,663.1	$	127.1	$	1,209.6	$	1,410.8	$	395.5
Issuances	674.9		91.1		—		20.4		—		—
Premiums received	.2		1.6		15.4		101.6		—		134.3
Policy charges	(9.2)		(.4)		—		(93.3)		—		—
Surrenders and withdrawals	(360.8)		(85.4)		(20.7)		(16.3)		(14.3)		(144.2)
Benefit payments	(122.3)		(55.9)		(3.1)		(13.7)		—		—
Interest credited	23.3		22.5		1.2		18.5		14.4		1.3
Other	11.2		—		(.2)		(.2)		—		—
Balance, end of period excluding contracts 100% ceded	9,707.7		1,636.6		119.7		1,226.6		1,410.9		386.9
Balance, end of period for contracts 100% ceded	144.9		612.4		22.3		109.1		—		10.6
Balance, end of period	$	9,852.6	$	2,249.0	$	142.0	$	1,335.7	$	1,410.9	$	397.5

Balance, end of period, reinsurance ceded	(144.9)		(612.4)		(22.3)		(128.0)		—		(24.7)
Balance, end of period, net of reinsurance	$	9,707.7	$	1,636.6	$	119.7	$	1,207.7	$	1,410.9	$	372.8



Weighted average crediting rate	1.7		%	2.7		%	2.3		%	3.0		%	2.0		%	0.8		%
Net amount at risk (b)	$	—		$	—		$	—		$	27,483.2		$	—		$	—
Cash surrender value, net of reinsurance	$	9,047.8		$	1,616.5		$	119.7		$	980.1		$	—		$	372.8

_______________

(a) Predominantly consists of retained asset accounts associated with our traditional life and supplemental health blocks.

(b) Represents the amount of insurance policy benefit expense that we would incur if death claims were filed on all annuity and interest-sensitive life contracts at the balance sheet date.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________


	Six months ended
	June 30, 2022
	Fixed indexed annuities		Fixed interest annuities		Other annuities		Interest-sensitive life		Funding agreements		Other (a)
Balance, beginning of period excluding contracts 100% ceded	$	8,681.0	$	1,806.1	$	131.2	$	1,163.9	$	502.0	$	368.0
Issuances	765.9		30.5		—		20.9		899.0		—
Premiums received	.1		2.1		18.6		95.5		—		129.6
Policy charges	(6.6)		(.3)		—		(90.0)		—		—
Surrenders and withdrawals	(260.9)		(78.6)		(18.7)		(13.3)		(4.4)		(113.1)
Benefit payments	(125.4)		(71.5)		(2.8)		(13.4)		—		(.1)
Interest credited	98.3		22.9		1.2		26.7		14.1		1.4
Other	10.5		.1		.1		—		—		—
Balance, end of period excluding contracts 100% ceded	9,162.9		1,711.3		129.6		1,190.3		1,410.7		385.8
Balance, end of period for contracts 100% ceded	162.6		652.3		27.3		115.1		—		11.5
Balance, end of period	$	9,325.5	$	2,363.6	$	156.9	$	1,305.4	$	1,410.7	$	397.3

Balance, end of period, reinsurance ceded	(162.6)		(652.3)		(27.3)		(136.2)		—		(26.2)
Balance, end of period, net of reinsurance	$	9,162.9	$	1,711.3	$	129.6	$	1,169.2	$	1,410.7	$	371.1



Weighted average crediting rate	1.4		%	2.6		%	2.2		%	5.3		%	2.0		%	0.8		%
Net amount at risk (b)	$	—		$	—		$	—		$	25,681.3		$	—		$	—
Cash surrender value, net of reinsurance	$	8,537.0		$	1,702.3		$	129.6		$	947.2		$	—		$	371.1

_________________

(a) Predominantly consists of retained asset accounts associated with our traditional life and supplemental health blocks.

(b) Represents the amount of insurance policy benefit expense that we would incur if death claims were filed on all annuity and interest-sensitive life contracts at the balance sheet date.

The following table reconciles the liability for policyholder account balances to the amount presented in the consolidated balance sheet (dollars in millions):


	June 30, 2023		June 30, 2022
Amounts included in the liability for policyholder account balances rollforwards:
Fixed indexed annuities	$	9,852.6	$	9,325.5
Fixed interest annuities	2,249.0		2,363.6
Other annuities	142.0		156.9
Interest-sensitive life	1,335.7		1,305.4
Funding agreements	1,410.9		1,410.7
Other	397.5		397.3
Total	$	15,387.7	$	14,959.4

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following tables present the account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums (dollars in millions):


	June 30, 2023
Range of guaranteed minimum crediting rates (a)	At guaranteed minimum		1-50 basis points above		51-150 basis points above		Greater than 150 basis points above		Total
Fixed interest annuities
0.00%-2.99%	$	136.3	$	278.1	$	128.4	$	73.2	$	616.0
3.00%-4.99%	1,517.3		27.3		—		—		1,544.6
5.00% and greater	88.4		—		—		—		88.4
Subtotal	1,742.0		305.4		128.4		73.2		2,249.0
Other annuities
0.00%-2.99%	38.8		27.1		—		—		65.9
3.00%-4.99%	44.5		—		—		—		44.5
5.00% and greater	31.6		—		—		—		31.6
Subtotal	114.9		27.1		—		—		142.0
Interest-sensitive life
0.00%-2.99%	60.8		295.6		167.7		—		524.1
3.00%-4.99%	456.0		51.6		151.1		127.6		786.3
5.00% and greater	21.8		.5		2.7		.3		25.3
Subtotal	538.6		347.7		321.5		127.9		1,335.7
Funding agreements
0.00%-2.99%	1,410.9		—		—		—		1,410.9
3.00%-4.99%	—		—		—		—		—
5.00% and greater	—		—		—		—		—
Subtotal	1,410.9		—		—		—		1,410.9
Other
0.00%-2.99%	17.6		356.1		—		—		373.7
3.00%-4.99%	23.4		—		—		—		23.4
5.00% and greater	.4		—		—		—		.4
Subtotal	41.4		356.1		—		—		397.5
Total
0.00%-2.99%	1,664.4		956.9		296.1		73.2		2,990.6
3.00%-4.99%	2,041.2		78.9		151.1		127.6		2,398.8
5.00% and greater	142.2		.5		2.7		.3		145.7
Total policyholder account balances, excluding fixed indexed annuities	$	3,847.8	$	1,036.3	$	449.9	$	201.1	5,535.1
Fixed indexed annuity account balances									9,852.6
Total policyholder account balances									$	15,387.7

____________________

(a) Excludes the account balances related to our fixed indexed annuity contracts which do not have a minimum crediting rate since returns are based on an index.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________


	June 30, 2022
Range of guaranteed minimum crediting rates (a)	At guaranteed minimum		1-50 basis points above		51-150 basis points above		Greater than 150 basis points above		Total
Fixed interest annuities
0.00%-2.99%	$	165.4	$	332.2	$	33.8	$	26.2	$	557.6
3.00%-4.99%	1,689.5		23.2		.1		—		1,712.8
5.00% and greater	93.2		—		—		—		93.2
Subtotal	1,948.1		355.4		33.9		26.2		2,363.6
Other annuities
0.00%-2.99%	53.2		30.5		—		—		83.7
3.00%-4.99%	62.1		—		—		—		62.1
5.00% and greater	11.1		—		—		—		11.1
Subtotal	126.4		30.5		—		—		156.9
Interest-sensitive life
0.00%-2.99%	7.8		—		—		—		7.8
3.00%-4.99%	406.3		56.1		200.0		153.3		815.7
5.00% and greater	22.6		.4		—		458.9		481.9
Subtotal	436.7		56.5		200.0		612.2		1,305.4
Funding agreements
0.00%-2.99%	1,410.7		—		—		—		1,410.7
3.00%-4.99%	—		—		—		—		—
5.00% and greater	—		—		—		—		—
Subtotal	1,410.7		—		—		—		1,410.7
Other
0.00%-2.99%	18.4		353.5		—		—		371.9
3.00%-4.99%	24.4		—		—		—		24.4
5.00% and greater	1.0		—		—		—		1.0
Subtotal	43.8		353.5		—		—		397.3
Total
0.00%-2.99%	1,655.5		716.2		33.8		26.2		2,431.7
3.00%-4.99%	2,182.3		79.3		200.1		153.3		2,615.0
5.00% and greater	127.9		.4		—		458.9		587.2
Total policyholder account balances, excluding fixed indexed annuities	$	3,965.7	$	795.9	$	233.9	$	638.4	5,633.9
Fixed indexed annuity account balances									9,325.5
Total policyholder account balances									$	14,959.4

____________________

(a) Excludes the account balances related to our fixed indexed annuity contracts which do not have a minimum crediting rate since returns are based on an index.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

DEFERRED ACQUISITION COSTS, PRESENT VALUE OF FUTURE PROFITS AND SALES INDUCEMENTS

Changes in deferred acquisition costs were as follows (dollars in millions):


	Six months ended
	June 30, 2023
	Fixed indexed annuities		Fixed interest annuities		Supplemental health		Medicare supplement		Long-term care		Interest-sensitive life		Traditional life		Funding agreements		Total
Beginning of period	$	365.6	$	19.6	$	378.8	$	161.2	$	137.9	$	212.2	$	409.1	$	6.0	$	1,690.4
Capitalizations	45.0		5.2		28.4		11.8		7.5		17.9		59.3		—		175.1
Amortization expense	(22.4)		(1.8)		(15.4)		(14.1)		(7.7)		(7.1)		(24.7)		(.8)		(94.0)
End of period	$	388.2	$	23.0	$	391.8	$	158.9	$	137.7	$	223.0	$	443.7	$	5.2	$	1,771.5


	Six months ended
	June 30, 2022
	Fixed indexed annuities		Fixed interest annuities		Supplemental health		Medicare supplement		Long-term care		Interest-sensitive life		Traditional life		Funding agreements		Total
Beginning of period	$	313.0	$	19.0	$	357.5	$	170.2	$	136.4	$	196.3	$	357.6	$	3.3	$	1,553.3
Capitalizations	46.3		1.5		24.7		10.8		8.9		15.1		45.2		4.2		156.7
Amortization expense	(19.4)		(1.8)		(14.4)		(15.0)		(7.6)		(6.9)		(20.7)		(.7)		(86.5)
End of period	$	339.9	$	18.7	$	367.8	$	166.0	$	137.7	$	204.5	$	382.1	$	6.8	$	1,623.5

Changes in the present value of future profits were as follows (dollars in millions):


	Six months ended
	June 30, 2023
	Supplemental health		Medicare supplement		Long-term care		Traditional life		Fixed indexed annuities		Fixed interest annuities		Total
Beginning of period	$	154.0	$	27.5	$	6.2	$	14.8	$	.8	$	.4	$	203.7

Amortization expense	(6.6)		(3.7)		(.5)		(1.0)		(.1)		—		(11.9)
End of period	$	147.4	$	23.8	$	5.7	$	13.8	$	.7	$	.4	$	191.8


	Six months ended
	June 30, 2022
	Supplemental health		Medicare supplement		Long-term care		Traditional life		Fixed indexed annuities		Fixed interest annuities		Total
Beginning of period	$	168.1	$	36.5	$	7.3	$	16.9	$	.9	$	.4	$	230.1

Amortization expense	(7.2)		(4.7)		(.6)		(1.1)		(.1)		—		(13.7)
End of period	$	160.9	$	31.8	$	6.7	$	15.8	$	.8	$	.4	$	216.4

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

Changes in sales inducements were as follows (dollars in millions):


	Six months ended
	June 30, 2023
	Fixed indexed annuities		Fixed interest annuities		Total
Beginning of period	$	76.0	$	4.5	$	80.5
Capitalizations	11.0		.3		11.3
Amortization expense	(5.2)		(.4)		(5.6)
End of period	$	81.8	$	4.4	$	86.2


	Six months ended
	June 30, 2022
	Fixed indexed annuities		Fixed interest annuities		Total
Beginning of period	$	63.0	$	5.0	$	68.0
Capitalizations	10.5		.2		10.7
Amortization expense	(4.3)		(.5)		(4.8)
End of period	$	69.2	$	4.7	$	73.9

EARNINGS PER SHARE

A reconciliation of net income and shares used to calculate basic and diluted earnings per share is as follows (dollars in millions and shares in thousands):


		Three months ended				Nine months ended					Three months ended				Six months ended
		September 30,				September 30,					June 30,				June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Net income for basic and diluted earnings per share	Net income for basic and diluted earnings per share	$	105.0	$	99.8	$	353.4	$	325.2	Net income for basic and diluted earnings per share	$	73.7	$	233.3	$	72.9	$	416.7
Shares:	Shares:									Shares:
Weighted average shares outstanding for basic earnings per share	Weighted average shares outstanding for basic earnings per share	114,354		126,429		116,170		130,528		Weighted average shares outstanding for basic earnings per share	114,273		115,533		114,409		117,078
Effect of dilutive securities on weighted average shares:	Effect of dilutive securities on weighted average shares:									Effect of dilutive securities on weighted average shares:
Amounts related to employee benefit plans	Amounts related to employee benefit plans	1,574		2,589		1,902		2,634		Amounts related to employee benefit plans	1,377		1,753		1,780		2,066
Weighted average shares outstanding for diluted earnings per share	Weighted average shares outstanding for diluted earnings per share	115,928		129,018		118,072		133,162		Weighted average shares outstanding for diluted earnings per share	115,650		117,286		116,189		119,144

Basic earnings per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Restricted shares (including our performance units) are not included in basic earnings per share until vested. Diluted earnings per share reflect the potential dilution that could occur if outstanding stock options were exercised and restricted stock was vested. The dilution from options and restricted shares is calculated using the treasury stock method. Under this method, we assume the proceeds from the exercise of the options (or the unrecognized compensation expense with respect to restricted stock and performance units) will be used to purchase shares of our common stock at the average market price during the period, reducing the dilutive effect of the exercise of the options (or the vesting of the restricted stock and performance units).

1939

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

BUSINESS SEGMENTS

We view our operations as three insurance product lines (annuity, health and life) and the investment and fee ~~revenue~~income segments. Our segments are aligned based on their common characteristics, comparability of profit margins and the way management makes operating decisions and assesses the performance of the business.

Our insurance product line segments (annuity, health and life) include marketing, underwriting and administration of the policies our insurance subsidiaries sell. The business written in each of the three product categories through all of our insurance subsidiaries is aggregated allowing management and investors to assess the performance of each product category. When analyzing profitability of these segments, we use insurance product margin as the measure of profitability, which is: (i) insurance policy income; and (ii) net investment income allocated to the insurance product lines; less (i) insurance policy benefits and interest credited to policyholders; and (ii) amortization, non-deferred commissions and advertising expense. Net investment income is allocated to the product lines using the book yield of investments backing the block of business, which is applied to the average net insurance liabilities ~~net of insurance intangibles,~~ for the block in each period. Net insurance liabilities for the purpose of allocating investment income to product lines are equal to: (i) policyholder account balances for annuity products; (ii) total reserves before the fair value adjustments reflected in accumulated other comprehensive income (loss), if applicable, for all other products; less (iii) amounts related to reinsurance business; (iv) deferred acquisition costs; (v) the present value of future profits; and (vi) the value of unexpired options credited to insurance liabilities.

Income from insurance products is the sum of the insurance product margins of the annuity, health and life product lines, less expenses allocated to the insurance lines. It excludes the income from our fee income business, investment income not allocated to product lines, net expenses not allocated to product lines (primarily holding company expenses) and income taxes. Management believes insurance product margin and income from insurance products help provide a better understanding of the business and a more meaningful analysis of the results of our insurance product lines.

We market our ~~insurance~~ products through the Consumer and Worksite Divisions that reflect the customers served by the Company.

The Consumer Division serves individual consumers, engaging with them on the phone, virtually, online, face-to-face with agents, or through a combination of sales channels. This structure unifies consumer capabilities into a single division and integrates the strength of our agent sales forces with one of the largest direct-to-consumer insurance businesses with proven experience in advertising, web/digital and call center support.

The Worksite Division focuses on worksite and group sales for businesses, associations, and other membership groups, interacting with customers at their place of employment and virtually. With a separate Worksite Division, we are bringing a sharper focus to this high-growth business while further capitalizing on the strength of our ~~acquisitions of Web Benefits Design Corporation ("WBD") in April 2019 and DirectPath, LLC ("DirectPath", now known as~~wholly-owned subsidiary, Optavise, LLC ("Optavise") subsequent to its name change in April 2022) in February 2021. Sales in the Worksite Division have been particularly adversely impacted by the novel coronavirus ("COVID-19") pandemic given the challenges, a national provider of ~~interacting with customers at their place of employment.~~year-round technology-driven employee benefits management services.

The Consumer and Worksite Divisions are primarily focused on marketing insurance products, several types of which are sold in both divisions and underwritten in the same manner. Sales of group underwritten policies are currently not significant, but are expected to increase within the Worksite Division.

The investment segment involves the management of our capital resources, including investments and the management of corporate debt and liquidity. Our measure of profitability of this segment is the total net investment income not allocated to the insurance products. Investment income not allocated to product lines represents net investment income less: (i) equity returns credited to policyholder account balances; (ii) the investment income allocated to our product lines; (iii) interest expense on notes payable and investment borrowings; (iv) expenses related to the ~~funding agreement-backed note ("FABN")~~FABN program; and (v) certain expenses related to benefit plans that are offset by special-purpose investment ~~income.~~income; plus (vi) the impact of annual option forfeitures related to fixed indexed annuity surrenders. Investment income not allocated to product lines includes investment income on investments in excess of ~~average insurance liabilities,~~amounts allocated to product lines, investments held by our holding companies, the spread we earn from our Federal Home Loan Bank ("FHLB") investment borrowing and FABN programs and variable components of investment income (including call and prepayment income, adjustments to returns on structured securities due to cash flow changes, income (loss) from company-owned life insurance ("COLI") and alternative investments income not allocated to product lines), net of interest expense on corporate debt. The spread earned from our FHLB investment borrowing and FABN programs includes the investment income on the matched assets less: (i) interest on investment borrowings related to the FHLB ~~investment borrowing program; (ii) interest credited on funding agreements; and (iii) amortization of deferred acquisition costs related to the FABN program.~~

2040

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

investment borrowing program; (ii) interest credited on funding agreements; and (iii) amortization of deferred acquisition costs related to the FABN program.

Our fee income segment includes the earnings generated from sales of third-party insurance products, services provided by ~~WBD (our on-line benefit administration firm),~~ Optavise ~~(a national provider of year-round technology-driven employee benefits management services)~~ and the operations of our ~~broker~~ broker/dealer and registered investment advisor.

Expenses not allocated to product lines include the expenses of our corporate operations, excluding interest expense on debt.

We measure segment performance by excluding total investment gains (losses), changes in fair value ~~changes in~~of embedded derivative liabilities ~~(net of related amortization),~~and MRBs, fair value changes related to the agent deferred compensation plan, income taxes and other non-operating items consisting primarily of earnings attributable to VIEs ("pre-tax operating earnings") because we believe that this performance measure is a better indicator of the ongoing business and trends in our business. Our primary investment focus is on investment income to support our liabilities for insurance products as opposed to the generation of investment gains (losses), and a long-term focus is necessary to maintain profitability over the life of the business.

Investment gains (losses), changes in fair value ~~changes in~~of embedded derivative liabilities ~~(net of related amortization),~~and MRBs, fair value changes related to the agent deferred compensation plan and other non-operating items consisting primarily of earnings attributable to VIEs depend on market conditions or represent unusual items that do not necessarily relate to the underlying business of our segments. Investment gains (losses) and changes in fair value ~~changes in~~of embedded derivative liabilities ~~(net of related amortization)~~and MRBs may affect future earnings levels since our underlying business is long-term in nature and changes in our investment portfolio may impact our ability to earn the assumed interest rates needed to maintain the profitability of our business.

Operating information by segment is as follows (dollars in millions):

Three months ended Nine months ended
September 30, September 30,
2022 2021 2022 2021
Revenues:
Annuity:
Insurance policy income $ 6.3 $ 5.8 $ 17.1 $ 15.5
Net investment income 117.3 115.5 347.2 346.1
Total annuity revenues 123.6 121.3 364.3 361.6
Health:
Insurance policy income 403.5 414.4 1,213.7 1,246.3
Net investment income 71.9 72.2 215.3 215.3
Total health revenues 475.4 486.6 1,429.0 1,461.6
Life:
Insurance policy income 213.4 210.4 643.0 631.7
Net investment income 36.6 36.4 109.1 108.3
Total life revenues 250.0 246.8 752.1 740.0
Change in market values of the underlying options supporting the fixed index annuity and life products (offset by market value changes credited to policyholder balances) (34.9) 7.2 (199.2) 125.8
Investment income not allocated to product lines 63.6 69.8 197.9 207.2
Fee revenue and other income:
Fee income 30.6 28.0 102.0 91.4
Amounts netted in expenses not allocated to product lines 1.8 4.7 28.9 13.3
Total segment revenues $ 910.1 $ 964.4 $ 2,675.0 $ 3,000.9


	Three months ended				Six months ended
	June 30,				June 30,
	2023		2022		2023		2022
Revenues:
Annuity:
Insurance policy income	$	8.1	$	5.8	$	13.2	$	10.8
Net investment income	127.7		117.8		253.1		235.3
Total annuity revenues	135.8		123.6		266.3		246.1
Health:
Insurance policy income	397.1		403.5		798.5		810.2
Net investment income	74.3		73.0		148.3		146.3
Total health revenues	471.4		476.5		946.8		956.5
Life:
Insurance policy income	223.1		216.3		442.1		429.6
Net investment income	36.1		35.2		72.4		70.7
Total life revenues	259.2		251.5		514.5		500.3
Change in market values of the underlying options supporting the fixed indexed annuity and life products (offset by market value changes credited to policyholder balances)	62.3		(92.4)		80.9		(164.3)
Investment income not allocated to product lines	80.3		81.2		148.1		127.8
Fee revenue and other income:
Fee income	29.4		31.1		80.7		71.4
Amounts netted in expenses not allocated to product lines	1.5		24.3		3.1		27.1
Total segment revenues	$	1,039.9	$	895.8	$	2,040.4	$	1,764.9

(continued on next page)

2141

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

(continued from previous page)


		Three months ended				Nine months ended					Three months ended				Six months ended
		September 30,				September 30,					June 30,				June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Expenses:	Expenses:									Expenses:
Annuity:	Annuity:									Annuity:
Insurance policy benefits	Insurance policy benefits	$	23.7	$	16.2	$	69.1	$	23.7	Insurance policy benefits	$	10.6	$	6.8	$	19.3	$	16.3
Interest credited	Interest credited	46.3		38.1		129.9		113.7		Interest credited	50.6		41.4		98.7		83.9
Amortization and non-deferred commissions	Amortization and non-deferred commissions	13.8		14.5		43.8		47.8		Amortization and non-deferred commissions	17.5		15.3		33.9		29.9
Total annuity expenses	Total annuity expenses	83.8		68.8		242.8		185.2		Total annuity expenses	78.7		63.5		151.9		130.1
Health:	Health:									Health:
Insurance policy benefits	Insurance policy benefits	307.8		325.4		924.8		955.3		Insurance policy benefits	322.7		309.9		640.8		633.0
Amortization and non-deferred commissions	Amortization and non-deferred commissions	43.5		43.3		141.9		142.8		Amortization and non-deferred commissions	40.5		41.2		81.3		82.8
Total health expenses	Total health expenses	351.3		368.7		1,066.7		1,098.1		Total health expenses	363.2		351.1		722.1		715.8
Life:	Life:									Life:
Insurance policy benefits	Insurance policy benefits	142.6		141.3		444.6		454.4		Insurance policy benefits	142.8		127.7		290.0		280.8
Interest credited	Interest credited	12.2		11.1		35.1		32.7		Interest credited	12.2		11.7		24.3		23.7
Amortization, non-deferred commissions and advertising expense	Amortization, non-deferred commissions and advertising expense	51.8		41.2		152.4		132.9		Amortization, non-deferred commissions and advertising expense	46.3		41.9		94.9		89.6
Total life expenses	Total life expenses	206.6		193.6		632.1		620.0		Total life expenses	201.3		181.3		409.2		394.1
Allocated expenses	Allocated expenses	150.5		140.5		447.5		423.2		Allocated expenses	149.5		152.2		307.0		297.0
Expenses not allocated to product lines	Expenses not allocated to product lines	17.9		22.0		56.9		76.4		Expenses not allocated to product lines	22.6		21.4		42.5		39.0
Market value changes of options credited to fixed index annuity and life policyholders		(34.9)		7.2		(199.2)		125.8
Market value changes of options credited to fixed indexed annuity and life policyholders										Market value changes of options credited to fixed indexed annuity and life policyholders	62.3		(92.4)		80.9		(164.3)
Amounts netted in investment income not allocated to product lines:	Amounts netted in investment income not allocated to product lines:									Amounts netted in investment income not allocated to product lines:
Interest expense	Interest expense	25.9		17.9		64.3		54.2		Interest expense	39.8		20.3		77.2		38.4
Interest credited	Interest credited	7.2		—		21.3		—		Interest credited	7.2		7.2		14.4		14.1
Impact of annual option forfeitures related to fixed indexed annuity surrenders										Impact of annual option forfeitures related to fixed indexed annuity surrenders	(1.4)		.5		(1.4)		(1.1)
Amortization	Amortization	.3		—		1.1		—		Amortization	.4		.4		.8		.8
Other expenses	Other expenses	(2.0)		1.0		(18.0)		11.3		Other expenses	6.3		(11.8)		13.6		(16.0)
Expenses netted in fee revenue:	Expenses netted in fee revenue:									Expenses netted in fee revenue:
Commissions and other operating expenses	Commissions and other operating expenses	29.2		25.4		87.5		74.9		Commissions and other operating expenses	28.8		27.9		64.6		58.3
Total segment expenses	Total segment expenses	835.8		845.1		2,403.0		2,669.1		Total segment expenses	958.7		721.6		1,882.8		1,506.2
Pre-tax measure of profitability:	Pre-tax measure of profitability:									Pre-tax measure of profitability:
Annuity margin	Annuity margin	39.8		52.5		121.5		176.4		Annuity margin	57.1		60.1		114.4		116.0
Health margin	Health margin	124.1		117.9		362.3		363.5		Health margin	108.2		125.4		224.7		240.7
Life margin	Life margin	43.4		53.2		120.0		120.0		Life margin	57.9		70.2		105.3		106.2
Total insurance product margin	Total insurance product margin	207.3		223.6		603.8		659.9		Total insurance product margin	223.2		255.7		444.4		462.9
Allocated expenses	Allocated expenses	(150.5)		(140.5)		(447.5)		(423.2)		Allocated expenses	(149.5)		(152.2)		(307.0)		(297.0)
Income from insurance products	Income from insurance products	56.8		83.1		156.3		236.7		Income from insurance products	73.7		103.5		137.4		165.9
Fee income	Fee income	1.4		2.6		14.5		16.5		Fee income	.6		3.2		16.1		13.1
Investment income not allocated to product lines	Investment income not allocated to product lines	32.2		50.9		129.2		141.7		Investment income not allocated to product lines	28.0		64.6		43.5		91.6
Expenses not allocated to product lines	Expenses not allocated to product lines	(16.1)		(17.3)		(28.0)		(63.1)		Expenses not allocated to product lines	(21.1)		2.9		(39.4)		(11.9)
Operating earnings before taxes	Operating earnings before taxes	74.3		119.3		272.0		331.8		Operating earnings before taxes	81.2		174.2		157.6		258.7
Income tax expense on operating income	Income tax expense on operating income	17.4		26.5		63.9		74.7		Income tax expense on operating income	18.9		39.1		36.7		59.1
Net operating income	Net operating income	$	56.9	$	92.8	$	208.1	$	257.1	Net operating income	$	62.3	$	135.1	$	120.9	$	199.6

2242

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

A reconciliation of segment revenues and expenses to consolidated revenues and expenses and net income is as follows (dollars in millions):


		Three months ended				Nine months ended					Three months ended				Six months ended
		September 30,				September 30,					June 30,				June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Total segment revenues	Total segment revenues	$	910.1	$	964.4	$	2,675.0	$	3,000.9	Total segment revenues	$	1,039.9	$	895.8	$	2,040.4	$	1,764.9
Total investment gains (losses)		(17.7)		(2.3)		(99.2)		26.2
Total investment losses										Total investment losses	(35.3)		(48.8)		(49.9)		(81.5)
Revenues related to earnings attributable to VIEs	Revenues related to earnings attributable to VIEs	12.9		6.2		27.4		20.3		Revenues related to earnings attributable to VIEs	18.2		8.0		38.3		14.5
Consolidated revenues	Consolidated revenues	905.3		968.3		2,603.2		3,047.4		Consolidated revenues	1,022.8		855.0		2,028.8		1,697.9

Total segment expenses	Total segment expenses	835.8		845.1		2,403.0		2,669.1		Total segment expenses	958.7		721.6		1,882.8		1,506.2
Insurance policy benefits - fair value changes in embedded derivative liabilities		(92.7)		(14.5)		(326.5)		(64.3)
Amortization related to fair value changes in embedded derivative liabilities		26.7		3.6		90.0		16.2
Amortization related to investment gains (losses)		(.6)		.1		(1.7)		1.4
Insurance policy benefits - changes in fair value of embedded derivative liabilities and market risk benefits										Insurance policy benefits - changes in fair value of embedded derivative liabilities and market risk benefits	(50.4)		(160.6)		14.7		(326.0)
Expenses attributable to VIEs	Expenses attributable to VIEs	11.9		6.0		26.2		18.6		Expenses attributable to VIEs	18.4		8.2		36.2		14.3
Fair value changes related to agent deferred compensation plan	Fair value changes related to agent deferred compensation plan	(12.0)		—		(48.7)		(13.2)		Fair value changes related to agent deferred compensation plan	—		(14.0)		—		(36.7)

Other expenses		(1.0)		—		(1.0)		—

Consolidated expenses	Consolidated expenses	768.1		840.3		2,141.3		2,627.8		Consolidated expenses	926.7		555.2		1,933.7		1,157.8
Income before tax	Income before tax	137.2		128.0		461.9		419.6		Income before tax	96.1		299.8		95.1		540.1

Income tax expense on period income	Income tax expense on period income	32.2		28.2		108.5		94.4		Income tax expense on period income	22.4		66.5		22.2		123.4

Net income	Net income	$	105.0	$	99.8	$	353.4	$	325.2	Net income	73.7		$	233.3	$	72.9	$	416.7

2343

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

ACCOUNTING FOR DERIVATIVES

Our freestanding and embedded derivatives, which are not designated as hedging instruments, are held at fair value and are summarized as follows (dollars in millions):


		Fair value					Fair value
		September 30, 2022		December 31, 2021			June 30, 2023		December 31, 2022
Assets:	Assets:					Assets:
Other invested assets:	Other invested assets:					Other invested assets:
Fixed index call options		$	24.0	$	225.0
Other		—		2.5
Fixed indexed call options						Fixed indexed call options	$	194.2	$	56.7

Reinsurance receivables	Reinsurance receivables	(17.8)		(1.7)		Reinsurance receivables	(18.1)		(17.8)
Total assets	Total assets	$	6.2	$	225.8	Total assets	$	176.1	$	38.9
Liabilities:	Liabilities:					Liabilities:
Future policy benefits:	Future policy benefits:					Future policy benefits:
Fixed index products		$	1,253.9	$	1,724.1
Fixed indexed products						Fixed indexed products	$	1,355.4	$	1,297.0
Total liabilities	Total liabilities	$	1,253.9	$	1,724.1	Total liabilities	$	1,355.4	$	1,297.0

We are required to establish an embedded derivative related to a modified coinsurance agreement pursuant to which we assume the risks of a block of health insurance business. The embedded derivative represents the mark-to-market adjustment for approximately ~~$93~~$87 million in underlying investments held by the ceding reinsurer at ~~September~~June 30, ~~2022.~~2023.

Our fixed ~~index~~indexed annuity products provide a guaranteed minimum rate of return and a higher potential return that is based on a percentage (the "participation rate") of the amount of increase in the value of a particular index, such as the Standard & Poor's 500 Index, over a specified period. We are generally able to change the participation rate at the beginning of each index period (typically on each policy anniversary date), subject to contractual minimums. The Company accounts for the options attributed to the policyholder for the estimated life of the contract as embedded derivatives. These accounting requirements often create volatility in the earnings from these products. We typically buy call options (including call spreads) referenced to the applicable indices in an effort to offset or hedge potential increases to policyholder benefits resulting from increases in the particular index to which the policy's return is linked. The notional amount of these options was ~~$3.0~~$2.8 billion at both ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021.~~2022, respectively.

We purchase certain fixed maturity securities that contain embedded derivatives that are required to be held at fair value on the consolidated balance sheet. We have elected the fair value option to carry the entire security at fair value with changes in fair value recognized in net income.

2444

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table provides the pre-tax gains (losses) recognized in revenues for derivative instruments, which are not designated as hedges for the periods indicated (dollars in millions):


		Three months ended				Nine months ended					Three months ended				Six months ended
		September 30,				September 30,					June 30,				June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Net investment income (loss) from policyholder and other special-purpose portfolios:	Net investment income (loss) from policyholder and other special-purpose portfolios:									Net investment income (loss) from policyholder and other special-purpose portfolios:
Fixed index call options		$	(34.7)	$	7.4	$	(200.4)	$	127.0
Total investment losses:
Fixed indexed call options										Fixed indexed call options	$	61.3	$	(92.8)	$	79.9	$	(165.7)
Total investment gains (losses):										Total investment gains (losses):
Embedded derivative related to modified coinsurance agreement	Embedded derivative related to modified coinsurance agreement	(4.4)		(.7)		(16.1)		(1.9)		Embedded derivative related to modified coinsurance agreement	(1.7)		(5.2)		(.3)		(11.7)
Total revenues from derivative instruments, not designated as hedges	Total revenues from derivative instruments, not designated as hedges	$	(39.1)	$	6.7	$	(216.5)	$	125.1	Total revenues from derivative instruments, not designated as hedges	$	59.6	$	(98.0)	$	79.6	$	(177.4)

Derivative Counterparty Risk

If the counterparties to the call options fail to meet their obligations, we may recognize a loss. We limit our exposure to such a loss by diversifying among several counterparties believed to be strong and creditworthy. At ~~September~~June 30, ~~2022,~~2023, all of our counterparties were rated "A" or higher by S&P Global Ratings ("S&P").

The Company and its subsidiaries are parties to master netting arrangements with its counterparties related to entering into various derivative contracts.

The following table summarizes information related to derivatives with master netting arrangements or collateral as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 (dollars in millions):

Gross amounts not offset in the balance sheet
Gross amounts recognized Gross amounts offset in the balance sheet Net amounts of assets presented in the balance sheet Financial instruments Cash collateral received Net amount
September 30, 2022:
Fixed index call options $ 24.0 $ — $ 24.0 $ — $ — $ 24.0
December 31, 2021:
Fixed index call options 225.0 — 225.0 — — 225.0


								Gross amounts not offset in the balance sheet
		Gross amounts recognized		Gross amounts offset in the balance sheet		Net amounts of assets presented in the balance sheet		Financial instruments		Cash collateral received		Net amount
June 30, 2023:
	Fixed indexed call options	$	194.2	$	—	$	194.2	$	—	$	—	$	194.2
December 31, 2022:
	Fixed indexed call options	56.7		—		56.7		—		—		56.7

REINSURANCE

The cost of reinsurance ceded totaled ~~$51.9~~$49.7 million and ~~$54.3~~$49.1 million in the ~~third~~second quarters of ~~2022~~2023 and ~~2021,~~2022, respectively, and ~~$153.0~~$98.0 million and ~~$163.3~~$101.1 million in the first ~~nine~~six months of ~~2022~~2023 and ~~2021,~~2022, respectively. We deduct this cost from insurance policy income. Reinsurance recoveries netted against insurance policy benefits totaled ~~$56.2~~$86.9 million and ~~$76.5~~$80.5 million in the ~~third~~second quarters of ~~2022~~2023 and ~~2021,~~2022, respectively, and ~~$230.6~~$221.8 million and ~~$232.9~~$200.9 million in the first ~~nine~~six months of ~~2022~~2023 and ~~2021,~~2022, respectively.

From time to time, we assume insurance from other companies. Any costs associated with the assumption of insurance are amortized consistent with the method used to amortize deferred acquisition costs. Reinsurance premiums assumed totaled ~~$4.7~~$4.3 million and ~~$5.1~~$4.6 million in the ~~third~~second quarters of ~~2022~~2023 and ~~2021,~~2022, respectively, and ~~$14.2~~$8.4 million and ~~$15.4~~$9.5 million in the first ~~nine~~six months of ~~2022~~2023 and ~~2021,~~2022, respectively. Insurance policy benefits related to reinsurance assumed totaled ~~$6.4~~$5.8 million and ~~$6.4~~$7.0 million in the ~~third~~second quarters of ~~2022~~2023 and ~~2021,~~2022, respectively, and ~~$19.5~~$10.5 million and ~~$21.7~~$12.5 million in the first ~~nine~~six months of ~~2022~~2023 and ~~2021,~~2022, respectively.

2545

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

INCOME TAXES

The Company's interim tax expense is based upon the estimated annual effective tax rate for the respective period. Under authoritative guidance, certain items are required to be excluded from the estimated annual effective tax rate calculation. Such items include changes in judgment about the realizability of deferred tax assets resulting from changes in projections of income expected to be available in future years, and items deemed to be unusual, infrequent, or that cannot be reliably estimated. In these cases, the actual tax expense or benefit applicable to that item is treated discretely and is reported in the same period as the related item. The components of income tax expense are as follows (dollars in millions):


		Three months ended				Nine months ended					Three months ended				Six months ended
		September 30,				September 30,					June 30,				June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Current tax expense	Current tax expense	$	14.9	$	14.1	$	19.9	$	50.9	Current tax expense	$	19.7	$	.6	$	33.7	$	5.0
Deferred tax expense		17.3		14.1		88.6		43.5
Deferred tax expense (benefit)										Deferred tax expense (benefit)	2.7		65.9		(11.5)		118.4

Total income tax expense	Total income tax expense	$	32.2	$	28.2	$	108.5	$	94.4	Total income tax expense	$	22.4	$	66.5	$	22.2	$	123.4

A reconciliation of the U.S. statutory corporate tax rate to the estimated annual effective rate, reflected in the consolidated statement of operations is as follows:


		Nine months ended					Six months ended
		September 30,					June 30,
		2022		2021			2023		2022
U.S. statutory corporate rate	U.S. statutory corporate rate	21.0	%	21.0	%	U.S. statutory corporate rate	21.0	%	21.0	%

Non-taxable income and nondeductible benefits, net	Non-taxable income and nondeductible benefits, net	—		(.1)		Non-taxable income and nondeductible benefits, net	(.5)		(.4)

State taxes	State taxes	2.5		1.6		State taxes	2.8		2.2

Effective tax rate	Effective tax rate	23.5	%	22.5	%	Effective tax rate	23.3	%	22.8	%

The increase in our effective tax rate in the first nine months of 2022 was driven by a new Illinois income tax regulation that will limit our use of Illinois net operating loss carryforwards ("NOLs") in 2022 and 2023, triggering retaliatory taxes in other states.

2646

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The components of the Company's income tax assets and liabilities are summarized below (dollars in millions):


		September 30, 2022		December 31, 2021			June 30, 2023		December 31, 2022
Deferred tax assets:	Deferred tax assets:					Deferred tax assets:
Net federal operating loss carryforwards	Net federal operating loss carryforwards	$	188.4	$	241.4	Net federal operating loss carryforwards	$	123.8	$	166.0
Net state operating loss carryforwards	Net state operating loss carryforwards	2.5		2.3		Net state operating loss carryforwards	2.5		2.5

Insurance liabilities	Insurance liabilities	302.3		390.7		Insurance liabilities	341.7		298.5
Indirect costs allocable to self-constructed real estate assets	Indirect costs allocable to self-constructed real estate assets	199.3		158.3		Indirect costs allocable to self-constructed real estate assets	234.9		214.8
Accumulated other comprehensive loss	Accumulated other comprehensive loss	606.3		—		Accumulated other comprehensive loss	489.3		552.4
Other	Other	9.4		27.5		Other	.8		7.3
Gross deferred tax assets	Gross deferred tax assets	1,308.2		820.2		Gross deferred tax assets	1,193.0		1,241.5
Deferred tax liabilities:	Deferred tax liabilities:					Deferred tax liabilities:
Investments	Investments	(35.6)		(48.2)		Investments	(32.4)		(37.2)
Present value of future profits and deferred acquisition costs	Present value of future profits and deferred acquisition costs	(99.3)		(119.4)		Present value of future profits and deferred acquisition costs	(155.9)		(148.9)
Accumulated other comprehensive income		—		(540.4)
Other						Other	—		—
Gross deferred tax liabilities	Gross deferred tax liabilities	(134.9)		(708.0)		Gross deferred tax liabilities	(188.3)		(186.1)

Net deferred tax assets	Net deferred tax assets	1,173.3		112.2		Net deferred tax assets	1,004.7		1,055.4
Current income taxes prepaid	Current income taxes prepaid	6.9		6.1		Current income taxes prepaid	2.4		8.0
Income tax assets, net	Income tax assets, net	$	1,180.2	$	118.3	Income tax assets, net	$	1,007.1	$	1,063.4

Our income tax expense includes deferred income taxes arising from temporary differences between the financial reporting and tax bases of assets and liabilities and ~~NOLs.~~net operating loss carryforwards ("NOLs"). Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which temporary differences are expected to be recovered or paid. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in earnings in the period when the changes are enacted.

A reduction of the net carrying amount of deferred tax assets by establishing a valuation allowance is required if, based on the available evidence, it is more likely than not that such assets will not be realized. In assessing the need for a valuation allowance, all available evidence, both positive and negative, are considered to determine whether, based on the weight of that evidence, a valuation allowance for deferred tax assets is needed. This assessment requires significant judgment and considers, among other matters, the nature, frequency and severity of current and cumulative losses, forecasts of future profitability, the duration of carryforward periods, our experience with operating loss and tax credit carryforwards expiring unused, and tax planning strategies.

We evaluate the need to establish a valuation allowance for our deferred income tax assets on an ongoing basis using a deferred tax valuation model. Our model is adjusted to reflect changes in our projections of future taxable income including changes resulting from the Tax Cuts and Jobs Act, investment strategies, the impact of the sale or reinsurance of business, the recapture of business previously ceded, tax planning strategies and the COVID-19 pandemic.income. Our estimates of future taxable income are based on evidence we consider to be objectively verifiable. At ~~September~~June 30, ~~2022,~~2023, our projection of future taxable income for purposes of determining the valuation allowance is based on our estimates of such future taxable income through the date our NOLs expire. Such estimates are subject to ~~the~~numerous risks and uncertainties ~~associated with the COVID-19 pandemic~~ and the extent to which actual impacts differ from the assumptions used in our deferred tax valuation model. Based on our assessment, we have concluded that it is more likely than not that all our deferred tax assets of ~~$1,173.3~~$1,004.7 million will be realized through future taxable earnings.

Recovery of our deferred tax asset is dependent on achieving the level of future taxable income projected in our deferred tax valuation model and failure to do so could result in ~~an increase in~~ the recognition of a valuation allowance in a future period. ~~Any future increase in the~~The recognition of a valuation allowance ~~may result in additional~~would increase income tax expense and reduce shareholders' equity, and such an increase could have a significant impact upon our earnings in the future.

The Internal Revenue Code (the "Code") limits the extent to which losses realized by a non-life entity (or entities) may offset income from a life insurance company (or companies) to the lesser of: (i) 35 percent of the income of the life insurance company; or (ii) 35 percent of the total loss of the non-life entities (including NOLs of the non-life entities). There is no similar

2747

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

~~company; or (ii) 35 percent of the total loss of the non-life entities (including NOLs of the non-life entities). There is no similar~~ limitation on the extent to which losses realized by a life insurance entity (or entities) may offset income from a non-life entity (or entities).

Section 382 of the Code imposes limitations on a corporation's ability to use its NOLs when the company undergoes a 50 percent ownership change over a three-year period. Future transactions and the timing of such transactions could cause an ownership change for Section 382 income tax purposes. Such transactions may include, but are not limited to, additional repurchases under our securities repurchase program, issuances of common stock and acquisitions or sales of shares of CNO stock by certain holders of our shares, including persons who have held, currently hold or may accumulate in the future five percent or more of our outstanding common stock for their own account. Many of these transactions are beyond our control. If an additional ownership change were to occur for purposes of Section 382, we would be required to calculate an annual restriction on the use of our NOLs to offset future taxable income. The annual restriction would be calculated based upon the value of CNO's equity at the time of such ownership change, multiplied by a federal long-term tax exempt rate ~~(2.54~~(3.04 percent at ~~September~~June 30, ~~2022)~~2023), and the annual restriction could limit our ability to use a substantial portion of our NOLs to offset future taxable income. We regularly monitor ownership change (as calculated for purposes of Section 382) and, as of ~~September~~June 30, ~~2022,~~2023, we were below the 50 percent ownership change level that could limit our ability to utilize our NOLs.

We have ~~$0.9 billion~~$589.6 million of federal non-life NOLs as of ~~September~~June 30, ~~2022,~~2023, as summarized below (dollars in millions):


		Net operating loss			Net operating loss
Year of expiration	Year of expiration	carryforwards		Year of expiration	carryforwards
2023	2023	$	310.8	2023	$	3.0
2025	2025	85.2		2025	85.2
2026	2026	149.9		2026	149.9
2027	2027	10.8		2027	10.8
2028	2028	80.3		2028	80.3
2029	2029	213.2		2029	213.2
2030	2030	.3		2030	.3
2031	2031	.2		2031	.2
2032	2032	44.4		2032	44.4
2033	2033	.6		2033	.6
2034	2034	.9		2034	.9
2035	2035	.8		2035	.8
Total federal non-life NOLs	Total federal non-life NOLs	$	897.4	Total federal non-life NOLs	$	589.6

Our non-life NOLs can be used to offset 35 percent of life insurance company taxable income and 100 percent of non-life company taxable income until all non-life NOLs are utilized or expire.

We also had deferred tax assets related to NOLs for state income taxes of $2.5 million ~~and $2.3 million~~ at ~~September~~both June 30, ~~2022~~2023 and December 31, ~~2021, respectively.~~2022. The related state NOLs are available to offset future state taxable income in certain states and are expected to be fully utilized prior to expiration.

The ~~IRS~~Internal Revenue Service is conducting an examination of our 2016 through 2018 tax returns. The federal statute of limitations remains open with respect to tax years 2016 through ~~2021.~~2022. The Company’s various state income tax returns are generally open for tax years based on individual state statutes of limitation. Generally, for tax years which generate NOLs, capital losses or tax credit carryforwards, the statute remains open until the expiration of the statute of limitations for the tax year in which such carryforwards are utilized. The outcome of tax audits cannot be predicted with certainty. If the Company’s tax audits are not resolved in a manner consistent with management’s expectations, the Company may be required to adjust its provision for income taxes.

2848

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS

The following notes payable were direct corporate obligations of the Company as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 (dollars in millions):


		September 30, 2022		December 31, 2021			June 30, 2023		December 31, 2022
5.250% Senior Notes due May 2025	5.250% Senior Notes due May 2025	$	500.0	$	500.0	5.250% Senior Notes due May 2025	$	500.0	$	500.0
5.250% Senior Notes due May 2029	5.250% Senior Notes due May 2029	500.0		500.0		5.250% Senior Notes due May 2029	500.0		500.0
5.125% Subordinated Debentures due November 2060	5.125% Subordinated Debentures due November 2060	150.0		150.0		5.125% Subordinated Debentures due November 2060	150.0		150.0
Revolving Credit Agreement (as defined below)	Revolving Credit Agreement (as defined below)	—		—		Revolving Credit Agreement (as defined below)	—		—
Unamortized debt issue costs	Unamortized debt issue costs	(11.6)		(12.7)		Unamortized debt issue costs	(10.3)		(11.2)
Direct corporate obligations	Direct corporate obligations	$	1,138.4	$	1,137.3	Direct corporate obligations	$	1,139.7	$	1,138.8

Revolving Credit Agreement

~~On July 16, 2021, the Company amended and restated its~~The $250.0 million revolving credit agreement ~~(as so amended and restated, the~~(the "Revolving Credit Agreement")~~. The Revolving Credit Agreement,~~, among other things, (i) requires the Company to maintain (each as calculated in accordance with the Revolving Credit Agreement): (i) a debt to total capitalization ratio (excluding hybrid securities, except to the extent that the aggregate amount outstanding of all such hybrid securities exceeds an amount equal to 15 percent of total capitalization) of not more than 35.0 percent (such ratio was ~~22.0~~21.3 percent at ~~September~~June 30, ~~2022)~~2023); and (ii) a minimum consolidated net worth of not less than the sum of (x) $2,674 million plus (y) 25.0 percent of the net equity proceeds received by the Company from the issuance and sale of equity interests in the Company (the Company's consolidated net worth was ~~$3,463.6~~$3,729.3 million at ~~September~~June 30, ~~2022~~2023 compared to the minimum requirement of ~~$2,692.7~~$2,696.3 million). The maturity date of the Revolving Credit Agreement is July 16, 2026. The Revolving Credit Agreement contains certain other restrictive covenants with which the Company must comply. The interest rate applicable to loans under the Revolving Credit Agreement is calculated as the ~~eurodollar rate~~Secured Overnight Financing Rate ("SOFR") (plus a credit spread adjustment of 0.10 percent for all available interest periods) or the base rate, at the Company’s option, plus a margin based on the Company’s unsecured debt rating. The margins under the Revolving Credit Agreement range from 1.375 percent to 2.125 percent, in the case of loans at the ~~eurodollar rate,~~SOFR, and 0.375 percent to 1.125 percent, in the case of loans at the base rate. The commitment fee under the Revolving Credit Agreement is based on the Company's unsecured debt ~~rating and the Revolving Credit Agreement includes updated LIBOR fallback provisions.~~rating. There were no amounts outstanding under the Revolving Credit Agreement during the ~~nine~~six months ended ~~September~~June 30, ~~2022.~~2023.

INVESTMENT BORROWINGS

Three of the Company's insurance subsidiaries (Bankers Life and Casualty Company ("Bankers Life"), Washington National Insurance Company ("Washington National") and Colonial Penn Life Insurance Company ("Colonial Penn")) are members of the FHLB. As members of the FHLB, our insurance subsidiaries have the ability to borrow on a collateralized basis from the FHLB. We are required to hold certain minimum amounts of FHLB common stock as a condition of membership in the FHLB, and additional amounts based on the amount of the borrowings. At ~~September~~June 30, ~~2022,~~2023, the carrying value of the FHLB common stock was ~~$75.2~~$79.7 million. As of ~~September~~June 30, ~~2022,~~2023, collateralized borrowings from the FHLB totaled ~~$1.6~~$1.8 billion and the proceeds were used to purchase matched variable rate fixed maturity securities. The borrowings are classified as investment borrowings in the accompanying consolidated balance sheet. The borrowings are collateralized by investments with an estimated fair value of ~~$2.1~~$2.3 billion at ~~September~~June 30, ~~2022,~~2023, which are maintained in a custodial account for the benefit of the FHLB. Substantially all of such investments are classified as fixed maturities, available for sale, in our consolidated balance sheet.

2949

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following summarizes the terms of the borrowings from the FHLB by our insurance subsidiaries (dollars in millions):

Amount

Maturity

Interest rate at

borrowed

date

~~September~~June 30, ~~2022~~2023

~~21.0~~

~~March 2023~~

~~Fixed rate – 2.160%~~

~~50.0~~

~~July 2023~~

~~Variable rate – 3.170%~~

~~100.0~~

~~July 2023~~

~~Variable rate – 3.170%~~

~~50.0~~

~~July 2023~~

~~Variable rate – 3.170%~~

100.0

April 2024

Variable rate – ~~3.080%~~

~~50.0~~

~~May 2024~~

~~Variable rate – 3.643%~~5.366%

22.0

May 2024

Variable rate – ~~3.319%~~

~~75.0~~

~~June 2024~~

~~Variable rate – 3.951%~~

~~100.0~~

~~July 2024~~

~~Variable rate – 2.595%~~5.667%

15.5

July 2024

Fixed rate – 1.990%

~~34.5~~

~~July 2024~~

~~Variable rate – 3.266%~~

~~15.0~~

~~July 2024~~

~~Variable rate – 3.256%~~

27.0

August 2024

Fixed rate – .640%

~~25.0~~

~~September 2024~~

~~Variable rate – 3.726%~~

21.7

May 2025

Variable rate – ~~3.389%~~5.464%

~~18.7~~18.3

June 2025

Fixed rate – 2.940%

12.5

June 2025

Variable rate – 5.630%

125.0

September 2025

Variable rate – ~~3.310%~~5.410%

100.0

October 2025

Variable rate – ~~3.234%~~5.621%

100.0

October 2025

Variable rate – ~~3.330%~~5.616%

57.7

October 2025

Variable rate – ~~3.068%~~5.574%

50.0

November 2025

Variable rate – ~~3.394%~~5.577%

12.5

December 2025

Variable rate – 5.646%

50.0

January 2026

Variable rate – ~~3.013%~~5.400%

50.0

January 2026

Variable rate – ~~2.935%~~5.514%

100.0

January 2026

Variable rate – ~~3.029%~~5.536%

15.0

January 2026

Variable rate – 5.727%

21.8

May 2026

Variable rate – ~~2.919%~~5.426%

50.0

May 2026

Variable rate – ~~3.230%~~5.330%

75.0

December 2026

Variable rate – 5.486%

75.0

January 2027

Variable rate – 5.243%

50.0

January 2027

Variable rate – 5.331%

50.0

January 2027

Variable rate – 5.556%

100.0

February 2027

Variable rate – 5.526%

50.0

April 2027

Variable rate – ~~3.261%~~5.427%

50.0

May 2027

Variable rate – ~~3.271%~~5.437%

100.0

June 2027

Variable rate – ~~3.330%~~5.430%

10.0

June 2027

Variable rate – ~~3.553%~~5.653%

75.0

January 2028

Variable rate – 5.524%

50.0

January 2028

Variable rate – 5.371%

50.0

January 2028

Variable rate – 5.611%

34.5

February 2028

Variable rate – 5.644%

21.0

February 2028

Variable rate – 5.531%

100.0

February 2028

Variable rate – 5.546%

~~1,639.9~~1,839.5

~~The~~Generally, the variable ~~rate borrowings are pre-payable on each interest reset date without penalty. The~~and fixed rate borrowings are ~~pre-payable subject to payment of a yield maintenance fee based on prevailing market interest rates.~~pre-payable. At ~~September~~June 30, ~~2022,~~2023, the aggregate ~~yield maintenance fee to prepay all fixed rate~~prepayment penalty on such outstanding borrowings was ~~$1.0 million.~~not material.

Interest expense of ~~$17.4~~$45.9 million and ~~$7.5~~$7.1 million in the first ~~nine~~six months of ~~2022~~2023 and ~~2021,~~2022, respectively, was recognized related to total borrowings from the ~~FHLB.~~

FHLB, reflecting higher interest rates on the variable rate investment borrowings in the 2023 period.

3050

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

CHANGES IN COMMON STOCK

In the first ~~nine~~six months of ~~2022,~~2023, we repurchased ~~7.2~~2.0 million shares of common stock for ~~$170.0~~$45.1 million under our securities repurchase ~~program.~~program (including $0.9 million of repurchases settled in the third quarter of 2023). In May 2023, the Company's Board of Directors approved an additional $500.0 million to repurchase the Company's outstanding shares of common stock. The Company had remaining repurchase authority of ~~$196.9~~$641.8 million as of ~~September~~June 30, ~~2022.~~2023.

In the first ~~nine~~six months of ~~2022,~~2023, we issued 1.3 million shares of common stock, net of shares withheld to pay tax withholdings, pursuant to employee benefit plans.

In the first six months of 2023, dividends declared on common stock totaled ~~$48.7~~$33.8 million ($~~0.41~~0.29 per common share). In May ~~2022,~~2023, the Company increased its quarterly common stock dividend to ~~$0.14~~$0.15 per share from ~~$0.13~~$0.14 per share.

~~SALES INDUCEMENTS~~

Certain of our annuity products offer sales inducements to contract holders in the form of enhanced crediting rates or bonus payments in the initial period of the contract. Certain of our life insurance products offer persistency bonuses credited to the contract holder's balance after the policy has been outstanding for a specified period of time. These enhanced rates and persistency bonuses are considered sales inducements in accordance with GAAP. Such amounts are deferred and amortized in the same manner as deferred acquisition costs. Sales inducements deferred totaled $15.8 million and $12.2 million during the nine months ended September 30, 2022 and 2021, respectively. Amounts amortized totaled $20.0 million and $10.2 million during the nine months ended September 30, 2022 and 2021, respectively. The unamortized balance of deferred sales inducements was $57.0 million and $61.2 million at September 30, 2022 and December 31, 2021, respectively.

~~RECENTLY ISSUED ACCOUNTING STANDARDS~~

~~Pending Accounting Standards~~

In August 2018, the Financial Accounting Standards Board issued authoritative guidance revising the accounting for long-duration insurance contracts. The new guidance: (i) improves the timeliness of recognizing changes in the liability for future benefits and modifies the rate used to discount future cash flows; (ii) simplifies and improves the accounting for certain market-based options or guarantees associated with deposit (or account balance) contracts; (iii) simplifies the amortization of deferred acquisition costs; and (iv) requires enhanced disclosures, including disaggregated rollforwards of the liability for future policy benefits, policyholder account liabilities, market risk benefits and deferred acquisition costs. Additionally, qualitative and quantitative information about expected cash flows, estimates and assumptions will be required. The new measurement guidance for traditional and limited-payment contract liabilities and the new guidance for the amortization of deferred acquisition costs are required to be adopted on a modified retrospective transition approach, with an option to elect a full retrospective transition if certain criteria are met. The transition approach for deferred acquisition costs is required to be consistent with the transition applied to the liability for future policyholder benefits. Under the modified retrospective approach, for contracts in-force at the transition date, an entity would continue to use the existing locked-in investment yield interest rate assumption to calculate the net premium ratio, rather than the upper-medium grade fixed-income corporate instrument yield. However, for balance sheet remeasurement purposes, the current upper-medium grade fixed-income corporate instrument yield would be used at transition through accumulated other comprehensive income (loss) and subsequently through other comprehensive income. For market risk benefits, retrospective application is required, with the ability to use hindsight to measure fair value components to the extent assumptions in a prior period are unobservable or otherwise unavailable.

~~We have selected the modified retrospective transition method, except for market risk benefits where we are required to use the full retrospective approach.~~

We have made progress in determining certain accounting decisions related to the standard including, but not limited to, conclusions related to: (i) the method to determine discount rates; (ii) a process to group policies into cohorts for the measurement of future policy benefits; (iii) a process to develop experience studies at a cohort level to substantiate mortality, morbidity, terminations and other actuarial assumptions; and (iv) a method to estimate the fair value of certain annuity product features which guarantee a defined stream of income to the policyholder for life (which is considered a market risk benefit).

With respect to the method to determine interest rates, we have made certain conclusions, but we continue to refine our methodology. The process involves the determination of discount rate curves for discounting cash flows to calculate the liability for future policy benefits at a cohort level. Each discount rate curve is developed to reflect the duration characteristics

~~Table of Contents~~

~~CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES~~

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~

~~___________________~~

~~of the underlying insurance liabilities using discount rates comparable to upper-medium grade (low credit risk) fixed income yields. Discount rates will be updated quarterly.~~

Our long duration insurance contracts will be grouped into annual calendar-year cohorts primarily based on the contractual issue date, marketing distribution channel, legal entity and product type. Single premium contracts will be grouped into separate cohorts from other traditional products. Riders will generally be combined with the base policy. Insurance contracts which were issued prior to September 10, 2003 (the effective date of the bankruptcy reorganization of Conseco, Inc. (our Predecessor)) will be grouped by marketing distribution channel, legal entity and product type in a single issue year cohort.

Using the cash flow assumptions underlying our insurance contracts, we have completed preliminary testing of the potential loss recognition on the January 1, 2021 transition date (the "Transition Date"). Under the new guidance, this testing is performed at the Transition Date at a cohort level, rather than the current requirements to aggregate all vintages within a block.

Although we do not have variable annuity business with guaranteed features considered "market risk benefits," we do issue certain fixed index annuities with lifetime income riders. These riders are currently accounted for using traditional insurance accounting, but must be carried at fair value under the new standard. We have made preliminary determinations of the Transition Date impact of this change.

We continue to evaluate the impact of adoption and expect that the adoption will have a significant impact on our financial position, results of operations, and disclosures. We anticipate that the requirement to update assumptions for the liability for future policy benefits will have a significant impact on our results of operations, systems, processes and controls and that the requirement to update discount rates will have a significant impact on shareholders’ equity.

Based upon the modified retrospective transition method, we currently estimate that the new discount rate impact from adoption on the Transition Date is likely to result in a decrease to the accumulated other comprehensive income (loss) balance in the range of approximately $1,800 million to $2,200 million, resulting in a balance approximating zero at the Transition Date. This is primarily due to updating the liability for future policy benefits discount rate assumptions from the rates locked in for reserves held as of the Transition Date to rates determined by reference to the Transition Date market level yields for upper-medium-grade (low credit risk) fixed income instruments as of December 31, 2020. The impacts on accumulated other comprehensive income (loss) in periods following the Transition Date will be based on market yields in effect on the date of the financial statements, and such impact may differ significantly from the estimated range disclosed above.

In addition, we currently estimate that the Transition Date impact on retained earnings will be a decrease in the range of approximately $100 million to $200 million primarily due to certain "cohorts" of older long-term care policies having negative margins. The overall margin on our long-term care block continues to be positive. In addition, our estimate of the Transition Date impact on retained earnings includes the impact of carrying the lifetime income riders on certain fixed index annuities at fair value. The estimated impact on retained earnings is based on numerous assumptions and preliminary methodologies including: (i) our methodology of defining cohorts; (ii) the assumptions used to estimate the market value of features which guarantee a defined stream of income to the policyholder for life; and (iii) numerous assumptions regarding future policy benefits.

Under the new standard, we estimate that recast GAAP earnings from the Transition Date into 2021 and 2022 will be modestly higher and less volatile. We base this estimate on a number of factors: First, there is less quarter-to-quarter volatility in most products as temporary deviations from experience (including the impacts of COVID-19) are offset by reserve changes. This is different than current GAAP accounting for health and traditional life products where no such change to reserves is made for temporary deviations from experience. Second, the gradual release of provisions for adverse deviations or PADs, embedded in our transition balance sheet reserves are expected to positively impact earnings. This will affect our health and traditional life inforce blocks of business and will be spread over the remaining life of those blocks. Third, we expect positive impacts from lower amortization of deferred acquisition costs and other similar intangible assets. Fourth, the transition impacts to retained earnings, primarily from reserve changes on certain cohorts of older long-term care policies, will increase earnings in 2021 and 2022 due to favorable experience during these periods. This positive impact is not expected to persist materially past year-end 2022.

We are testing our reporting and disclosure capabilities under the new guidance for post-Transition Date accounting periods. We are also enhancing certain modeling, data management, experience study and analytical capabilities and increasing

~~Table of Contents~~

~~CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES~~

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~

~~___________________~~

the automation of key reporting and analytical processes. As part of our implementation plan, we are putting in place internal controls related to the new processes and will continue to refine and develop these internal controls until the formal implementation of the new standard in the first quarter of 2023. The actual impact of adoption will be updated as the model validation, system testing and parallel runs continue through the remainder of 2022; therefore, our estimates are subject to change.

LITIGATION AND OTHER LEGAL PROCEEDINGS

Legal Proceedings

The Company and its subsidiaries are involved in various legal actions in the normal course of business, in which claims for compensatory and punitive damages are asserted, some for substantial amounts. We recognize an estimated loss from these loss contingencies when we believe it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Some of the pending matters have been filed as purported class actions and some actions have been filed in certain jurisdictions that permit punitive damage awards that are disproportionate to the actual damages incurred. The amounts sought in certain of these actions are often large or indeterminate and the ultimate outcome of certain actions is difficult to predict. In the event of an adverse outcome in one or more of these matters, there is a possibility that the ultimate liability may be in excess of the liabilities we have established and could have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, the resolution of pending or future litigation may involve modifications to the terms of outstanding insurance policies or could impact the timing and amount of rate increases, which could adversely affect the future profitability of the related insurance policies. Based upon information presently available, and in light of legal, factual and other defenses available to the Company and its subsidiaries, the Company does not believe that it is probable that the ultimate liability from either pending or threatened legal actions, after consideration of existing loss provisions, will have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows. However, given the inherent difficulty in predicting the outcome of legal proceedings, there exists the possibility that such legal actions could have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows.

In addition to the inherent difficulty of predicting litigation outcomes, particularly those that will be decided by a jury, some matters purport to seek substantial or an unspecified amount of damages for unsubstantiated conduct spanning several years based on complex legal theories and damages models. The alleged damages typically are indeterminate or not factually supported in the complaint, and, in any event, the Company's experience indicates that monetary demands for damages often bear little relation to the ultimate loss. In some cases, plaintiffs are seeking to certify classes in the litigation and class certification either has been denied or is pending and we have filed oppositions to class certification or sought to decertify a prior class certification. In addition, for many of these cases: (i) there is uncertainty as to the outcome of pending appeals or motions; (ii) there are significant factual issues to be resolved; and/or (iii) there are novel legal issues presented. Accordingly, the Company cannot reasonably estimate the possible loss or range of loss in excess of amounts accrued, if any, or predict the timing of the eventual resolution of these matters. The Company reviews these matters on an ongoing basis. When assessing reasonably possible and probable outcomes, the Company bases its assessment on the expected ultimate outcome following all appeals.

On April 9, 2019, Bankers Conseco Life Insurance Company ("BCLIC") and Washington National commenced an action entitled Bankers Conseco Life Insurance Company and Washington National Insurance Company v. Wilmington Trust, National Association, in the Supreme Court of the State of New York, County of New York, Commercial Division (the "Wilmington Action"). BCLIC and Washington National seek an unspecified amount of damages, costs, attorney's fees, and other relief as the court deems appropriate. In the Wilmington Action, BCLIC and Washington National assert claims against Wilmington Trust, National Association ("Wilmington") for breaching its express contractual obligations under four trust agreements pursuant to which Wilmington was the trustee in regard to trust assets ceded as part of reinsurance agreements with

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

Beechwood Re Ltd. ("BRe"), as well as for breaching its fiduciary duties to BCLIC and Washington National. The Court granted Wilmington's motion to dismiss this litigation. BCLIC and Washington National appealed the Court's decision. On April 20, 2021, the New York Appellate Division of the Supreme Court, First Judicial Department unanimously reversed the trial court and reinstated breach of contract and breach of fiduciary duty claims against Wilmington. ~~The~~As of June 30, 2023, the Wilmington Action ~~is currently~~was pending in the Supreme Court of the State of New York, County of New York, Commercial Division.

On June 7, 2019, the Joint Official Liquidators of Platinum Partners Value Arbitrage Fund L.P. (in Official Liquidation) and Principal Growth Strategies, LLC, commenced suit against, among others, CNO Financial Group, Inc., BCLIC,

~~Table of Contents~~

~~CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES~~

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~

~~___________________~~

Washington National and 40|86 Advisors, Inc. (collectively, the "CNO Parties") in Delaware Chancery Court. Plaintiffs seek an unspecified amount of damages, costs, attorney's fees, and other relief as the court deems appropriate. Plaintiffs allege that the CNO Parties were unjustly enriched when they terminated BCLIC and Washington National's reinsurance agreements with BRe and recaptured assets from reinsurance trusts, in particular, Agera securities. Plaintiffs contend that the Agera securities were fraudulently transferred to the reinsurance trusts by other Platinum-related entities and they are seeking to claw back those Agera securities, or the value of those assets, from the CNO Parties. The CNO Parties are vigorously contesting the plaintiff's claims. The CNO Parties had removed the case to the United States District Court for the District of Delaware but on April 6, 2020, the District Court granted the plaintiff's motion to remand the case back to the Delaware Chancery Court. Plaintiffs have filed an Amended Complaint and the CNO Parties have moved to dismiss the Amended Complaint. The Delaware Chancery Court denied the CNO Parties’ motions to dismiss the Amended Complaint on the basis of forum non conveniens, but granted the CNO Parties’ motion to stay the case pending the conclusion of a related matter. After the stay is lifted, the court will address the CNO Parties’ and other defendants’ motions to dismiss the Amended Complaint on numerous other grounds.

On June 28, 2019, BCLIC and Washington National commenced an action entitled Bankers Conseco Life Insurance Company and Washington National Insurance Company v. KPMG LLP, in the Supreme Court of the State of New York, County of New York, Commercial Division (the "KPMG Action"). BCLIC and Washington National seek an unspecified amount of damages, costs, attorney's fees, and other relief as the court deems appropriate. In the KPMG Action, BCLIC and Washington National assert claims against KPMG LLP ("KPMG") for aiding and abetting fraud, constructive fraud and negligent misrepresentation arising from KPMG's alleged role in the Platinum Partners' scheme to defraud BCLIC and Washington National into reinsuring its long-term care business with BRe. The Court granted KPMG’s motion to dismiss this litigation. BCLIC and Washington National appealed the Court's decision. On December 1, 2020, the New York Appellate Division of the Supreme Court, First Judicial Department unanimously reversed the trial court and reinstated the aiding and abetting claim against KPMG. ~~The~~As of June 30, 2023, the KPMG Action ~~is currently~~was pending in the Supreme Court of the State of New York, County of New York, Commercial Division.

On October 5, 2012, plaintiffs William Jeffrey Burnett and Joe H. Camp commenced an action entitled Burnett v. Conseco Life Ins. Co. against, among others, CNO Financial Group, Inc. and CNO Services, LLC (collectively, the "CNO Entities") in the United States District Court for the Central District of California on behalf of a putative class of former interest-sensitive whole life insurance policyholders who surrendered their policies or let them lapse. Plaintiffs' ~~First Amended Complaint~~first amended complaint alleges that the CNO Entities are liable under an alter ego theory for Conseco Life Insurance Company's purported breach of the ~~Optional~~optional premium payment provision (the "Optional Premium ~~Payment Provision~~Payment") of plaintiffs' insurance policies. In January 2018, the case was transferred to the United States District Court for the Southern District of Indiana. On August 17, 2020, the Court denied the CNO Entities' motions to dismiss. On January 13, 2021, the Court granted final approval of a class action settlement between plaintiffs and co-defendant Conseco Life Insurance Company (n/k/a Wilco Life Insurance Company). The case remains pending against the CNO Entities. On March 25, 2022, the Court certified a Rule 23(b)(3) class of under 2,000 policyholders who invoked the policy's Optional Premium Payment prior to October 2008 and who surrendered their policies between October 7, 2008 and September 1, 2011. The Court's certification order acknowledged the existence of individualized issues of causation and damages, which the ~~court~~Court stated could be addressed in individualized proceedings following a class trial on the alter ego allegations and the meaning of the subject insurance policy language. The CNO Entities continue to vigorously defend the case.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

Regulatory Examinations and Fines

Insurance companies face significant risks related to regulatory investigations and actions. Regulatory investigations generally result from matters related to sales or underwriting practices, payment of contingent or other sales commissions, claim payments and procedures, product design, product disclosure, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, procedures related to canceling policies, changing the way cost of insurance charges are calculated for certain life insurance products or recommending unsuitable products to customers. We are, in the ordinary course of our business, subject to various examinations, inquiries and information requests from state, federal and other authorities. The ultimate outcome of these regulatory actions (including the costs of complying with information requests and policy reviews) cannot be predicted with certainty. In the event of an unfavorable outcome in one or more of these matters, the ultimate liability may be in excess of liabilities we have established and we could suffer significant reputational harm as a result of these matters, which could also have a material adverse effect on our business, financial condition, results of operations or cash flows.

~~Table of Contents~~

~~CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES~~

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~

~~___________________~~

In August 2011, we were notified of an examination to be done on behalf of a number of states for the purpose of determining compliance with unclaimed property laws by the Company and its subsidiaries. Such examination included inquiries related to the use of data available on the U.S. Social Security Administration's Death Master File ("SSADMF") to identify instances where benefits under life insurance policies, annuities and retained asset accounts are payable. We provided information to the examiners in response to their requests. A total of 42 states and the District of Columbia participated in this examination. In November 2018, we entered into an agreement for compliance with laws and regulations concerning the identification, reporting and escheatment of unclaimed contract benefits or abandoned funds (the "Global Resolution Agreement"). Under the terms of the Global Resolution Agreement, a third-party auditor acting on behalf of the signatory jurisdictions compared expanded matching criteria to the SSADMF to identify deceased insureds and contract holders where a valid claim has not been made. In May 2022, we received written notification that the exam is closed.

CONSOLIDATED STATEMENT OF CASH FLOWS

The following reconciles net income to net cash from operating activities (dollars in millions):


		Nine months ended					Six months ended
		September 30,					June 30,
		2022		2021			2023		2022
Cash flows from operating activities:	Cash flows from operating activities:					Cash flows from operating activities:
Net income	Net income	$	353.4	$	325.2	Net income	$	72.9	$	416.7
Adjustments to reconcile net income to net cash from operating activities:	Adjustments to reconcile net income to net cash from operating activities:					Adjustments to reconcile net income to net cash from operating activities:
Amortization and depreciation	Amortization and depreciation	305.6		227.3		Amortization and depreciation	131.9		122.5
Income taxes	Income taxes	87.8		123.3		Income taxes	(5.5)		105.3
Insurance liabilities	Insurance liabilities	(292.3)		255.2		Insurance liabilities	259.6		(370.8)
Accrual, amortization and fair value changes included in investment income	Accrual, amortization and fair value changes included in investment income	132.0		(232.5)		Accrual, amortization and fair value changes included in investment income	(94.4)		115.4
Deferral of policy acquisition costs	Deferral of policy acquisition costs	(245.7)		(213.3)		Deferral of policy acquisition costs	(186.4)		(167.4)
Net investment (gains) losses		99.2		(26.2)
Net investment losses						Net investment losses	49.9		81.5

Other (a)	Other (a)	(105.5)		20.0		Other (a)	(4.6)		(136.2)
Net cash from operating activities	Net cash from operating activities	$	334.5	$	479.0	Net cash from operating activities	$	223.4	$	167.0

_____________

(a) Primarily relates to: (i) changes in other assets and liabilities related to the timing of payments and receipts; and (ii) the change in fair value of the deferred compensation plan liability.

Other non-cash items not reflected in the investing and financing activities sections of the consolidated statement of cash flows (dollars in millions):

Nine months ended
September 30,
2022 2021
Amounts related to employee benefit plans $ 19.8 $ 19.2


	Six months ended
	June 30,
	2023		2022
Amounts related to employee benefit plans	$	13.0	$	13.8

~~Table of Contents~~

~~CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES~~

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~

~~___________________~~

INVESTMENTS IN VARIABLE INTEREST ENTITIES

We have concluded that we are the primary beneficiary with respect to certain VIEs, which are consolidated in our financial statements. In consolidating the VIEs, we consistently use the financial information most recently distributed to investors in the VIE.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

All of the VIEs are collateralized loan trusts that were established to issue securities to finance the purchase of corporate loans and other permitted investments. The assets held by the trusts are legally isolated and not available to the Company. The liabilities of the VIEs are expected to be satisfied from the cash flows generated by the underlying loans held by the trusts, not from the assets of the Company. The Company has no financial obligation to the VIEs beyond its investment in each VIE.

Certain of our subsidiaries are noteholders of the VIEs. Another subsidiary of the Company is the investment manager for the VIEs. As such, it has the power to direct the most significant activities of the VIEs which materially impacts the economic performance of the VIEs.

The following tables provide supplemental information about the assets and liabilities of the VIEs which have been consolidated in accordance with authoritative guidance (dollars in millions):


		September 30, 2022							June 30, 2023
		VIEs		Eliminations		Net effect on consolidated balance sheet			VIEs		Eliminations		Net effect on consolidated balance sheet
Assets:	Assets:							Assets:
Investments held by variable interest entities	Investments held by variable interest entities	$	1,099.2	$	—	$	1,099.2	Investments held by variable interest entities	$	948.2	$	—	$	948.2
Notes receivable of VIEs held by subsidiaries	Notes receivable of VIEs held by subsidiaries	—		(113.8)		(113.8)		Notes receivable of VIEs held by subsidiaries	—		(113.8)		(113.8)
Cash and cash equivalents held by variable interest entities	Cash and cash equivalents held by variable interest entities	55.5		—		55.5		Cash and cash equivalents held by variable interest entities	104.2		—		104.2
Accrued investment income	Accrued investment income	3.0		—		3.0		Accrued investment income	3.8		—		3.8
Income tax assets, net	Income tax assets, net	21.6		—		21.6		Income tax assets, net	15.5		—		15.5
Other assets	Other assets	13.2		(.8)		12.4		Other assets	3.6		(.8)		2.8
Total assets	Total assets	$	1,192.5	$	(114.6)	$	1,077.9	Total assets	$	1,075.3	$	(114.6)	$	960.7
Liabilities:	Liabilities:							Liabilities:
Other liabilities	Other liabilities	$	46.0	$	(2.1)	$	43.9	Other liabilities	$	21.3	$	(3.4)	$	17.9
Borrowings related to variable interest entities	Borrowings related to variable interest entities	1,115.3		—		1,115.3		Borrowings related to variable interest entities	1,001.0		—		1,001.0
Notes payable of VIEs held by subsidiaries	Notes payable of VIEs held by subsidiaries	126.1		(126.1)		—		Notes payable of VIEs held by subsidiaries	126.1		(126.1)		—
Total liabilities	Total liabilities	$	1,287.4	$	(128.2)	$	1,159.2	Total liabilities	$	1,148.4	$	(129.5)	$	1,018.9


	December 31, 2022
	VIEs		Eliminations		Net effect on consolidated balance sheet
Assets:
Investments held by variable interest entities	$	1,077.6	$	—	$	1,077.6
Notes receivable of VIEs held by subsidiaries	—		(113.8)		(113.8)
Cash and cash equivalents held by variable interest entities	69.2		—		69.2
Accrued investment income	3.5		—		3.5
Income tax assets, net	19.6		—		19.6
Other assets	2.5		(.8)		1.7
Total assets	$	1,172.4	$	(114.6)	$	1,057.8
Liabilities:
Other liabilities	$	29.3	$	(2.4)	$	26.9
Borrowings related to variable interest entities	1,104.6		—		1,104.6
Notes payable of VIEs held by subsidiaries	126.1		(126.1)		—
Total liabilities	$	1,260.0	$	(128.5)	$	1,131.5

3654

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

December 31, 2021
VIEs Eliminations Net effect on
consolidated
balance sheet
Assets:
Investments held by variable interest entities $ 1,199.6 $ — $ 1,199.6
Notes receivable of VIEs held by subsidiaries — (113.8) (113.8)
Cash and cash equivalents held by variable interest entities 99.6 — 99.6
Accrued investment income 1.6 — 1.6
Income tax assets, net 8.4 — 8.4
Other assets 7.1 (.9) 6.2
Total assets $ 1,316.3 $ (114.7) $ 1,201.6
Liabilities:
Other liabilities $ 89.5 $ (4.3) $ 85.2
Borrowings related to variable interest entities 1,147.9 — 1,147.9
Notes payable of VIEs held by subsidiaries 126.1 (126.1) —
Total liabilities $ 1,363.5 $ (130.4) $ 1,233.1

The investment portfolios held by the VIEs are primarily comprised of commercial bank loans to corporate obligors which are almost entirely rated below-investment grade. At ~~September~~June 30, ~~2022,~~2023, such loans had an amortized cost of ~~$1,166.7~~$982.2 million; gross unrealized gains of ~~$0.3~~$1.6 million; gross unrealized losses of ~~$61.3~~$31.1 million; allowance for credit losses of ~~$6.5~~$4.5 million; and an estimated fair value of ~~$1,099.2~~$948.2 million.

The following table summarizes changes in the allowance for credit losses related to corporate securities held by VIEs for the three months ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022 (dollars in millions):


		Three months ended					Three months ended
		September 30,					June 30,
		2022		2021			2023		2022
Allowance at the beginning of the period	Allowance at the beginning of the period	$	12.2	$	3.2	Allowance at the beginning of the period	$	3.5	$	5.9
Additions for securities for which credit losses were not previously recorded	Additions for securities for which credit losses were not previously recorded	.9		.1		Additions for securities for which credit losses were not previously recorded	.4		4.8
Additions for purchased securities with deteriorated credit	Additions for purchased securities with deteriorated credit	—		—		Additions for purchased securities with deteriorated credit	—		—
Additions (reductions) for securities where an allowance was previously recorded	Additions (reductions) for securities where an allowance was previously recorded	(5.7)		(.2)		Additions (reductions) for securities where an allowance was previously recorded	.8		1.9
Reduction for securities sold during the period	Reduction for securities sold during the period	(.9)		(.6)		Reduction for securities sold during the period	(.2)		(.4)
Reduction for securities for which the Company made the decision to sell where an allowance was previously recorded	Reduction for securities for which the Company made the decision to sell where an allowance was previously recorded	—		—		Reduction for securities for which the Company made the decision to sell where an allowance was previously recorded	—		—
Write-offs	Write-offs	—		—		Write-offs	—		—
Recoveries of previously written-off amount	Recoveries of previously written-off amount	—		—		Recoveries of previously written-off amount	—		—
Allowance at the end of the period	Allowance at the end of the period	$	6.5	$	2.5	Allowance at the end of the period	$	4.5	$	12.2

3755

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table summarizes changes in the allowance for credit losses related to corporate securities held by VIEs for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022 (dollars in millions):


	Six months ended
	June 30,
	2023		2022
Allowance at the beginning of the period	$	5.5	$	3.7
Additions for securities for which credit losses were not previously recorded	.7		6.3
Additions for purchased securities with deteriorated credit	—		—
Additions (reductions) for securities where an allowance was previously recorded	.1		3.2
Reduction for securities sold during the period	(1.8)		(1.0)
Reduction for securities for which the Company made the decision to sell where an allowance was previously recorded	—		—
Write-offs	—		—
Recoveries of previously written-off amount	—		—
Allowance at the end of the period	$	4.5	$	12.2

Nine months ended
September 30,
2022 2021
Allowance at the beginning of the period $ 3.7 $ 15.1
Additions for securities for which credit losses were not previously recorded 7.2 .7
Additions for purchased securities with deteriorated credit — —
Additions (reductions) for securities where an allowance was previously recorded (2.5) (3.7)
Reduction for securities sold during the period (1.9) (9.6)
Reduction for securities for which the Company made the decision to sell where an allowance was previously recorded — —
Write-offs — —
Recoveries of previously written-off amount — —
Allowance at the end of the period $ 6.5 $ 2.5

The following table sets forth the amortized cost and estimated fair value of the investments held by the VIEs at ~~September~~June 30, ~~2022,~~2023, by contractual maturity. Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.


		Amortized cost		Estimated fair value			Amortized cost		Estimated fair value
		(Dollars in millions)					(Dollars in millions)
Due in one year or less	Due in one year or less	$	4.5	$	4.3	Due in one year or less	$	6.6	$	5.9
Due after one year through five years	Due after one year through five years	687.5		652.9		Due after one year through five years	803.2		774.6
Due after five years through ten years	Due after five years through ten years	474.7		442.0		Due after five years through ten years	172.4		167.7

Total	Total	$	1,166.7	$	1,099.2	Total	$	982.2	$	948.2

During the first ~~nine~~six months of ~~2022,~~2023, the VIEs recognized investment losses of ~~$6.7~~$4.0 million which were comprised of: (i) $3.9 million of net losses from the sales of fixed maturities; and (ii) an increase in the allowance for credit losses of $2.8 million. Such net realized losses included gross realized losses of $3.9 million from the sale of $55.9 million of investments. During the first nine months of 2021, the VIEs recognized net investment gains of $5.1 million which were comprised of: (i) $7.5$5.0 million of net losses from the sales of fixed maturities; and (ii) a decrease in the allowance for credit losses of ~~$12.6~~$1.0 million. Such net realized losses included gross realized losses of ~~$7.7~~$5.2 million from the sale of ~~$56.1~~$11.0 million of investments. During the first six months of 2022, the VIEs recognized net investment losses of $10.2 million which were comprised of: (i) $1.4 million of net losses from the sales of fixed maturities; (ii) the change in market value of other investments of $(0.3) million; and (iii) an increase in the allowance for credit losses of $8.5 million. Such net realized losses included gross realized losses of $1.4 million from the sale of $21.2 million of investments.

At ~~September~~June 30, ~~2022,~~2023, there were no fixed maturity investments held by the VIEs in default.

At ~~September~~June 30, ~~2022,~~2023, the VIEs held: (i) investments (for which an allowance for credit losses has not been recorded) with a fair value of ~~$477.4~~$109.1 million and gross unrealized losses not deemed to have credit losses of ~~$19.7~~$0.9 million that had been in an unrealized loss position for less than twelve months; and (ii) investments (for which an allowance for credit losses has not been recorded) with a fair value of ~~$395.4~~$551.3 million and gross unrealized losses not deemed to have credit losses of ~~$19.5~~$15.0 million that had been in an unrealized loss position for twelve months or greater.

At December 31, ~~2021,~~2022, the VIEs held: (i) investments (for which an allowance for credit losses has not been recorded) with a fair value of ~~$417.7~~$392.2 million and gross unrealized losses of ~~$2.2~~$14.2 million that had been in an unrealized loss position for less than twelve months; and (ii) investments (for which an allowance for credit losses has not been recorded) with a fair value of ~~$279.7~~$477.9 million and gross unrealized losses of ~~$3.1~~$17.3 million that had been in an unrealized loss position for twelve months or greater.

3856

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The investments held by the VIEs are evaluated for impairment in a manner that is consistent with the Company's fixed maturities, available for sale.

In addition, the Company, in the normal course of business, makes passive investments in structured securities issued by VIEs for which the Company is not the investment manager. These structured securities include asset-backed securities, collateralized loan obligations, commercial mortgage-backed securities, agency residential mortgage-backed securities and

non-agency residential mortgage-backed securities. Our maximum exposure to loss on these securities is limited to our cost basis in the investment. We have determined that we are not the primary beneficiary of these structured securities due to the relative size of our investment in comparison to the total principal amount of the individual structured securities and the level of credit subordination which reduces our obligation to absorb gains or losses.

At ~~September~~June 30, ~~2022,~~2023, we held investments in various limited partnerships and hedge funds, in which we are not the primary beneficiary, totaling ~~$620.2~~$564.6 million (classified as other invested assets). At ~~September~~June 30, ~~2022,~~2023, we had unfunded commitments to these partnerships totaling ~~$358.1~~$430.7 million. Our maximum exposure to loss on these investments is limited to the amount of our investment.

~~Table of Contents~~

~~CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES~~

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~

~~___________________~~

FAIR VALUE MEASUREMENTS

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and, therefore, represents an exit price, not an entry price. We carry certain assets and liabilities at fair value on a recurring basis, including fixed maturities, equity securities, trading securities, investments held by VIEs, derivatives, separate account assets and embedded derivatives. We carry our COLI, which is invested in a series of mutual funds, at its cash surrender value which approximates fair value. In addition, we disclose fair value for certain financial instruments, including mortgage loans, policy loans, cash and cash equivalents, insurance liabilities for interest-sensitive products and funding agreements, investment borrowings, notes payable and borrowings related to VIEs.

The degree of judgment utilized in measuring the fair value of financial instruments is largely dependent on the level to which pricing is based on observable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information. Financial instruments with readily available active quoted prices would be considered to have fair values based on the highest level of observable inputs, and little judgment would be utilized in measuring fair value. Financial instruments that rarely trade would often have fair value based on a lower level of observable inputs, and more judgment would be utilized in measuring fair value.

Valuation Hierarchy

There is a three-level hierarchy for valuing assets or liabilities at fair value based on whether inputs are observable or unobservable.

•Level 1 – includes assets and liabilities valued using inputs that are unadjusted quoted prices in active markets for identical assets or liabilities. Our Level 1 assets primarily include cash and cash equivalents and exchange-traded securities.

•Level 2 – includes assets and liabilities valued using inputs that are quoted prices for similar assets in an active market, quoted prices for identical or similar assets in a market that is not active, observable inputs, or observable inputs that can be corroborated by market data. Level 2 assets and liabilities include those financial instruments that are valued by independent pricing services using models or other valuation methodologies. These models consider various inputs such as credit rating, maturity, corporate credit spreads, reported trades and other inputs that are observable or derived from observable information in the marketplace or are supported by transactions executed in the marketplace. Financial assets in this category primarily include: certain publicly registered and privately placed corporate fixed maturity securities; certain government or agency securities; certain mortgage and asset-backed securities; certain equity securities; most investments held by our consolidated VIEs; and derivatives such as call options. Financial liabilities in this category include investment borrowings, notes payable and borrowings related to VIEs.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

•Level 3 – includes assets and liabilities valued using unobservable inputs that are used in model-based valuations that contain management assumptions. Level 3 assets and liabilities include those financial instruments whose fair value is estimated based on broker/dealer quotes, pricing services or internally developed models or methodologies utilizing significant inputs not based on, or corroborated by, readily available market information. Financial assets in this category include certain corporate securities, certain structured securities, mortgage loans, and other less liquid securities. Financial liabilities in this category include our insurance liabilities for interest-sensitive products, which includes embedded derivatives (including embedded derivatives related to our fixed ~~index~~indexed annuity products and to a modified coinsurance arrangement), and funding agreements since their values include significant unobservable inputs including actuarial assumptions.

At each reporting date, we classify assets and liabilities into the three input levels based on the lowest level of input that is significant to the measurement of fair value for each asset and liability reported at fair value. This classification is impacted by a number of factors, including the type of financial instrument, whether the financial instrument is new to the market and not yet established, the characteristics specific to the transaction and overall market conditions. Our assessment

~~Table of Contents~~

~~CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES~~

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~

~~___________________~~

of the significance of a particular input to the fair value measurement and the ultimate classification of each asset and liability requires judgment and is subject to change from period to period based on the observability of the valuation inputs.

The vast majority of our assets carried at fair value use Level 2 inputs for the determination of fair value. These fair values are obtained primarily from independent pricing services, which use Level 2 inputs for the determination of fair value. Our Level 2 assets are valued as follows:

•Fixed maturities available for sale, equity securities and trading securities

Corporate securities are generally priced using market and income approaches using independent pricing services. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, issuer rating, benchmark yields, maturity and credit spreads.

U.S. Treasuries and obligations of U.S. Government corporations and agencies are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets and maturity.

States and political subdivisions are generally priced using the market approach using independent pricing services. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, new issuances and credit spreads.

Foreign governments are generally priced using the market approach using independent pricing services. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, new issuances, benchmark yields, credit spreads and issuer rating.

Asset-backed securities, agency and non-agency residential mortgage-backed securities, collateralized loan obligations and commercial mortgage-backed securities are generally priced using market and income approaches using independent pricing services. Inputs generally consist of quoted prices in inactive markets, spreads on actively traded securities, expected prepayments, expected default rates, expected recovery rates and issue specific information including, but not limited to, collateral type, seniority and vintage.

Equity securities are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, issuer rating, benchmark yields, maturity and credit spreads.

•Investments held by VIEs

Corporate securities are generally priced using market and income approaches using pricing vendors. Inputs generally consist of issuer rating, benchmark yields, maturity, and credit spreads.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

•Other invested assets - derivatives

The fair value measurements for derivative instruments, including embedded derivatives requiring bifurcation, are determined based on the consideration of several inputs including closing exchange or over-the-counter market price quotes, time value and volatility factors underlying options, market interest rates and non-performance risk.

Third-party pricing services normally derive security prices through recently reported trades for identical or similar securities making adjustments through the reporting date based upon available market observable information. If there are no recently reported trades, the third-party pricing services may use matrix or model processes to develop a security price where future cash flow expectations are discounted at an estimated risk-adjusted market rate. The number of prices obtained for a given security is dependent on the Company's analysis of such prices as further described below.

As the Company is responsible for the determination of fair value, we have control processes designed to ensure that the fair values received from third-party pricing sources are reasonable and the valuation techniques and assumptions used

~~Table of Contents~~

~~CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES~~

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~

~~___________________~~

appear reasonable and consistent with prevailing market conditions. Additionally, when inputs are provided by third-party pricing sources, we have controls in place to review those inputs for reasonableness. As part of these controls, we perform monthly quantitative and qualitative analysis on the prices received from third parties to determine whether the prices are reasonable estimates of fair value. The Company's analysis includes: (i) a review of the methodology used by third-party pricing services; (ii) where available, a comparison of multiple pricing services' valuations for the same security; (iii) a review of month to month price fluctuations; (iv) a review to ensure valuations are not unreasonably dated; and (v) back testing to compare actual purchase and sale transactions with valuations received from third parties. As a result of such procedures, the Company may conclude a particular price received from a third party is not reflective of current market conditions. In those instances, we may request additional pricing quotes or apply internally developed valuations. However, the number of such instances is insignificant and the aggregate change in value of such investments is not materially different from the original prices received.

The categorization of the fair value measurements of our investments priced by independent pricing services was based upon the Company's judgment of the inputs or methodologies used by the independent pricing services to value different asset classes. Such inputs typically include: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, benchmark securities, bids, offers and other relevant data. The Company categorizes such fair value measurements based upon asset classes and the underlying observable or unobservable inputs used to value such investments.

For securities that are not priced by pricing services and may not be reliably priced using pricing models, we obtain broker quotes. These broker quotes are non-binding and represent an exit price, but assumptions used to establish the fair value may not be observable and therefore represent Level 3 inputs. Approximately 8784 percent of our Level 3 fixed maturity securities and trading securities were valued using unadjusted broker quotes or broker-provided valuation inputs. The remaining Level 3 fixed maturity investments do not have readily determinable market prices and/or observable inputs. For these securities, we use internally developed valuations. Key assumptions used to determine fair value for these securities may include risk premiums, projected performance of underlying collateral and other factors involving significant assumptions which may not be reflective of an active market. For certain investments, we use a matrix or model process to develop a security price where future cash flow expectations are discounted at an estimated market rate. The pricing matrix incorporates term interest rates as well as a spread level based on the issuer's credit rating, other factors relating to the issuer, and the security's maturity. In some instances issuer-specific spread adjustments, which can be positive or negative, are made based upon internal analysis of security specifics such as liquidity, deal size, and time to maturity.

4259

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The categorization of fair value measurements, by input level, for our financial instruments carried at fair value on a recurring basis at ~~September~~June 30, ~~2022~~2023 is as follows (dollars in millions):


		Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)		Total			Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)		Total
Assets:	Assets:									Assets:
Fixed maturities, available for sale:	Fixed maturities, available for sale:									Fixed maturities, available for sale:
Corporate securities	Corporate securities	$	—	$	11,656.5	$	122.1	$	11,778.6	Corporate securities	$	—	$	11,603.1	$	136.2	$	11,739.3
United States Treasury securities and obligations of United States government corporations and agencies	United States Treasury securities and obligations of United States government corporations and agencies	—		157.8		—		157.8		United States Treasury securities and obligations of United States government corporations and agencies	—		164.1		—		164.1
States and political subdivisions	States and political subdivisions	—		2,400.2		—		2,400.2		States and political subdivisions	—		2,453.6		—		2,453.6
Foreign governments	Foreign governments	—		69.3		—		69.3		Foreign governments	—		83.8		—		83.8
Asset-backed securities	Asset-backed securities	—		1,221.2		48.9		1,270.1		Asset-backed securities	—		1,309.7		39.8		1,349.5
Agency residential mortgage-backed securities	Agency residential mortgage-backed securities	—		38.5		—		38.5		Agency residential mortgage-backed securities	—		348.8		—		348.8
Non-agency residential mortgage-backed securities	Non-agency residential mortgage-backed securities	—		1,609.8		29.1		1,638.9		Non-agency residential mortgage-backed securities	—		1,611.6		6.0		1,617.6
Collateralized loan obligations	Collateralized loan obligations	—		719.8		13.4		733.2		Collateralized loan obligations	—		933.9		—		933.9
Commercial mortgage-backed securities	Commercial mortgage-backed securities	—		2,176.9		37.6		2,214.5		Commercial mortgage-backed securities	—		2,256.7		12.4		2,269.1
Total fixed maturities, available for sale	Total fixed maturities, available for sale	—		20,050.0		251.1		20,301.1		Total fixed maturities, available for sale	—		20,765.3		194.4		20,959.7

Equity securities - corporate securities	Equity securities - corporate securities	61.0		—		74.8		135.8		Equity securities - corporate securities	23.6		—		72.8		96.4

Trading securities:	Trading securities:									Trading securities:

Asset-backed securities	Asset-backed securities	—		13.0		—		13.0		Asset-backed securities	—		35.7		—		35.7
Agency residential mortgage-backed securities	Agency residential mortgage-backed securities	—		.3		—		.3		Agency residential mortgage-backed securities	—		3.6		—		3.6
Non-agency residential mortgage-backed securities	Non-agency residential mortgage-backed securities	—		63.4		—		63.4		Non-agency residential mortgage-backed securities	—		62.0		—		62.0

Commercial mortgage-backed securities	Commercial mortgage-backed securities	—		146.6		—		146.6		Commercial mortgage-backed securities	—		117.6		—		117.6

Total trading securities	Total trading securities	—		223.3		—		223.3		Total trading securities	—		218.9		—		218.9
Investments held by variable interest entities - corporate securities	Investments held by variable interest entities - corporate securities	—		1,099.2		—		1,099.2		Investments held by variable interest entities - corporate securities	—		948.2		—		948.2
Other invested assets:	Other invested assets:									Other invested assets:
Derivatives	Derivatives	—		24.0		—		24.0		Derivatives	—		194.2		—		194.2
Residual tranches	Residual tranches	—		15.1		4.0		19.1		Residual tranches	—		14.6		7.5		22.1
Total other invested assets	Total other invested assets	—		39.1		4.0		43.1		Total other invested assets	—		208.8		7.5		216.3
Market risk benefit asset										Market risk benefit asset	—		—		66.0		66.0
Assets held in separate accounts	Assets held in separate accounts	—		2.7		—		2.7		Assets held in separate accounts	—		3.0		—		3.0
Total assets carried at fair value by category	Total assets carried at fair value by category	$	61.0	$	21,414.3	$	329.9	$	21,805.2	Total assets carried at fair value by category	$	23.6	$	22,144.2	$	340.7	$	22,508.5

Liabilities:	Liabilities:									Liabilities:
Embedded derivatives associated with fixed index annuity products (classified as policyholder account liabilities)		$	—	$	—	$	1,253.9	$	1,253.9
Market risk benefit liability										Market risk benefit liability	$	—	$	—	$	10.5	$	10.5
Embedded derivatives associated with fixed indexed annuity products (classified as future policy benefits)										Embedded derivatives associated with fixed indexed annuity products (classified as future policy benefits)	—		—		1,355.4		1,355.4
Total liabilities carried at fair value by category										Total liabilities carried at fair value by category	$	—	$	—	$	1,365.9	$	1,365.9

4360

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The categorization of fair value measurements, by input level, for our financial instruments carried at fair value on a recurring basis at December 31, ~~2021~~2022 is as follows (dollars in millions):


		Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)		Total			Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)		Total
Assets:	Assets:									Assets:
Fixed maturities, available for sale:	Fixed maturities, available for sale:									Fixed maturities, available for sale:
Corporate securities	Corporate securities	$	—	$	15,361.1	$	89.7	$	15,450.8	Corporate securities	$	—	$	11,584.9	$	127.8	$	11,712.7
United States Treasury securities and obligations of United States government corporations and agencies	United States Treasury securities and obligations of United States government corporations and agencies	—		219.6		—		219.6		United States Treasury securities and obligations of United States government corporations and agencies	—		158.7		—		158.7
States and political subdivisions	States and political subdivisions	—		3,004.2		—		3,004.2		States and political subdivisions	—		2,388.5		—		2,388.5
Foreign governments	Foreign governments	—		98.5		—		98.5		Foreign governments	—		74.7		—		74.7
Asset-backed securities	Asset-backed securities	—		1,136.3		26.6		1,162.9		Asset-backed securities	—		1,230.0		57.0		1,287.0
Agency residential mortgage-backed securities	Agency residential mortgage-backed securities	—		40.4		—		40.4		Agency residential mortgage-backed securities	—		175.0		—		175.0
Non-agency residential mortgage-backed securities	Non-agency residential mortgage-backed securities	—		2,023.8		—		2,023.8		Non-agency residential mortgage-backed securities	—		1,492.3		56.2		1,548.5
Collateralized loan obligations	Collateralized loan obligations	—		583.3		5.0		588.3		Collateralized loan obligations	—		782.5		3.4		785.9
Commercial mortgage-backed securities	Commercial mortgage-backed securities	—		2,197.9		19.0		2,216.9		Commercial mortgage-backed securities	—		2,207.9		14.5		2,222.4
Total fixed maturities, available for sale	Total fixed maturities, available for sale	—		24,665.1		140.3		24,805.4		Total fixed maturities, available for sale	—		20,094.5		258.9		20,353.4

Equity securities - corporate securities	Equity securities - corporate securities	100.8		18.8		11.5		131.1		Equity securities - corporate securities	59.6		—		75.7		135.3

Trading securities:	Trading securities:									Trading securities:

Asset-backed securities	Asset-backed securities	—		5.8		—		5.8		Asset-backed securities	—		15.1		—		15.1
Agency residential mortgage-backed securities	Agency residential mortgage-backed securities	—		.4		—		.4		Agency residential mortgage-backed securities	—		.3		—		.3
Non-agency residential mortgage-backed securities	Non-agency residential mortgage-backed securities	—		77.5		3.5		81.0		Non-agency residential mortgage-backed securities	—		60.2		.5		60.7

Commercial mortgage-backed securities	Commercial mortgage-backed securities	—		127.1		12.9		140.0		Commercial mortgage-backed securities	—		131.8		—		131.8

Total trading securities	Total trading securities	—		210.8		16.4		227.2		Total trading securities	—		207.4		.5		207.9
Investments held by variable interest entities - corporate securities	Investments held by variable interest entities - corporate securities	—		1,197.4		2.2		1,199.6		Investments held by variable interest entities - corporate securities	—		1,077.6		—		1,077.6
Other invested assets - derivatives		—		227.5		—		227.5
Other invested assets:										Other invested assets:
Derivatives										Derivatives	—		56.7		—		56.7
Residual tranches										Residual tranches	—		—		18.3		18.3
Total other invested assets										Total other invested assets	—		56.7		18.3		75.0
Market risk benefit asset										Market risk benefit asset	—		—		65.3		65.3
Assets held in separate accounts	Assets held in separate accounts	—		3.9		—		3.9		Assets held in separate accounts	—		2.7		—		2.7
Total assets carried at fair value by category	Total assets carried at fair value by category	$	100.8	$	26,323.5	$	170.4	$	26,594.7	Total assets carried at fair value by category	$	59.6	$	21,438.9	$	418.7	$	21,917.2

Liabilities:	Liabilities:									Liabilities:
Embedded derivatives associated with fixed index annuity products (classified as policyholder account liabilities)		$	—	$	—	$	1,724.1	$	1,724.1
Market risk benefit liability										Market risk benefit liability	$	—	$	—	$	11.3	$	11.3
Embedded derivatives associated with fixed indexed annuity products (classified as future policy benefits)										Embedded derivatives associated with fixed indexed annuity products (classified as future policy benefits)	—		—		1,297.0		1,297.0
Total liabilities carried at fair value by category										Total liabilities carried at fair value by category	$	—	$	—	$	1,308.3	$	1,308.3

4461

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The fair value of our financial instruments disclosed at fair value on a recurring basis are as follows (dollars in millions):


		September 30, 2022											June 30, 2023
		Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)		Total estimated fair value		Total carrying amount			Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)		Total estimated fair value		Total carrying amount
Assets:	Assets:											Assets:
Mortgage loans	Mortgage loans	$	—	$	—	$	1,092.0	$	1,092.0	$	1,227.3	Mortgage loans	$	—	$	—	$	1,692.5	$	1,692.5	$	1,825.9
Policy loans	Policy loans	—		—		120.2		120.2		120.2		Policy loans	—		—		124.2		124.2		124.2
Other invested assets:	Other invested assets:											Other invested assets:
Company-owned life insurance	Company-owned life insurance	—		197.6		—		197.6		197.6		Company-owned life insurance	—		200.9		—		200.9		200.9
Cash and cash equivalents:	Cash and cash equivalents:											Cash and cash equivalents:
Unrestricted	Unrestricted	498.0		—		—		498.0		498.0		Unrestricted	457.7		—		—		457.7		457.7
Held by variable interest entities	Held by variable interest entities	55.5		—		—		55.5		55.5		Held by variable interest entities	104.2		—		—		104.2		104.2
Liabilities:	Liabilities:											Liabilities:
Policyholder account liabilities		—		—		14,653.7		14,653.7		14,653.7
Policyholder account balances												Policyholder account balances	—		—		15,387.7		15,387.7		15,387.7
Investment borrowings	Investment borrowings	—		1,640.9		—		1,640.9		1,639.9		Investment borrowings	—		1,840.4		—		1,840.4		1,839.5
Borrowings related to variable interest entities	Borrowings related to variable interest entities	—		1,068.7		—		1,068.7		1,115.3		Borrowings related to variable interest entities	—		978.4		—		978.4		1,001.0
Notes payable – direct corporate obligations	Notes payable – direct corporate obligations	—		1,073.8		—		1,073.8		1,138.4		Notes payable – direct corporate obligations	—		1,115.2		—		1,115.2		1,139.7


		December 31, 2021											December 31, 2022
		Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)		Total estimated fair value		Total carrying amount			Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)		Total estimated fair value		Total carrying amount
Assets:	Assets:											Assets:
Mortgage loans	Mortgage loans	$	—	$	—	$	1,297.5	$	1,297.5	$	1,218.6	Mortgage loans	$	—	$	—	$	1,273.6	$	1,273.6	$	1,411.9
Policy loans	Policy loans	—		—		120.2		120.2		120.2		Policy loans	—		—		121.6		121.6		121.6
Other invested assets:	Other invested assets:											Other invested assets:
Company-owned life insurance	Company-owned life insurance	—		207.0		—		207.0		207.0		Company-owned life insurance	—		199.1		—		199.1		199.1
Cash and cash equivalents:	Cash and cash equivalents:											Cash and cash equivalents:
Unrestricted	Unrestricted	632.1		—		—		632.1		632.1		Unrestricted	575.7		—		—		575.7		575.7
Held by variable interest entities	Held by variable interest entities	99.6		—		—		99.6		99.6		Held by variable interest entities	69.2		—		—		69.2		69.2
Liabilities:	Liabilities:											Liabilities:
Policyholder account liabilities		—		—		13,689.7		13,689.7		13,689.7
Policyholder account balances												Policyholder account balances	—		—		15,234.2		15,234.2		15,234.2
Investment borrowings	Investment borrowings	—		1,719.6		—		1,719.6		1,715.8		Investment borrowings	—		1,640.5		—		1,640.5		1,639.5
Borrowings related to variable interest entities	Borrowings related to variable interest entities	—		1,144.8		—		1,144.8		1,147.9		Borrowings related to variable interest entities	—		1,066.3		—		1,066.3		1,104.6
Notes payable – direct corporate obligations	Notes payable – direct corporate obligations	—		1,283.4		—		1,283.4		1,137.3		Notes payable – direct corporate obligations	—		1,077.0		—		1,077.0		1,138.8

4562

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table presents additional information about assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the three months ended ~~September~~June 30, ~~2022~~2023 (dollars in millions):


		September 30, 2022																			June 30, 2023
		Beginning balance as of June 30, 2022		Purchases, sales, issuances and settlements, net (b)		Total realized and unrealized gains (losses) included in net income		Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)		Transfers into Level 3 (a)		Transfers out of Level 3 (a)		Ending balance as of September 30, 2022		Amount of total gains (losses) for the three months ended September 30, 2022 included in our net income relating to assets still held as of the reporting date		Amount of total gains (losses) for the three months ended September 30, 2022 included in accumulated other comprehensive income (loss) relating to assets still held as of the reporting date			Beginning balance as of March 31, 2023		Purchases, sales, issuances and settlements, net (b)		Total realized and unrealized gains (losses) included in net income		Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)		Transfers into Level 3 (a)		Transfers out of Level 3 (a)		Ending balance as of June 30, 2023		Amount of total gains (losses) for the three months ended June 30, 2023 included in our net income relating to assets still held as of the reporting date		Amount of total gains (losses) for the three months ended June 30, 2023 included in accumulated other comprehensive income (loss) relating to assets still held as of the reporting date
Assets:	Assets:																			Assets:
Fixed maturities, available for sale:	Fixed maturities, available for sale:																			Fixed maturities, available for sale:
Corporate securities	Corporate securities	$	124.0	$	2.7	$	(.9)	$	(13.4)	$	9.7	$	—	$	122.1	$	(.9)	$	(14.2)	Corporate securities	$	127.8	$	1.7	$	(11.0)	$	11.1	$	6.6	$	—	$	136.2	$	(11.0)	$	10.3

Asset-backed securities	Asset-backed securities	29.7		18.3		—		(3.2)		4.1		—		48.9		—		(3.2)		Asset-backed securities	41.1		.1		—		(1.4)		—		—		39.8		—		(1.4)
Non-agency residential mortgage-backed securities	Non-agency residential mortgage-backed securities	40.5		(.1)		—		(2.5)		13.6		(22.4)		29.1		—		(2.5)		Non-agency residential mortgage-backed securities	33.8		—		—		(.1)		—		(27.7)		6.0		—		(.1)
Collateralized loan obligations		4.4		—		—		—		13.4		(4.4)		13.4		—		—

Commercial mortgage-backed securities	Commercial mortgage-backed securities	16.5		—		—		(1.1)		22.2		—		37.6		—		(1.1)		Commercial mortgage-backed securities	13.8		—		—		(1.4)		—		—		12.4		—		(1.4)
Total fixed maturities, available for sale	Total fixed maturities, available for sale	215.1		20.9		(.9)		(20.2)		63.0		(26.8)		251.1		(.9)		(21.0)		Total fixed maturities, available for sale	216.5		1.8		(11.0)		8.2		6.6		(27.7)		194.4		(11.0)		7.4

Equity securities - corporate securities	Equity securities - corporate securities	8.2		—		(.5)		—		67.1		—		74.8		(.5)		—		Equity securities - corporate securities	75.0		(2.1)		(.1)		—		—		—		72.8		(.1)		—

Trading securities:

Non-agency residential mortgage-backed securities		3.4		—		—		—		—		(3.4)		—		—		—

Commercial mortgage-backed securities		6.0		—		—		—		—		(6.0)		—		—		—
Trading securities - non-agency residential mortgage-backed securities																				Trading securities - non-agency residential mortgage-backed securities	.5		—		—		—		—		(.5)		—		—		—

Total trading securities		9.4		—		—		—		—		(9.4)		—		—		—

Other invested assets - residual tranches	Other invested assets - residual tranches	2.6		1.6		(.5)		—		.3		—		4.0		(.5)		—		Other invested assets - residual tranches	19.2		.1		.1		—		.9		(12.8)		7.5		.1		—

4663

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

_________

(a)Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b)Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset but does not represent changes in fair value for the instruments held at the beginning of the period. Such activity primarily consists of purchases and sales of fixed maturity and equity securities. The following summarizes such activity for the three months ended ~~September~~June 30, ~~2022~~2023 (dollars in millions):


		Purchases		Sales		Issuances		Settlements		Purchases, sales, issuances and settlements, net			Purchases		Sales		Issuances		Settlements		Purchases, sales, issuances and settlements, net
Assets:	Assets:											Assets:
Fixed maturities, available for sale:	Fixed maturities, available for sale:											Fixed maturities, available for sale:
Corporate securities	Corporate securities	$	9.3	$	(6.6)	$	—	$	—	$	2.7	Corporate securities	$	1.7	$	—	$	—	$	—	$	1.7

Asset-backed securities	Asset-backed securities	19.0		(.7)		—		—		18.3		Asset-backed securities	.3		(.2)		—		—		.1
Non-agency residential mortgage-backed securities		—		(.1)		—		—		(.1)

Total fixed maturities, available for sale	Total fixed maturities, available for sale	28.3		(7.4)		—		—		20.9		Total fixed maturities, available for sale	2.0		(.2)		—		—		1.8

Equity securities - corporate securities												Equity securities - corporate securities	—		(2.1)		—		—		(2.1)

Other invested assets - residual tranches	Other invested assets - residual tranches	1.6		—		—		—		1.6		Other invested assets - residual tranches	.1		—		—		—		.1

4764

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table presents additional information about assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 (dollars in millions):


		September 30, 2022																			June 30, 2023
		Beginning balance as of December 31, 2021		Purchases, sales, issuances and settlements, net (b)		Total realized and unrealized gains (losses) included in net income		Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)		Transfers into Level 3 (a)		Transfers out of Level 3 (a)		Ending balance as of September 30, 2022		Amount of total gains (losses) for the nine months ended September 30, 2022 included in our net income relating to assets still held as of the reporting date		Amount of total gains (losses) for the nine months ended September 30, 2022 included in accumulated other comprehensive income (loss) relating to assets still held as of the reporting date			Beginning balance as of December 31, 2022		Purchases, sales, issuances and settlements, net (b)		Total realized and unrealized gains (losses) included in net income		Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)		Transfers into Level 3 (a)		Transfers out of Level 3 (a)		Ending balance as of June 30, 2023		Amount of total gains (losses) for the six months ended June 30, 2023 included in our net income relating to assets still held as of the reporting date		Amount of total gains (losses) for the six months ended June 30, 2023 included in accumulated other comprehensive income (loss) relating to assets still held as of the reporting date
Assets:	Assets:																			Assets:
Fixed maturities, available for sale:	Fixed maturities, available for sale:																			Fixed maturities, available for sale:
Corporate securities	Corporate securities	$	89.7	$	13.0	$	(.1)	$	(41.7)	$	68.6	$	(7.4)	$	122.1	$	.4	$	(43.1)	Corporate securities	$	127.8	$	1.3	$	—	$	1.2	$	5.9	$	—	$	136.2	$	—	$	(.3)

Asset-backed securities	Asset-backed securities	26.6		26.0		—		(6.4)		2.7		—		48.9		—		(6.4)		Asset-backed securities	57.0		(5.0)		(.2)		(1.6)		—		(10.4)		39.8		.1		(1.6)
Non-agency residential mortgage-backed securities	Non-agency residential mortgage-backed securities	—		6.0		—		(10.3)		33.4		—		29.1		—		(10.3)		Non-agency residential mortgage-backed securities	56.2		—		—		.1		—		(50.3)		6.0		—		.1
Collateralized loan obligations	Collateralized loan obligations	5.0		—		—		(.4)		13.8		(5.0)		13.4		—		(.4)		Collateralized loan obligations	3.4		—		—		—		—		(3.4)		—		—		—
Commercial mortgage-backed securities	Commercial mortgage-backed securities	19.0		28.0		—		(9.4)		—		—		37.6		—		(9.5)		Commercial mortgage-backed securities	14.5		—		—		(2.1)		—		—		12.4		—		(2.1)
Total fixed maturities, available for sale	Total fixed maturities, available for sale	140.3		73.0		(.1)		(68.2)		118.5		(12.4)		251.1		.4		(69.7)		Total fixed maturities, available for sale	258.9		(3.7)		(.2)		(2.4)		5.9		(64.1)		194.4		.1		(3.9)

Equity securities - corporate securities	Equity securities - corporate securities	11.5		63.9		(.6)		—		—		—		74.8		(.5)		—		Equity securities - corporate securities	75.7		(2.1)		(.8)		—		—		—		72.8		(.4)		—

Trading securities:

Non-agency residential mortgage-backed securities		3.5		—		—		—		—		(3.5)		—		—		—

Commercial mortgage-backed securities		12.9		—		—		—		—		(12.9)		—		—		—
Trading securities - non-agency residential mortgage-backed securities																				Trading securities - non-agency residential mortgage-backed securities	.5		—		—		—		—		(.5)		—		—		—

Total trading securities		16.4		—		—		—		—		(16.4)		—		—		—
Investments held by variable interest entities - corporate securities		2.2		(2.1)		(.1)		—		—		—		—		—		—

Other invested assets - residual tranches	Other invested assets - residual tranches	—		2.8		—		(.6)		1.8		—		4.0		—		(.6)		Other invested assets - residual tranches	18.3		1.5		.4		—		—		(12.7)		7.5		.4		—

4865

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

_________

(b)Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset but does not represent changes in fair value for the instruments held at the beginning of the period. Such activity primarily consists of purchases and sales of fixed maturity and equity securities. The following summarizes such activity for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 (dollars in millions):


	Purchases		Sales		Issuances		Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	2.7	$	(1.4)	$	—	$	—	$	1.3



Asset-backed securities	2.5		(7.5)		—		—		(5.0)



Total fixed maturities, available for sale	5.2		(8.9)		—		—		(3.7)

Equity securities - corporate securities	—		(2.1)		—		—		(2.1)









Other invested assets - residual tranches	1.8		(.3)		—		—		1.5

Purchases Sales Issuances Settlements Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities $ 24.2 $ (11.2) $ — $ — $ 13.0
Asset-backed securities 26.9 (.9) — — 26.0
Non-agency residential mortgage-backed securities 6.5 (.5) — — 6.0
Commercial mortgage-backed securities 28.0 — — — 28.0
Total fixed maturities, available for sale 85.6 (12.6) — — 73.0
Equity securities - corporate securities 67.0 (3.1) — — 63.9
Investments held by variable interest entities - corporate securities — (2.1) — — (2.1)
Other invested assets - residual tranches 2.8 — — — 2.8

4966

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________


		September 30, 2021																			June 30, 2022
		Beginning balance as of June 30, 2021		Purchases, sales, issuances and settlements, net (b)		Total realized and unrealized gains (losses) included in net income		Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)		Transfers into Level 3 (a)		Transfers out of Level 3 (a)		Ending balance as of September 30, 2021		Amount of total gains (losses) for the three months ended September 30, 2021 included in our net income relating to assets still held as of the reporting date		Amount of total gains (losses) for the three months ended September 30, 2021 included in accumulated other comprehensive income (loss) relating to assets still held as of the reporting date			Beginning balance as of March 31, 2022		Purchases, sales, issuances and settlements, net (b)		Total realized and unrealized gains (losses) included in net income		Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)		Transfers into Level 3 (a)		Transfers out of Level 3 (a)		Ending balance as of June 30, 2022		Amount of total gains (losses) for the three months ended June 30, 2022 included in our net income relating to assets still held as of the reporting date		Amount of total gains (losses) for the three months ended June 30, 2022 included in accumulated other comprehensive income (loss) relating to assets still held as of the reporting date
Assets:	Assets:																			Assets:
Fixed maturities, available for sale:	Fixed maturities, available for sale:																			Fixed maturities, available for sale:
Corporate securities	Corporate securities	$	82.5	$	18.5	$	(1.2)	$	1.1	$	—	$	(5.1)	$	95.8	$	(1.2)	$	.6	Corporate securities	$	118.0	$	(6.9)	$	(5.0)	$	(12.3)	$	37.1	$	(6.9)	$	124.0	$	(3.5)	$	(13.0)

Asset-backed securities	Asset-backed securities	12.0		8.0		—		.1		—		—		20.1		—		$	.1	Asset-backed securities	41.2		(.2)		—		(1.5)		—		(9.8)		29.7		—		(1.6)

Non-agency residential mortgage-backed securities																				Non-agency residential mortgage-backed securities	4.4		(.2)		—		(4.9)		45.6		(4.4)		40.5		—		(4.9)
Collateralized loan obligations																				Collateralized loan obligations	9.8		—		—		(.6)		5.0		(9.8)		4.4		—		(.6)
Commercial mortgage-backed securities	Commercial mortgage-backed securities	—		6.4		—		.4		12.6		—		19.4		—		$	.4	Commercial mortgage-backed securities	17.5		—		—		(1.0)		—		—		16.5		—		(1.0)
Total fixed maturities, available for sale	Total fixed maturities, available for sale	94.5		32.9		(1.2)		1.6		12.6		(5.1)		135.3		(1.2)		1.1		Total fixed maturities, available for sale	190.9		(7.3)		(5.0)		(20.3)		87.7		(30.9)		215.1		(3.5)		(21.1)

Equity securities - corporate securities	Equity securities - corporate securities	27.0		—		(1.8)		—		—		—		25.2		(1.8)		—		Equity securities - corporate securities	8.4		—		—		—		—		(.2)		8.2		—		—

Trading securities:	Trading securities:																			Trading securities:

Non-agency residential mortgage-backed securities	Non-agency residential mortgage-backed securities	4.8		(.7)		(.2)		.2		—		—		4.1		(.2)		—		Non-agency residential mortgage-backed securities	—		(.5)		(.2)		.1		4.0		—		3.4		(.2)		—

Commercial mortgage-backed securities	Commercial mortgage-backed securities	12.6		—		—		.2		—		—		12.8		—		—		Commercial mortgage-backed securities	12.7		(7.2)		.4		.1		—		—		6.0		.4		—

Total trading securities	Total trading securities	17.4		(.7)		(.2)		.4		—		—		16.9		(.2)		—		Total trading securities	12.7		(7.7)		.2		.2		4.0		—		9.4		.2		—

Other invested assets - residual tranches																				Other invested assets - residual tranches	2.1		.3		.2		—		—		—		2.6		.2		—

5067

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

____________


		Purchases		Sales		Issuances		Settlements		Purchases, sales, issuances and settlements, net			Purchases		Sales		Issuances		Settlements		Purchases, sales, issuances and settlements, net
Assets:	Assets:											Assets:
Fixed maturities, available for sale:	Fixed maturities, available for sale:											Fixed maturities, available for sale:
Corporate securities	Corporate securities	$	18.5	$	—	$	—	$	—	$	18.5	Corporate securities	$	1.2	$	(8.1)	$	—	$	—	$	(6.9)

Asset-backed securities	Asset-backed securities	8.2		(.2)		—		—		8.0		Asset-backed securities	—		(.2)		—		—		(.2)

Non-agency residential mortgage-backed securities												Non-agency residential mortgage-backed securities	—		(.2)		—		—		(.2)

Commercial mortgage-backed securities		6.4		—		—		—		6.4

Total fixed maturities, available for sale	Total fixed maturities, available for sale	33.1		(.2)		—		—		32.9		Total fixed maturities, available for sale	1.2		(8.5)		—		—		(7.3)

Trading securities:												Trading securities:
Non-agency residential mortgage-backed securities												Non-agency residential mortgage-backed securities	—		(.5)		—		—		(.5)

Trading securities - non-agency residential mortgage-backed securities		—		(.7)		—		—		(.7)
Commercial mortgage-backed securities												Commercial mortgage-backed securities	—		(7.2)		—		—		(7.2)

Total trading securities												Total trading securities	—		(7.7)		—		—		(7.7)

Other invested assets - residual tranches												Other invested assets - residual tranches	.3		—		—		—		.3

5168

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table presents additional information about assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 (dollars in millions):


		September 30, 2021																			June 30, 2022
		Beginning balance as of December 31, 2020		Purchases, sales, issuances and settlements, net (b)		Total realized and unrealized gains (losses) included in net income		Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)		Transfers into Level 3 (a)		Transfers out of Level 3 (a)		Ending balance as of September 30, 2021		Amount of total gains (losses) for the nine months ended September 30, 2021 included in our net income relating to assets still held as of the reporting date		Amount of total gains (losses) for the nine months ended September 30, 2021 included in accumulated other comprehensive income (loss) relating to assets still held as of the reporting date			Beginning balance as of December 31, 2021		Purchases, sales, issuances and settlements, net (b)		Total realized and unrealized gains (losses) included in net income		Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)		Transfers into Level 3 (a)		Transfers out of Level 3 (a)		Ending balance as of June 30, 2022		Amount of total gains (losses) for the six months ended June 30, 2022 included in our net income relating to assets still held as of the reporting date		Amount of total gains (losses) for the six months ended June 30, 2022 included in accumulated other comprehensive income (loss) relating to assets still held as of the reporting date
Assets:	Assets:																			Assets:
Fixed maturities, available for sale:	Fixed maturities, available for sale:																			Fixed maturities, available for sale:
Corporate securities	Corporate securities	$	146.9	$	18.4	$	(.3)	$	.8	$	6.1	$	(76.1)	$	95.8	$	(.3)	$	(.6)	Corporate securities	$	89.7	$	(4.6)	$	(2.8)	$	(24.6)	$	73.7	$	(7.4)	$	124.0	$	(2.1)	$	(26.1)

Asset-backed securities	Asset-backed securities	14.3		7.7		—		.1		—		(2.0)		20.1		—		.1		Asset-backed securities	26.6		5.8		—		(2.7)		—		—		29.7		—		(2.8)

Non-agency residential mortgage-backed securities	Non-agency residential mortgage-backed securities	1.6		—		—		—		—		(1.6)		—		—		—		Non-agency residential mortgage-backed securities	—		(2.3)		(.2)		(9.1)		52.1		—		40.5		—		(9.1)

Collateralized loan obligations																				Collateralized loan obligations	5.0		5.0		—		(.6)		—		(5.0)		4.4		—		(.6)
Commercial mortgage-backed securities	Commercial mortgage-backed securities	—		6.4		—		(.2)		13.2		—		19.4		—		(.4)		Commercial mortgage-backed securities	19.0		—		—		(2.5)		—		—		16.5		—		(2.5)
Total fixed maturities, available for sale	Total fixed maturities, available for sale	162.8		32.5		(.3)		.7		19.3		(79.7)		135.3		(.3)		(.9)		Total fixed maturities, available for sale	140.3		3.9		(3.0)		(39.5)		125.8		(12.4)		215.1		(2.1)		(41.1)

Equity securities - corporate securities	Equity securities - corporate securities	26.8		.2		(1.8)		—		—		—		25.2		(1.8)		—		Equity securities - corporate securities	11.5		(3.2)		(.1)		—		—		—		8.2		—		—

Trading securities:	Trading securities:																			Trading securities:

Non-agency residential mortgage-backed securities	Non-agency residential mortgage-backed securities	5.9		(1.8)		(.4)		.4		—		—		4.1		(.4)		—		Non-agency residential mortgage-backed securities	3.5		(.8)		(.3)		.2		.8		—		3.4		(.3)		—

Commercial mortgage-backed securities	Commercial mortgage-backed securities	17.0		—		—		.5		—		(4.7)		12.8		—		—		Commercial mortgage-backed securities	12.9		(7.2)		—		.3		—		—		6.0		—		—

Total trading securities	Total trading securities	22.9		(1.8)		(.4)		.9		—		(4.7)		16.9		(.4)		—		Total trading securities	16.4		(8.0)		(.3)		.5		.8		—		9.4		(.3)		—

Investments held by variable interest entities - corporate securities																				Investments held by variable interest entities - corporate securities	2.2		(2.1)		(.1)		—		—		—		—		—		—
Other invested assets - residual tranches																				Other invested assets - residual tranches	—		.9		(.1)		—		1.8		—		2.6		(.1)		—

5269

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

____________

(b)Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset but does not represent changes in fair value for the instruments held at the beginning of the period. Such activity primarily consists of purchases and sales of fixed maturity and equity securities. The following summarizes such activity for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 (dollars in millions):


		Purchases		Sales		Issuances		Settlements		Purchases, sales, issuances and settlements, net			Purchases		Sales		Issuances		Settlements		Purchases, sales, issuances and settlements, net
Assets:	Assets:											Assets:
Fixed maturities, available for sale:	Fixed maturities, available for sale:											Fixed maturities, available for sale:
Corporate securities	Corporate securities	$	18.5	$	(.1)	$	—	$	—	$	18.4	Corporate securities	$	9.2	$	(13.8)	$	—	$	—	$	(4.6)

Asset-backed securities	Asset-backed securities	8.2		(.5)		—		—		7.7		Asset-backed securities	6.1		(.3)		—		—		5.8

Non-agency residential mortgage-backed securities												Non-agency residential mortgage-backed securities	—		(2.3)		—		—		(2.3)
Collateralized loan obligations												Collateralized loan obligations	5.0		—		—		—		5.0

Commercial mortgage-backed securities		6.4		—		—		—		6.4

Total fixed maturities, available for sale	Total fixed maturities, available for sale	33.1		(.6)		—		—		32.5		Total fixed maturities, available for sale	20.3		(16.4)		—		—		3.9

Equity securities - corporate securities	Equity securities - corporate securities	.2		—		—		—		.2		Equity securities - corporate securities	—		(3.2)		—		—		(3.2)

Trading securities:												Trading securities:
Non-agency residential mortgage-backed securities												Non-agency residential mortgage-backed securities	—		(.8)		—		—		(.8)

Trading securities - non-agency residential mortgage-backed securities		—		(1.8)		—		—		(1.8)
Commercial mortgage-backed securities												Commercial mortgage-backed securities	—		(7.2)		—		—		(7.2)

Total trading securities												Total trading securities	—		(8.0)		—		—		(8.0)
Investments held by variable interest entities - corporate securities												Investments held by variable interest entities - corporate securities	—		(2.1)		—		—		(2.1)
Other invested assets - residual tranches												Other invested assets - residual tranches	.9		—		—		—		.9

Realized and unrealized investment gains and losses presented in the preceding tables represent gains and losses during the time the applicable financial instruments were classified as Level 3. Realized and unrealized gains (losses) on Level 3 assets are primarily reported in either net investment income for policyholder and other special-purpose portfolios or investment gains (losses) within the consolidated statement of ~~operations~~operations; or accumulated other comprehensive income (loss) within shareholders' equity based on the appropriate accounting treatment for the instrument. The amount presented for gains (losses) included in our net income for assets still held as of the reporting date primarily ~~represents~~represents: (i) the change in allowance for credit losses for fixed maturities, available for ~~sale,~~sale; and (ii) changes in fair value of equity securities and trading securities that ~~exist~~are held as of the reporting date. The amount presented for gains (losses) included in accumulated other comprehensive income (loss) for assets still held as of the reporting date primarily represents changes in the fair value of fixed maturities, available for sale, that are held as of the reporting date.

At ~~September~~June 30, ~~2022,~~2023, 84 percent of our Level 3 fixed maturities, available for sale, were investment grade and 4970 percent of our Level 3 fixed maturities, available for sale, consisted of corporate securities.

5370

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table summarizes changes in the value of our embedded derivatives associated with fixed ~~index~~indexed annuity products (classified as ~~policyholder account liabilities)~~future policy benefits) which are measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value (dollars in millions):


		Three months ended				Nine months ended					Three months ended				Six months ended
		September 30,				September 30,					June 30,				June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Balance at beginning of the period	Balance at beginning of the period	$	1,371.0	$	1,695.0	$	1,724.1	$	1,644.5	Balance at beginning of the period	$	1,347.9	$	1,543.5	$	1,297.0	$	1,724.1
Premiums less benefits	Premiums less benefits	12.0		27.9		55.3		71.3		Premiums less benefits	(15.7)		22.2		(29.7)		43.3
Change in fair value, net	Change in fair value, net	(129.1)		(18.7)		(525.5)		(11.6)		Change in fair value, net	23.2		(194.7)		88.1		(396.4)
Balance at end of the period	Balance at end of the period	$	1,253.9	$	1,704.2	$	1,253.9	$	1,704.2	Balance at end of the period	$	1,355.4	$	1,371.0	$	1,355.4	$	1,371.0

The change in fair value, net for each period in our embedded derivatives is included in the consolidated statement of operations.

5471

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

The following table provides additional information about the significant unobservable (Level 3) inputs developed internally by the Company to determine fair value for certain assets and liabilities carried at fair value at ~~September~~June 30, ~~2022~~2023 (dollars in millions):

~~Fair value at September 30, 2022~~

~~Valuation techniques~~

~~Unobservable inputs~~

~~Range (weighted average) (a)~~

~~Assets:~~

~~Corporate securities (b)~~

~~2.9~~

~~Discounted cash flow analysis~~

~~Discount margins~~

~~2.53% - 4.01% (2.56%)~~

~~Corporate securities (c)~~

~~10.5~~

~~Unadjusted purchase price~~

~~Not applicable~~

~~Asset-backed securities (d)~~

~~18.8~~

~~Discounted cash flow analysis~~

~~Discount margins~~

~~2.08% - 3.58% (2.80%)~~

~~Equity securities (e)~~

~~63.0~~

~~Market comparables~~

~~EBITDA multiples~~

~~Equity securities (f)~~

~~Recovery method~~

~~Percent of recovery expected~~

~~0.00% - 100.00% (100.00%)~~

~~Equity securities (g)~~

~~11.7~~

~~Unadjusted purchase price~~

~~Not applicable~~

~~Other assets categorized as Level 3 (h)~~

~~222.9~~

~~Unadjusted third-party price source~~

~~Not applicable~~

~~Total~~

~~329.9~~

~~Liabilities:~~

~~Embedded derivatives related to fixed index annuity products (classified as policyholder account liabilities) (i)~~

~~1,253.9~~

~~Discounted projected embedded derivatives~~

~~Projected portfolio yields~~

~~3.98% - 4.37% (3.99%)~~

~~Discount rates~~

~~3.23% - 5.55% (4.43%)~~

~~Surrender rates~~

~~1.50% - 26.40% (9.00%)~~

~~(a) The weighted average is based on the relative fair value of the related assets or liabilities.~~

(b) Corporate securities - The significant unobservable input used in the fair value measurement of our corporate securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would have resulted in a significantly lower (higher) fair value measurement.

~~(c) Corporate securities - For these assets, there were no adjustments to the purchase price.~~

(d) Asset-backed securities - The significant unobservable input used in the fair value measurement of these asset-backed securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would have resulted in a significantly lower (higher) fair value measurement.

(e) Equity securities - The significant unobservable input used in the fair value measurement of these equity securities is multiples of earnings before interest, taxes, depreciation and amortization ("EBITDA"). Generally, increases (decreases) in the EBITDA multiples would result in higher (lower) fair value measurements.

(f) Equity securities - The significant unobservable input used in the fair value measurement of these equity securities is percentage of recovery expected. Significant increases (decreases) in percentage of recovery expected in isolation would have resulted in a significantly higher (lower) fair value measurement.

~~(g) Equity securities - For these assets, there were no adjustments to the purchase price.~~

~~(h) Other assets categorized as Level 3 - For these assets, there were no adjustments to non-binding quoted market prices obtained from third-party pricing sources.~~

(i) Embedded derivatives related to fixed index annuity products (classified as policyholder account liabilities) - The significant unobservable inputs used in the fair value measurement of our embedded derivatives associated with fixed index annuity products are projected portfolio yields, discount rates and surrender rates. Increases (decreases) in projected portfolio yields in isolation would have resulted in a higher (lower) fair value measurement. The discount rate is based on risk free rates (U.S. Treasury rates for similar durations) adjusted for our non-performance risk and risk margins for non-capital market inputs. Increases (decreases) in the discount rates would have resulted in a lower (higher) fair value measurement. Assumed surrender rates are used to project how long the contracts remain in force. Generally, the longer the contracts are assumed to be in force the higher the fair value of the embedded derivative.

~~Table of Contents~~

~~CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES~~

~~Notes to Consolidated Financial Statements~~

~~(unaudited)~~

~~___________________~~

Fair value at December 31, 2021

Valuation techniques

Unobservable inputs

Range (weighted average) (a)

Fair value at June 30, 2023

Valuation techniques

Unobservable inputs

Range (weighted average) (a)

Assets:

Corporate securities (b)

Discounted cash flow analysis

Discount margins

4.49%

Corporate securities (b)

2.9

Discounted cash flow analysis

Discount margins

2.25%

Corporate securities (c)

2.3

Recovery method

Percent of recovery expected

0.00% - 100.00% (100.00%)

Corporate securities (c)

3.5

Recovery method

Percent of recovery expected

0.00% - 35.00% (35.00%)

Corporate securities (d)

12.5

Unadjusted purchase price

Not applicable

Corporate securities (d)

1.5

Unadjusted purchase price

Not applicable

Asset-backed securities (e)

11.6

Discounted cash flow analysis

Discount margins

1.50%

Asset-backed securities (e)

22.4

Discounted cash flow analysis

Discount margins

2.26% - 4.31% (3.51%)

Equity securities (f)

63.5

Market comparables

EBITDA multiples

9.9X

Equity securities (g)

Recovery method

Percent of recovery expected

0.00% - 100.00% (100.00%)

Equity securities (f)

3.3

Recovery method

Percent of recovery expected

0.00% - 100.00% (100.00%)

Equity securities (g)

8.2

Unadjusted purchase price

Not applicable

Other assets categorized as Level 3 (h)

132.4

Unadjusted third-party price source

Not applicable

Equity securities (h)

9.2

Unadjusted purchase price

Not applicable

Other assets categorized as Level 3 (i)

171.6

Unadjusted third-party price source

Not applicable

Market risk benefit asset (j)

66.0

Discounted cash flow analysis

Surrender rates

1.28% - 11.05% (3.68%)

Utilization rates

5.92% - 47.62% (22.54%)

Total

170.4

Total

340.7

Liabilities:

Embedded derivatives related to fixed index annuity products (classified as policyholder account liabilities) (i)

1,724.1

Discounted projected embedded derivatives

Projected portfolio yields

3.98% - 4.37% (3.99%)

Market risk benefit liability (j)

10.5

Discounted cash flow analysis

Surrender rates

1.28% - 11.05% (3.68%)

Utilization rates

5.92% - 47.62% (22.54%)

Embedded derivatives related to fixed indexed annuity products (classified as future policy benefits) (k)

1,355.4

Discounted projected embedded derivatives

Projected portfolio yields

4.30% - 4.63% (4.31%)

Discount rates

0.31% - 3.18% (1.89%)

Discount rates

3.46% - 5.54% (4.40%)

Surrender rates

1.50% - 26.40% (9.00%)

Surrender rates

1.90% - 27.70% (9.20%)

(a) The weighted average is based on the relative fair value of the related assets or liabilities.

(c) Corporate securities - The significant unobservable input used in the fair value measurement of these corporate securities is percentage of recovery expected. Significant increases (decreases) in percentage of recovery expected in isolation would have resulted in a significantly higher (lower) fair value measurement.

(d) Corporate securities - For these assets, there were no adjustments to the purchase price.

(e) Asset-backed securities - The significant unobservable input used in the fair value measurement of these asset-backed securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would have resulted in a significantly lower (higher) fair value measurement.

(f) Equity securities - The significant unobservable input used in the fair value measurement of these equity securities is multiples of earnings before interest, taxes, depreciation and amortization ("EBITDA"). Generally, increases (decreases) in the EBITDA multiples would result in higher (lower) fair value measurements.

(g) Equity securities - The significant unobservable input used in the fair value measurement of these equity securities is percentage of recovery expected. Significant increases (decreases) in percentage of recovery expected in isolation would have resulted in a significantly higher (lower) fair value measurement.

~~(g)~~

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

(h) Equity securities - For these assets, there were no adjustments to the purchase price.

~~(h)~~(i) Other assets categorized as Level 3 - For these assets, there were no adjustments to non-binding quoted market prices obtained from third-party pricing sources.

~~(i)~~(j) Market risk benefits – Many of our fixed indexed annuity products include a GLWB that is considered a MRB. The calculation of the value of MRBs are based on significant unobservable inputs including assumptions related to surrenders and utilization of policy benefits. These assumptions are based on actuarial estimates and past experience. Increases in assumed surrender rates would generally increase the value of a MRB asset or decrease the value of a MRB liability (with decreases in assumed surrender rates having the opposite impacts). Increases in utilization rates would generally decrease the value of a MRB asset or increase the value of a MRB liability (with decreases in utilization rates having the opposite impacts).

(k) Embedded derivatives related to fixed ~~index~~indexed annuity products (classified as ~~policyholder account liabilities)~~future policy benefits) - The significant unobservable inputs used in the fair value measurement of our embedded derivatives associated with fixed ~~index~~indexed annuity products are projected portfolio yields, discount rates and surrender rates. Increases (decreases) in projected portfolio yields in isolation would have resulted in a higher (lower) fair value measurement. The discount rate is based on risk free rates (U.S. Treasury rates for similar durations) adjusted for our non-performance risk and risk margins for non-capital market inputs. Increases (decreases) in the discount rates would have resulted in a lower (higher) fair value measurement. Assumed surrender rates are used to project how long the contracts remain in force. Generally, the longer the contracts are assumed to be in force the higher the fair value of the embedded derivative.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

Fair value at December 31, 2022

Valuation techniques

Unobservable inputs

Range (weighted average) (a)

Assets:

Corporate securities (b)

2.9

Discounted cash flow analysis

Discount margins

2.23% - 3.94% (2.25%)

Corporate securities (c)

3.5

Recovery method

Percent of recovery expected

0.00% - 35.00% (35.00%)

Corporate securities (d)

Unadjusted purchase price

Not applicable

Asset-backed securities (e)

21.8

Discounted cash flow analysis

Discount margins

2.50% - 3.86% (3.30%)

Equity securities (f)

63.9

Market comparables

EBITDA multiples

8.5X

Equity securities (g)

Recovery method

Percent of recovery expected

0.00% - 100.00% (100.00%)

Equity securities (h)

11.7

Unadjusted purchase price

Not applicable

Other assets categorized as Level 3 (i)

249.0

Unadjusted third-party price source

Not applicable

Market risk benefit asset (j)

65.3

Discounted cash flow analysis

Surrender rates

1.28% - 11.05% (3.45%)

Utilization rates

6.78% - 63.16% (20.09%)

Total

418.7

Liabilities:

Market risk benefit liability (j)

11.3

Discounted cash flow analysis

Surrender rates

1.28% - 11.05% (3.45%)

Utilization rates

6.78% - 63.16% (20.09%)

Embedded derivatives related to fixed indexed annuity products (classified as future policy benefits) (k)

1,297.0

Discounted projected embedded derivatives

Projected portfolio yields

4.30% - 4.63% (4.31%)

Discount rates

3.77% - 5.48% (4.47%)

Surrender rates

1.90% - 27.70% (9.20%)

(a) The weighted average is based on the relative fair value of the related assets or liabilities.

(d) Corporate securities - For these assets, there were no adjustments to the purchase price.

(f) Equity securities - The significant unobservable input used in the fair value measurement of these equity securities is multiples of earnings before EBITDA. Generally, increases (decreases) in the EBITDA multiples would result in higher (lower) fair value measurements.

Table of Contents

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

___________________

(h) Equity securities - For these assets, there were no adjustments to the purchase price.

(i) Other assets categorized as Level 3 - For these assets, there were no adjustments to non-binding quoted market prices obtained from third-party pricing sources.

(j) Market risk benefits – Many of our fixed indexed annuity products include a GLWB that is considered a MRB. The calculation of the value of MRBs are based on significant unobservable inputs including assumptions related to surrenders and utilization of policy benefits. These assumptions are based on actuarial estimates and past experience. Increases in assumed surrender rates would generally increase the value of a MRB asset or decrease the value of a MRB liability (with decreases in assumed surrender rates having the opposite impacts). Increases in utilization rates would generally decrease the value of a MRB asset or increase the value of a MRB liability (with decreases in utilization rates having the opposite impacts).

(k) Embedded derivatives related to fixed indexed annuity products (classified as future policy benefits) - The significant unobservable inputs used in the fair value measurement of our embedded derivatives associated with fixed indexed annuity products are projected portfolio yields, discount rates and surrender rates. Increases (decreases) in projected portfolio yields in isolation would have resulted in a higher (lower) fair value measurement. The discount rate is based on risk free rates (U.S. Treasury rates for similar durations) adjusted for our non-performance risk and risk margins for non-capital market inputs. Increases (decreases) in the discount rates would have resulted in a lower (higher) fair value measurement. Assumed surrender rates are used to project how long the contracts remain in force. Generally, the longer the contracts are assumed to be in force the higher the fair value of the embedded derivative.

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF CONSOLIDATED FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

In this section, we review the consolidated financial condition of CNO at ~~September~~June 30, ~~2022,~~2023, and its consolidated results of operations for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, and, where appropriate, factors that may affect future financial performance. Please read this discussion in conjunction with the accompanying consolidated financial statements and notes. Results for interim periods are not necessarily indicative of the results that may be expected for a full year.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

Our statements, trend analyses and other information contained in this report and elsewhere (such as in filings by CNO with the SEC, press releases, presentations by CNO or its management or oral statements) relative to markets for CNO's products and trends in CNO's operations or financial results, as well as other statements, contain forward-looking statements within the meaning of the federal securities laws and the Private Securities Litigation Reform Act of 1995. Forward-looking statements typically are identified by the use of terms such as "anticipate," "believe," "plan," "estimate," "expect," "project," "intend," "may," "will," "would," "contemplate," "possible," "attempt," "seek," "should," "could," "goal," "target," "on track," "comfortable with," "optimistic," "guidance," "outlook" and similar words, although some forward-looking statements are expressed differently. You should consider statements that contain these words carefully because they describe our expectations, plans, strategies and goals and our beliefs concerning future business conditions, our results of operations, financial position, and our business outlook or they state other "forward-looking" information based on currently available information. The "Risk Factors" section of our ~~2021~~2022 Annual Report on Form 10-K provides examples of risks, uncertainties and events that could cause our actual results to differ materially from the expectations expressed in our forward-looking statements. Assumptions and other important factors that could cause our actual results to differ materially from those anticipated in our forward-looking statements include, among other things:

•the ongoing COVID-19 pandemic and the resulting financial market, economic and other impacts, including the deferral of healthcare by policyholders and the potential for future resulting increased claim costs, could adversely affect our business, results of operations, financial condition and liquidity;

•general economic, market and political conditions and uncertainties, including the performance and fluctuations of the financial markets which may affect the value of our investments as well as our ability to raise capital or refinance existing indebtedness and the cost of doing so;

•the impact of pandemics and major public health issues, including the novel coronavirus pandemic and the resulting financial market, economic and other impacts;

•exposure to interest rate risk, including interest rate volatility, may negatively impact our results of operations, financial position or cash flow;

•future investment results, including the impact of realized losses (including other-than-temporary impairment charges) may diminish the value of our invested assets and negatively impact our profitability, our financial condition and our liquidity;

•the ultimate outcome of lawsuits filed against us and other legal and regulatory proceedings to which we are subject;

•our ability to make anticipated changes to certain non-guaranteed elements of our life insurance products;

•our ability to obtain adequate and timely rate increases on our health products, including our long-term care business;

•the receipt of any required regulatory approvals for dividend and surplus debenture interest payments from our insurance subsidiaries;

•mortality, morbidity, the increased cost and usage of health care services, persistency, the adequacy of our previous reserve estimates, changes in the health care market and other factors which may affect the profitability of our insurance products;

•changes in our assumptions related to deferred acquisition costs or the present value of future profits;

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

•the recoverability of our deferred tax assets and the effect of potential ownership changes and tax rate changes on their value;

•our assumption that the positions we take on our tax return filings will not be successfully challenged by the Internal Revenue Service;

•changes in accounting principles and the interpretation thereof;

•our ability to continue to satisfy the financial ratio and balance requirements and other covenants of our debt agreements;

•performance and valuation of our investments;

•our ability to identify products and markets in which we can compete effectively against competitors with greater market share, higher ratings, greater financial resources and stronger brand recognition;

•our ability to generate sufficient liquidity to meet our debt service obligations and other cash needs;

•changes in capital deployment opportunities;

•our ability to maintain effective controls over financial reporting and modeling;

•our ability to continue to recruit and retain productive agents and distribution partners;

•customer response to new products, distribution channels and marketing initiatives;

•inflation or other unfavorable economic or business conditions may impact the sales and persistency of insurance products, a portion of our insurance policy benefits affected by increased medical coverage costs and various selling, general and administrative expenses;

•our ability to maintain the financial strength ratings of CNO and our insurance company subsidiaries as well as the impact of our ratings on our business, our ability to access capital, and the cost of capital;

•regulatory changes or actions, including: those relating to regulation of the financial affairs of our insurance companies, such as the calculation of risk-based capital and minimum capital requirements, and payment of dividends and surplus debenture interest to us; regulation of the sale, underwriting and pricing of products; ~~and~~ health care regulation affecting health insurance products; and privacy laws and regulations;

•changes in the Federal income tax laws and regulations which may affect or eliminate the relative tax advantages of some of our products or affect the value of our deferred tax assets;

•availability and effectiveness of reinsurance arrangements, as well as the impact of any defaults or failure of reinsurers to perform;

•the performance of third party service providers (both domestic and international) and potential difficulties arising from outsourcing arrangements;

•expectations for the growth rate of sales, collected premiums, annuity deposits and assets;

•interruption in telecommunication, information technology or other operational systems or failure to maintain the security, confidentiality or privacy of sensitive data on such systems;

•events of terrorism, ~~cyber-attacks,~~ natural disasters or other catastrophic events, including ~~losses from a disease pandemic or~~ potential adverse impacts from climate ~~change;~~change which may increase the frequency or severity of weather-related disasters;

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

•cyber-security attacks, risk of data loss and other security breaches;

•ineffectiveness of risk management policies and procedures in identifying, monitoring and managing risks; and

~~CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES~~

~~___________________~~

•the risk factors or uncertainties listed from time to time in our filings with the SEC.

Other factors and assumptions not identified above are also relevant to the forward-looking statements, and if they prove incorrect, could also cause actual results to differ materially from those projected.

All written or oral forward-looking statements attributable to us are expressly qualified in their entirety by the foregoing cautionary statement. Our forward-looking statements speak only as of the date made. We assume no obligation to update or to publicly announce the results of any revisions to any of the forward-looking statements to reflect actual results, future events or developments, changes in assumptions or changes in other factors affecting the forward-looking statements.

The reporting of risk-based capital ("RBC") measures is not intended for the purpose of ranking any insurance company or for use in connection with any marketing, advertising or promotional activities.

OVERVIEW

We are a holding company for a group of insurance companies operating throughout the United States that develop, market and administer health insurance, annuity, individual life insurance and other insurance and financial services products. We focus on serving middle-income pre-retiree and retired Americans, which we believe are attractive, underserved, high growth markets. We sell our products through exclusive agents, independent producers (some of whom sell one or more of our product lines exclusively) and direct marketing.

We view our operations as three insurance product lines (annuity, health and life) and the investment and fee income segments. Our segments are aligned based on their common characteristics, comparability of profit margins and the way management makes operating decisions and assesses the performance of the business.

Our insurance product line segments (annuity, health and life) include marketing, underwriting and administration of the policies our insurance subsidiaries sell. The business written in each of the three product categories through all of our insurance subsidiaries is aggregated allowing management and investors to assess the performance of each product category. ~~When analyzing~~Insurance product margin is management’s measure of the profitability of ~~these segments, we use insurance~~its annuity, health and life product ~~margin as the measure~~lines' performance and consists of ~~profitability, which is: (i)~~ insurance policy ~~income; and (ii) net~~income plus allocated investment income ~~allocated to the insurance product lines;~~ less ~~(i)~~ insurance policy benefits, ~~and~~ interest credited, ~~to policyholders;~~commissions, advertising expense and ~~(ii)~~ amortization ~~non-deferred commissions and advertising expense. Net investment income is allocated to the product lines using the book yield~~ of ~~investments backing the block of business, which is applied to the average insurance liabilities, net of insurance intangibles, for the block in each period.~~

acquisition costs. Income from insurance products is the sum of the insurance margins of the annuity, health and life product lines, less expenses allocated to the insurance lines. It excludes the income from our fee income business, investment income not allocated to product lines, net expenses not allocated to product lines (primarily holding company expenses) and income taxes. Management believes ~~insurance product margin and income from insurance products help~~this information helps provide a better understanding of the business and a more meaningful analysis of the results of our insurance product lines.

We market our ~~insurance~~ products through the Consumer and Worksite Divisions that reflect the customers served by the Company.

The Worksite Division focuses on worksite and group sales for businesses, associations, and other membership groups, interacting with customers at their place of employment and virtually. With a separate Worksite Division, we are bringing a sharper focus to this high-growth business while further capitalizing on the strength of our ~~acquisitions~~wholly-owned subsidiary, Optavise, a national provider of WBD and DirectPath. Sales in the Worksite Division have been particularly adversely impacted by the COVID-19 pandemic given the challenges of interacting with customers at their place of employment. The Worksite Division is increasing its recruiting efforts to rebuild its agent force which was adversely impacted by the COVID-19 pandemic.year-round technology-driven employee benefits management services.

5978

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

The investment segment involves the management of our capital resources, including investments and the management of corporate debt and liquidity. Our measure of profitability of this segment is the total net investment income not allocated to the insurance products. Investment income not allocated to product lines represents net investment income less: (i) equity returns credited to policyholder account balances; (ii) the investment income allocated to our product lines; (iii) interest expense on notes payable and investment borrowings; (iv) expenses related to the FABN program; and (v) certain expenses related to benefit plans that are offset by special-purpose investment ~~income.~~income; plus (vi) the impact of annual option forfeitures related to fixed indexed annuity surrenders. Investment income not allocated to product lines includes investment income on investments in excess of ~~average insurance liabilities,~~amounts allocated to product lines, investments held by our holding companies, the spread we earn from our FHLB investment borrowing and FABN programs and variable components of investment income (including call and prepayment income, adjustments to returns on structured securities due to cash flow changes, income (loss) from COLI and alternative investment income not allocated to product lines), net of interest expense on corporate debt. The spread earned from our FHLB investment borrowing and FABN programs includes the investment income on the matched assets less: (i) interest on investment borrowings related to the FHLB investment borrowing program; (ii) interest credited on funding agreements; and (iii) amortization of deferred acquisition costs related to the FABN program.

Expenses not allocated to product lines include the expenses of our corporate operations, excluding interest expense on debt.

6079

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

The following summarizes our earnings for the three and ~~nine~~six months ending ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022 (dollars in millions, except per share data):


		Three months ended				Nine months ended					Three months ended				Six months ended
		September 30,				September 30,					June 30,				June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Insurance product margin	Insurance product margin									Insurance product margin
Annuity margin	Annuity margin	$	39.8	$	52.5	$	121.5	$	176.4	Annuity margin	$	57.1	$	60.1	$	114.4	$	116.0
Health margin	Health margin	124.1		117.9		362.3		363.5		Health margin	108.2		125.4		224.7		240.7
Life margin	Life margin	43.4		53.2		120.0		120.0		Life margin	57.9		70.2		105.3		106.2
Total insurance product margin	Total insurance product margin	207.3		223.6		603.8		659.9		Total insurance product margin	223.2		255.7		444.4		462.9
Allocated expenses	Allocated expenses	(150.5)		(140.5)		(447.5)		(423.2)		Allocated expenses	(149.5)		(152.2)		(307.0)		(297.0)
Income from insurance products	Income from insurance products	56.8		83.1		156.3		236.7		Income from insurance products	73.7		103.5		137.4		165.9

Fee income	Fee income	1.4		2.6		14.5		16.5		Fee income	.6		3.2		16.1		13.1
Investment income not allocated to product lines	Investment income not allocated to product lines	32.2		50.9		129.2		141.7		Investment income not allocated to product lines	28.0		64.6		43.5		91.6
Expenses not allocated to product lines	Expenses not allocated to product lines	(16.1)		(17.3)		(28.0)		(63.1)		Expenses not allocated to product lines	(21.1)		2.9		(39.4)		(11.9)
Operating earnings before taxes	Operating earnings before taxes	74.3		119.3		272.0		331.8		Operating earnings before taxes	81.2		174.2		157.6		258.7
Income tax expense on operating income	Income tax expense on operating income	(17.4)		(26.5)		(63.9)		(74.7)		Income tax expense on operating income	(18.9)		(39.1)		(36.7)		(59.1)
Net operating income (a)	Net operating income (a)	56.9		92.8		208.1		257.1		Net operating income (a)	62.3		135.1		120.9		199.6
Net realized investment gains (losses) from sales, impairments and change in allowance for credit losses (net of related amortization)		(.1)		2.2		(33.3)		30.1
Net realized investment losses from sales and change in allowance for credit losses										Net realized investment losses from sales and change in allowance for credit losses	(31.3)		(27.1)		(44.0)		(34.3)
Net change in market value of investments recognized in earnings	Net change in market value of investments recognized in earnings	(17.0)		(4.6)		(64.2)		(5.3)		Net change in market value of investments recognized in earnings	(4.0)		(21.7)		(5.9)		(47.2)
Fair value changes related to agent deferred compensation plan	Fair value changes related to agent deferred compensation plan	12.0		—		48.7		13.2		Fair value changes related to agent deferred compensation plan	—		14.0		—		36.7
Fair value changes in embedded derivative liabilities (net of related amortization)		66.0		10.9		236.5		48.1
Changes in fair value of embedded derivative liabilities and market risk benefits										Changes in fair value of embedded derivative liabilities and market risk benefits	50.4		160.6		(14.7)		326.0

Other	Other	2.0		.2		2.2		1.7		Other	(.2)		(.2)		2.1		.2
Net non-operating income before taxes		62.9		8.7		189.9		87.8
Net non-operating income (loss) before taxes										Net non-operating income (loss) before taxes	14.9		125.6		(62.5)		281.4

Income tax expense on non-operating income		(14.8)		(1.7)		(44.6)		(19.7)
Income tax (expense) benefit on non-operating income (loss)										Income tax (expense) benefit on non-operating income (loss)	(3.5)		(27.4)		14.5		(64.3)

Net non-operating income		48.1		7.0		145.3		68.1
Net non-operating income (loss)										Net non-operating income (loss)	11.4		98.2		(48.0)		217.1
Net income	Net income	$	105.0	$	99.8	$	353.4	$	325.2	Net income	$	73.7	$	233.3	$	72.9	$	416.7
Per diluted share	Per diluted share									Per diluted share
Net operating income	Net operating income	$	.49	$	.72	$	1.76	$	1.93	Net operating income	$	.54	$	1.15	$	1.04	$	1.68
Net non-operating income		.42		.05		1.23		.51
Net non-operating income (loss)										Net non-operating income (loss)	.10		.84		(.41)		1.82
Net income	Net income	$	.91	$	.77	$	2.99	$	2.44	Net income	$	.64	$	1.99	$	.63	$	3.50

6180

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

____________

(a)Management believes that an analysis of net income applicable to common stock before: (i) net realized investment gains ~~(losses)~~or losses from sales, impairments and change in allowance for credit losses, net of ~~related amortization and~~ taxes; (ii) net change in market value of investments recognized in earnings, net of taxes; (iii) changes in fair value ~~changes due to fluctuations in the interest rates used to discount~~of embedded derivative liabilities and MRBs related to our fixed ~~index~~indexed annuities, net of ~~related amortization and~~ taxes; (iv) fair value changes related to the agent deferred compensation plan, net of taxes; (v) loss related to reinsurance transaction, net of taxes; (vi) loss on extinguishment of debt, net of taxes; (vii) changes in the valuation allowance for deferred tax assets and other tax items; and ~~(vi)~~(viii) other non-operating items consisting primarily of earnings attributable to VIEs, (“net of taxes ("net operating income,”" a non-GAAP financial measure) is important to evaluate the financial performance of the company, and is a key measure commonly used in the life insurance industry. Management uses this measure to evaluate performance because the items excluded from net operating income can be affected by events that are unrelated to the Company's underlying fundamentals. The table above reconciles the non-GAAP measure to the corresponding GAAP measure.

In addition, management uses these non-GAAP financial measures in its budgeting process, financial analysis of segment performance and in assessing the allocation of resources. We believe these non-GAAP financial measures enhance an ~~investor’s~~investor's understanding of our financial performance and allows them to make more informed judgments about the Company as a whole. These measures also highlight operating trends that might not otherwise be apparent. However, net operating income is not a measurement of financial performance under GAAP and should not be considered as an alternative to cash flow from operating activities, as measures of liquidity, or as an alternative to net income as measures of our operating performance or any other measures of performance derived in accordance with GAAP. In addition, net operating income should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. Net operating income has limitations as an analytical tool, and you should not consider such measure either in isolation or as a substitute for analyzing our results as reported under GAAP. Our definition and calculation of net operating income are not necessarily comparable to other similarly titled measures used by other companies due to different methods of calculation. Also, as we adopted the new accounting standard related to targeted improvements to the accounting for long-duration insurance contracts effective January 1, 2023, we updated our method of determining non-operating earnings for our fixed indexed annuities to better identify the volatile non-economic impacts of that line of business. This resulted in fixed indexed annuity margins that more closely reflect the economics of the business.

GOVERNMENTAL REGULATION

Privacy and Cybersecurity Regulation

In July 2023, the SEC adopted the Risk Management, Strategy, Governance, and Incident Disclosure Final Rule (the "Cybersecurity Final Rule") requiring enhanced disclosures of material cybersecurity incidents in a Form 8-K and periodic disclosures of, among other things, details on the processes to assess, identify, and manage those risks, cybersecurity governance, and management's role in overseeing such a compliance program, including the board of directors' oversight of cybersecurity risks. Certain reporting requirements under the Cybersecurity Final Rule become effective as early as December 2023.

CRITICAL ACCOUNTING ~~POLICIES~~ESTIMATES

~~Refer~~The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of various assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period. Management has made estimates in the past that we believed to be appropriate but were subsequently revised to reflect actual experience. If our future experience differs materially from these estimates and assumptions, our results of operations and financial condition could be materially affected.

Effective January 1, 2023, we adopted ASU 2018-12. The adoption of ASU 2018-12 impacted the accounting and presentation related to long-duration insurance contracts and certain related balances for the years ended December 31, 2022 and 2021. Disclosures of the impacts of ASU 2018-12 as of the Transition Date are included within the tables in the note to the consolidated financial statements entitled "Recently Adopted Accounting Standards." For a discussion of our significant

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

accounting policies impacted by the adoption of ASU 2018-12, see the note to the consolidated financial statements entitled "Summary of Significant Accounting Policies".

The critical accounting estimates that were not impacted as a result of the adoption of ASU 2018-12 are described in "Critical Accounting ~~Policies"~~Estimates" in our ~~2021~~2022 Annual Report on Form ~~10-K for information on~~10-K. Below is a discussion of our ~~other~~updated critical accounting ~~policies that we consider critical in preparing our consolidated financial statements.~~estimates.

Present Value of Future Profits and Deferred Acquisition Costs

Amortization of the present value of future profits and deferred acquisition costs is calculated using the same contract groupings (or cohorts), mortality and lapse assumptions that are used in calculating the liability for future policy benefits, and these assumptions are reviewed and updated at least annually.

As a result of the adoption of ASU 2018-12, the amortization methodology related to these account balances is no longer subject to the same degree of variability and does not require a high degree of judgment. However, these accounts remain sensitive to unexpected lapses, due to higher mortality and lapse experience than expected. Such changes are recognized in the current period as a reduction of the capitalized balances. The effect of changes in assumptions related to future mortality and lapses are recognized prospectively over the remaining contract term. The carrying value of deferred acquisition costs is not subject to recovery testing upon the adoption of ASU 2018-12.

Liabilities for Insurance Products

The adoption of ASU 2018-12 significantly changes how we account for the liabilities for insurance products for long-duration contracts and amends existing recognition, measurement, presentation and disclosure requirements. As part of this adoption, we measure all payments under an insurance contract including future expected claims and unpaid policy claims (with the exception of life insurance policy and contract claims, which are classified in the "liability for life insurance policy claims") and related expenses as an integrated reserve. This resulted in unpaid claims on long-duration health insurance contracts that were previously in the "liability for policy and contract claims" pre-adoption to be now presented as part of the liability for future policy benefits.

Our liabilities for future policy benefits are measured using the net premium ratio approach as described in the note to the consolidated financial statements entitled "Summary of Significant Accounting Policies".

Cash flow assumptions related to our insurance contracts are established when a policy is issued and are evaluated each quarter to determine if assumption updates are required. A more detailed review of assumptions is performed annually during the fourth quarter. Changes to our cash flow assumptions are recognized in the liability for future policy benefits remeasurement (gain) loss in the consolidated statement of operations. Actual experience is reflected in the calculation of future policy benefits each quarter, and changes in the liability due to actual experience are also recognized in the liability for future policy benefits remeasurement (gain) loss in the consolidated statement of operations.

Discount rates used to calculate net premiums are locked in at policy inception and provide the basis to recognize interest expense in the consolidated statement of operations. Discount rates used to measure the carrying value of the liability for future policy benefits in the consolidated balance sheet are updated each reporting period, and differences between the liability balances calculated using the locked-in rate and the updated discount rates are recognized in accumulated other comprehensive income (loss). For additional discussion on the determination of discount rates, see the note to the consolidated financial statements entitled "Summary of Significant Accounting Policies".

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Market risk benefits

MRBs are contracts or contract features that both provide protection to the contract holder from other-than-nominal capital market risk and expose the Company to other-than-nominal capital market risk. Many of our fixed indexed annuity products include a GLWB that is considered a MRB. MRBs are measured at fair value using an option-based valuation model based on amount of exposure, market data, Company experience and other factors. Changes in fair value are recognized in earnings each period with the exception of the portion of the change in fair value due to a change in the instrument-specific credit risk, which is recognized in accumulated other comprehensive income (loss). MRBs in an asset position are presented separately from those in a liability position as there is no legal right of offset between contracts.

The cost of MRBs may rise in volatile or declining equity markets or in a low interest rate environment. Market conditions including, but not limited to, changes in interest rates, equity indices, market volatility, variations in actuarial assumptions regarding policyholder behavior, mortality and risk margins related to non-capital market inputs, may result in significant fluctuations in the estimated fair value of the guarantees that could affect net income and changes in our nonperformance risk could materially affect other comprehensive income.

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

RESULTS OF OPERATIONS

The following tables and narratives summarize the operating results of our segments (dollars in millions):


		Three months ended				Nine months ended					Three months ended				Six months ended
		September 30,				September 30,					June 30,				June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Insurance product margin	Insurance product margin									Insurance product margin
Annuity:	Annuity:									Annuity:
Insurance policy income	Insurance policy income	$	6.3	$	5.8	$	17.1	$	15.5	Insurance policy income	$	8.1	$	5.8	$	13.2	$	10.8
Net investment income	Net investment income	117.3		115.5		347.2		346.1		Net investment income	127.7		117.8		253.1		235.3
Insurance policy benefits	Insurance policy benefits	(23.7)		(16.2)		(69.1)		(23.7)		Insurance policy benefits	(10.6)		(6.8)		(19.3)		(16.3)
Interest credited	Interest credited	(46.3)		(38.1)		(129.9)		(113.7)		Interest credited	(50.6)		(41.4)		(98.7)		(83.9)
Amortization and non-deferred commissions	Amortization and non-deferred commissions	(13.8)		(14.5)		(43.8)		(47.8)		Amortization and non-deferred commissions	(17.5)		(15.3)		(33.9)		(29.9)
Annuity margin	Annuity margin	39.8		52.5		121.5		176.4		Annuity margin	57.1		60.1		114.4		116.0
Health:	Health:									Health:
Insurance policy income	Insurance policy income	403.5		414.4		1,213.7		1,246.3		Insurance policy income	397.1		403.5		798.5		810.2
Net investment income	Net investment income	71.9		72.2		215.3		215.3		Net investment income	74.3		73.0		148.3		146.3
Insurance policy benefits	Insurance policy benefits	(307.8)		(325.4)		(924.8)		(955.3)		Insurance policy benefits	(322.7)		(309.9)		(640.8)		(633.0)
Amortization and non-deferred commissions	Amortization and non-deferred commissions	(43.5)		(43.3)		(141.9)		(142.8)		Amortization and non-deferred commissions	(40.5)		(41.2)		(81.3)		(82.8)
Health margin	Health margin	124.1		117.9		362.3		363.5		Health margin	108.2		125.4		224.7		240.7
Life:	Life:									Life:
Insurance policy income	Insurance policy income	213.4		210.4		643.0		631.7		Insurance policy income	223.1		216.3		442.1		429.6
Net investment income	Net investment income	36.6		36.4		109.1		108.3		Net investment income	36.1		35.2		72.4		70.7
Insurance policy benefits	Insurance policy benefits	(142.6)		(141.3)		(444.6)		(454.4)		Insurance policy benefits	(142.8)		(127.7)		(290.0)		(280.8)
Interest credited	Interest credited	(12.2)		(11.1)		(35.1)		(32.7)		Interest credited	(12.2)		(11.7)		(24.3)		(23.7)
Amortization and non-deferred commissions	Amortization and non-deferred commissions	(29.7)		(21.4)		(78.4)		(64.9)		Amortization and non-deferred commissions	(20.8)		(19.3)		(40.7)		(37.7)
Advertising expense	Advertising expense	(22.1)		(19.8)		(74.0)		(68.0)		Advertising expense	(25.5)		(22.6)		(54.2)		(51.9)
Life margin	Life margin	43.4		53.2		120.0		120.0		Life margin	57.9		70.2		105.3		106.2
Total insurance product margin	Total insurance product margin	207.3		223.6		603.8		659.9		Total insurance product margin	223.2		255.7		444.4		462.9
Allocated expenses:	Allocated expenses:									Allocated expenses:
Branch office expenses	Branch office expenses	(16.5)		(14.8)		(50.0)		(49.5)		Branch office expenses	(15.9)		(15.4)		(35.7)		(33.5)
Other allocated expenses	Other allocated expenses	(134.0)		(125.7)		(397.5)		(373.7)		Other allocated expenses	(133.6)		(136.8)		(271.3)		(263.5)
Income from insurance products	Income from insurance products	56.8		83.1		156.3		236.7		Income from insurance products	73.7		103.5		137.4		165.9

Fee income	Fee income	1.4		2.6		14.5		16.5		Fee income	.6		3.2		16.1		13.1
Investment income not allocated to product lines	Investment income not allocated to product lines	32.2		50.9		129.2		141.7		Investment income not allocated to product lines	28.0		64.6		43.5		91.6
Expenses not allocated to product lines	Expenses not allocated to product lines	(16.1)		(17.3)		(28.0)		(63.1)		Expenses not allocated to product lines	(21.1)		2.9		(39.4)		(11.9)
Operating earnings before taxes	Operating earnings before taxes	74.3		119.3		272.0		331.8		Operating earnings before taxes	81.2		174.2		157.6		258.7
Income tax expense on operating income	Income tax expense on operating income	(17.4)		(26.5)		(63.9)		(74.7)		Income tax expense on operating income	(18.9)		(39.1)		(36.7)		(59.1)
Net operating income	Net operating income	$	56.9	$	92.8	$	208.1	$	257.1	Net operating income	$	62.3	$	135.1	$	120.9	$	199.6

CNO is the top tier holding company for a group of insurance companies operating throughout the United States that develop, market and administer health insurance, annuity, individual life insurance and other insurance and financial services products. We view our operations by segments, which consist of insurance product lines. These products are distributed by our two divisions. The Consumer Division serves individual consumers, engaging with them on the phone, virtually, online, face-to-face with agents, or through a combination of sales channels. The Worksite Division focuses on worksite and group sales for businesses, associations, and other membership groups, interacting with customers at their place of employment and virtually.

6384

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Insurance product margin is management’s measure of the profitability of its annuity, health and life product ~~lines’~~lines' performance and consists of insurance policy income plus allocated investment income less insurance policy benefits, interest credited, commissions, advertising expense and amortization of acquisition costs. Income from insurance products is the sum of the insurance margins of the annuity, health and life product lines, less expenses allocated to the insurance lines. It excludes the income from our fee income business, investment income not allocated to product lines, net expenses not allocated to product lines (primarily holding company expenses) and income taxes. Management believes ~~insurance product margin and income from insurance products help~~this information helps provide a better understanding of the business and a more meaningful analysis of the results of our insurance product lines.

~~Investment~~Net investment income is allocated to the product lines using the book yield of investments backing the block of business, which is applied to the average net insurance liabilities ~~net of insurance intangibles,~~ for the block in each period. Net insurance liabilities for the purpose of allocating investment income to product lines are equal to: (i) policyholder account balances for annuity products; (ii) total reserves before the fair value adjustments reflected in accumulated other comprehensive income (loss), if applicable, for all other products; less (iii) amounts related to reinsurance business; (iv) deferred acquisition costs; (v) the present value of future profits; and (vi) the value of unexpired options credited to insurance liabilities. Investment income not allocated to product lines represents net investment income less: (i) equity returns credited to policyholder account balances; (ii) the investment income allocated to our product lines; (iii) interest expense on notes payable and investment borrowings; (iv) expenses related to the FABN program; and (v) certain expenses related to benefit plans that are offset by special-purpose investment ~~income.~~income; plus (vi) the impact of annual option forfeitures related to fixed indexed annuity surrenders. Investment income not allocated to product lines includes investment income on investments in excess of ~~average insurance liabilities,~~amounts allocated to product lines, investments held by our holding companies, the spread we earn from our FHLB investment borrowing and FABN programs and variable components of investment income (including call and prepayment income, adjustments to returns on structured securities due to cash flow changes, income (loss) from COLI and alternative investment income not allocated to product lines), net of interest expense on corporate debt.

Summary of Operating Results: Net operating income was ~~$56.9~~$62.3 million in the ~~third~~second quarter of 2023, down from $135.1 million in the second quarter of 2022, ~~down from $92.8 million in the third quarter of 2021,~~ and was ~~$208.1~~$120.9 million in the first ~~nine~~six months of ~~2022,~~2023, down from ~~$257.1~~$199.6 million in the first ~~nine~~six months of ~~2021.~~2022.

Insurance product margin was ~~$207.3~~$223.2 million in the ~~third~~second quarter of 2023 compared to $255.7 million in the second quarter of 2022, ~~compared to $223.6 million in the third quarter of 2021,~~ and was ~~$603.8~~$444.4 million in the first ~~nine~~six months of ~~2022~~2023 compared to ~~$659.9~~$462.9 million in the first ~~nine~~six months of ~~2021.~~2022. Insurance product ~~margin has been significantly~~margins in the 2023 periods were impacted by ~~the COVID-19 pandemic. Our life margin reflected adverse mortality as a result~~unfavorable claim experience in our Medicare supplement and long-term care lines of increased deaths related to COVID-19 of approximately $5 million and $3 million in the third quarters of 2022 and 2021, respectively, and $21 million and $33 million in the first nine months of 2022 and 2021, respectively. Our health margin continues to compare favorably to the margins experienced prior to the COVID-19 pandemic. We estimate the favorable impacts on our health margin due to COVID-19 to be approximately $26 million and $25 million in the third quarters of 2022 and 2021, respectively, and $79 million and $95 million in the first nine months of 2022 and 2021, respectively.business. In addition, the traditional life margin ~~from fixed index annuities~~was favorably impacted in the ~~three and nine months ended September 30,~~second quarter of 2022 ~~decreased by $11 million and $47 million, respectively,~~ due to ~~recent market volatility, as compared~~a larger than typical reduction in claim liabilities due to the ~~same periods~~work down of a backlog of claims that were in-the-course-of-settlement. Such claim payments also had a positive impact (of approximately $10 million) on the change in ~~2021.~~the liability for future policy benefits as calculated under the new LDTI standard.

Total allocated and unallocated expenses are summarized in the table below. Expenses not allocated to product lines in the second quarter of 2022 include the impact of a significant item related to an experience refund pursuant to the terms of a reinsurance agreement. Total allocated and unallocated expenses as adjusted for the significant item are summarized below (dollars in millions):


	Three months ended				Six months ended
	June 30,				June 30,
	2023		2022		2023		2022
Expenses allocated to product lines	$	149.5	$	152.2	$	307.0	$	297.0
Expenses not allocated to product lines	21.1		(2.9)		39.4		11.9
Experience refund related to a reinsurance agreement (a)	—		22.5		—		22.5
Adjusted total	$	170.6	$	171.8	$	346.4	$	331.4

_______________

(a) Under the terms of the reinsurance agreement to cede a substantial portion of our legacy long-term care block, we were entitled to receive an experience refund of up to $22.5 million if certain rate increases were approved and implemented. As of June 30, 2022, all requirements to earn the maximum experience refund had been met and the refund was recognized. The refund was received in the second quarter of 2023.

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

~~Expenses allocated to insurance products~~

Though expenses were ~~$150.5 million in the third quarter of 2022, up 7.1 percent from the third quarter of 2021, and were $447.5 million~~elevated in the first ~~nine~~six months of ~~2022, up 5.7~~2023, our projected expense ratio for the full year of between 19.0 percent ~~from~~to 19.4 percent remains unchanged. The expense ratio is defined as total allocated and unallocated expenses (excluding any significant items) divided by the ~~comparable period in 2021. Such higher expenses primarily reflect our continued~~sum of insurance policy income and net investment ~~in growth initiatives.~~income allocated to products.

The fee income segment is summarized below (dollars in millions):


		Three months ended				Nine months ended					Three months ended				Six months ended
		September 30,				September 30,					June 30,				June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Fee revenue	Fee revenue	$	30.6	$	28.0	$	102.0	$	91.4	Fee revenue	$	29.4	$	31.1	$	80.7	$	71.4
Operating costs and expenses	Operating costs and expenses	(29.2)		(25.4)		(87.5)		(74.9)		Operating costs and expenses	(28.8)		(27.9)		(64.6)		(58.3)
Net fee income	Net fee income	$	1.4	$	2.6	$	14.5	$	16.5	Net fee income	$	.6	$	3.2	$	16.1	$	13.1

~~Operating costs and expenses~~The increase in net fee income in the ~~fee income segment~~first six months of 2023 is due to growth in the 2022 periods primarily reflect higher expenses related to our businesses that provide benefits administration and employee benefits management services. Such expenses in the 2022 periods are partially offset by the growth related to the sales of third party products in recent periods and changes to our revenue recognition assumptions reflecting favorable policy ~~persistency.~~persistency, partially offset by lower net fee income related to services provided by Optavise. The decrease in net fee income in the second quarter of 2023, as compared to the same period in 2022, reflects less favorable changes to our revenue recognition assumptions on the sales of third party products and higher expenses incurred by Optavise.

Investment income not allocated to product lines generally fluctuates from period to period based on the level of prepayment income (including call premiums) and trading account income; the performance of our alternative investments (which are typically reported a quarter in arrears); the earnings related to the investments underlying our COLI; and the spread we earn from our FHLB investment borrowing and FABN programs.

~~Expenses not allocated to product lines includes certain significant items listed in~~The effective tax rate for the ~~table below. Expenses not allocated to product lines as adjusted~~first six months of 2023 was 23.3 percent which was consistent with our expected annual effective tax rate for ~~such significant items are summarized below (dollars in millions):~~

Three months ended Nine months ended
September 30, September 30,
2022 2021 2022 2021
Expenses not allocated to product lines $ 16.1 $ 17.3 $ 28.0 $ 63.1
Experience refund related to a reinsurance agreement (a)
— — 22.5 —
Net expenses related to significant legal and regulatory matters — (3.0) — (12.8)
Transaction expenses related to acquisition of DirectPath — — — (2.5)
Adjusted total $ 16.1 $ 14.3 $ 50.5 $ 47.8

~~_______________~~

~~(a) Under the terms~~2023 of the reinsurance agreement to cede a substantial portion of our legacy long-term care block, we are entitled to receive an experience refund of up to $22.5 million if certain rate increases are approvedbetween 23 percent and implemented. As of June 30, 2022, all requirements to earn the maximum experience refund had been met and the refund had been recognized. Pursuant to the terms of the agreement, the refund is payable in the second half of 2023.24 percent.

6586

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Margin from Annuity Products (dollars in millions):


		Three months ended						Nine months ended							Three months ended						Six months ended
		September 30,						September 30,							June 30,						June 30,
		2022			2021			2022			2021				2023			2022			2023			2022
Annuity margin:	Annuity margin:													Annuity margin:
Fixed index annuities
Fixed indexed annuities														Fixed indexed annuities
Insurance policy income	Insurance policy income	$	3.6		$	3.3		$	10.3		$	9.6		Insurance policy income	$	5.5		$	3.7		$	9.1		$	6.7
Net investment income	Net investment income	91.3			86.3			267.4			256.1			Net investment income	101.2			91.4			200.0			181.5
Insurance policy benefits	Insurance policy benefits	(19.0)			(9.8)			(56.7)			(4.4)			Insurance policy benefits	(4.2)			(3.1)			(8.3)			(7.7)
Interest credited	Interest credited	(34.4)			(24.8)			(94.1)			(73.1)			Interest credited	(38.9)			(29.5)			(75.3)			(59.9)
Amortization and non-deferred commissions	Amortization and non-deferred commissions	(12.2)			(12.6)			(38.6)			(42.2)			Amortization and non-deferred commissions	(16.0)			(14.1)			(31.4)			(27.4)
Margin from fixed index annuities		$	29.3		$	42.4		$	88.3		$	146.0
Margin from fixed indexed annuities														Margin from fixed indexed annuities	$	47.6		$	48.4		$	94.1		$	93.2
Average net insurance liabilities	Average net insurance liabilities	$	8,555.6		$	7,881.9		$	8,414.8		$	7,663.4		Average net insurance liabilities	$	9,276.0		$	8,711.0		$	9,229.9		$	8,598.7
Margin/average net insurance liabilities	Margin/average net insurance liabilities	1.37		%	2.15		%	1.40		%	2.54		%	Margin/average net insurance liabilities	2.05		%	2.22		%	2.04		%	2.17		%
Fixed interest annuities	Fixed interest annuities													Fixed interest annuities
Insurance policy income	Insurance policy income	$	.2		$	.3		$	.6		$	.6		Insurance policy income	$	.2		$	.3		$	.5		$	.4
Net investment income	Net investment income	20.3			23.0			62.4			71.1			Net investment income	20.9			20.6			41.8			42.1
Insurance policy benefits	Insurance policy benefits	.1			(.2)			(.8)			(.7)			Insurance policy benefits	—			(.6)			(.1)			(1.0)
Interest credited	Interest credited	(11.3)			(12.7)			(34.0)			(38.7)			Interest credited	(11.1)			(11.3)			(22.2)			(22.8)
Amortization and non-deferred commissions	Amortization and non-deferred commissions	(1.5)			(1.8)			(4.9)			(5.4)			Amortization and non-deferred commissions	(1.3)			(1.1)			(2.2)			(2.3)
Margin from fixed interest annuities	Margin from fixed interest annuities	$	7.8		$	8.6		$	23.3		$	26.9		Margin from fixed interest annuities	$	8.7		$	7.9		$	17.8		$	16.4
Average net insurance liabilities	Average net insurance liabilities	$	1,677.4		$	1,856.3		$	1,717.6		$	1,902.4		Average net insurance liabilities	$	1,613.1		$	1,712.5		$	1,622.0		$	1,736.8
Margin/average net insurance liabilities	Margin/average net insurance liabilities	1.86		%	1.85		%	1.81		%	1.89		%	Margin/average net insurance liabilities	2.16		%	1.85		%	2.19		%	1.89		%
Other annuities	Other annuities													Other annuities
Insurance policy income	Insurance policy income	$	2.5		$	2.2		6.2			$	5.3		Insurance policy income	$	2.4		$	1.8		$	3.6		$	3.7
Net investment income	Net investment income	5.7			6.2			17.4			18.9			Net investment income	5.6			5.8			11.3			11.7
Insurance policy benefits	Insurance policy benefits	(4.8)			(6.2)			(11.6)			(18.6)			Insurance policy benefits	(6.4)			(3.1)			(10.9)			(7.6)
Interest credited	Interest credited	(.6)			(.6)			(1.8)			(1.9)			Interest credited	(.6)			(.6)			(1.2)			(1.2)
Amortization and non-deferred commissions	Amortization and non-deferred commissions	(.1)			(.1)			(.3)			(.2)			Amortization and non-deferred commissions	(.2)			(.1)			(.3)			(.2)
Margin from other annuities	Margin from other annuities	$	2.7		$	1.5		$	9.9		$	3.5		Margin from other annuities	$	.8		$	3.8		$	2.5		$	6.4
Average net insurance liabilities	Average net insurance liabilities	$	476.3		$	501.6		$	482.0		$	506.9		Average net insurance liabilities	$	462.5		$	484.2		$	466.0		$	487.2
Margin/average net insurance liabilities	Margin/average net insurance liabilities	2.27		%	1.20		%	2.74		%	.92		%	Margin/average net insurance liabilities	.69		%	3.14		%	1.07		%	2.63		%
Total annuity margin	Total annuity margin	$	39.8		$	52.5		$	121.5		$	176.4		Total annuity margin	$	57.1		$	60.1		$	114.4		$	116.0
Average net insurance liabilities	Average net insurance liabilities	$	10,709.3		$	10,239.8		$	10,614.4		$	10,072.7		Average net insurance liabilities	$	11,351.6		$	10,907.7		$	11,317.9		$	10,822.7
Margin/average net insurance liabilities	Margin/average net insurance liabilities	1.49		%	2.05		%	1.53		%	2.34		%	Margin/average net insurance liabilities	2.01		%	2.20		%	2.02		%	2.14		%

Margin from fixed ~~index~~indexed annuities was ~~$29.3~~$47.6 million in the ~~third~~second quarter of 2023 compared to $48.4 million in the second quarter of 2022, ~~compared to $42.4 million in the third quarter of 2021,~~ and was ~~$88.3~~$94.1 million in the first ~~nine~~six months of ~~2022~~2023 compared to ~~$146.0~~$93.2 million in the first ~~nine~~six months of ~~2021.~~2022. The ~~decrease~~margins in ~~margin in the 2022 periods is primarily driven by unfavorable impacts resulting from market conditions (primarily higher interest rates and lower equity markets) in 2022~~2023 are relatively flat, as compared to the ~~2021 periods. Such unfavorable market conditions reduced margins on this block of business by $17 million and $6 million~~same periods in the ~~third quarters of 2022 and 2021, respectively, and by $48 million and $1 million~~prior year, as growth in the ~~first nine months~~block is primarily being offset by spread compression driven by increased surrenders of ~~2022 and 2021, respectively.~~higher spread products. Average net insurance liabilities ~~(total insurance liabilities~~(policyholder account balances less: (i) amounts related to reinsured business; (ii) deferred acquisition costs; (iii) present value of future profits; and (iv) the value of unexpired options credited to insurance liabilities) were ~~$8,555.6~~$9,276.0 million and ~~$7,881.9~~$8,711.0 million in the ~~third~~second quarters of ~~2022~~2023 and ~~2021,~~2022, respectively, and were ~~$8,414.8~~$9,229.9 million and ~~$7,663.4~~$8,598.7 million in the first ~~nine~~six months of ~~2022~~2023 and ~~2021,~~2022, respectively, driven by deposits and reinvested returns in excess of withdrawals. The increase in net insurance liabilities results in higher net investment income ~~allocated, however, the~~allocated. The earned yield was ~~4.27~~4.36 percent in the second quarter of 2023 up from 4.20 percent in the second quarter of 2022, and was 4.33 percent in the first six months of 2023 up from 4.22 percent in the first six months of 2022, reflecting higher portfolio yields.

6687

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

third quarter of 2022, down from 4.38 percent in the third quarter of 2021, and was 4.24 percent in the first nine months of 2022 down from 4.46 percent in the first nine months of 2021, reflecting lower investment yields. We believe the margin on fixed index annuities was favorably impacted by approximately nil and $6 million in the three and nine months ended September 30, 2021, respectively, primarily due to persistency impacts indirectly related to the pandemic. There were no material COVID-19 impacts in the 2022 periods.

Net investment income and interest credited exclude the change in market values of the underlying options supporting the fixed ~~index~~indexed annuity products and corresponding offsetting amount credited to policyholder account balances. Such amounts were ~~$(30.9)~~$56.1 million and ~~$6.3~~$(80.1) million in the ~~third~~second quarters of ~~2022~~2023 and ~~2021,~~2022, respectively, and were ~~$(175.3)~~$72.6 million and ~~$112.3~~$(144.4) million in the first ~~nine~~six months of ~~2022~~2023 and ~~2021,~~2022, respectively.

Margin from fixed interest annuities was ~~$7.8~~$8.7 million in the ~~third~~second quarter of 2023 compared to $7.9 million in the second quarter of 2022, ~~compared to $8.6 million in the third quarter of 2021,~~ and was ~~$23.3~~$17.8 million in the first ~~nine~~six months of ~~2022~~2023 compared to ~~$26.9~~$16.4 million in the first ~~nine~~six months of ~~2021,~~2022, driven primarily by higher investment yields, partially offset by a reduction in the size of the ~~block and lower investment yields.~~block. Average net insurance liabilities were ~~$1,677.4~~$1,613.1 million in the ~~third~~second quarter of 2023 compared to $1,712.5 million in the second quarter of 2022, ~~compared to $1,856.3 million in the third quarter of 2021,~~ and were ~~$1,717.6~~$1,622.0 million in the first ~~nine~~six months of ~~2022~~2023 compared to ~~$1,902.4~~$1,736.8 million in the first ~~nine~~six months of ~~2021,~~2022, driven by withdrawals in excess of deposits and reinvested returns. The decrease in net insurance liabilities results in lower net investment income ~~allocated. The~~allocated, however, the earned yield ~~decreased~~increased to ~~4.84~~5.18 percent in the ~~third~~second quarter of 2023 from 4.81 percent in the second quarter of 2022, ~~from 4.96 percent in the third quarter of 2021,~~ and to ~~4.84~~5.15 percent in the first ~~nine~~six months of ~~2022~~2023 from ~~4.98~~4.85 percent in the first ~~nine~~six months of ~~2021,~~2022, reflecting ~~lower investment~~higher portfolio yields.

Margin from other annuities was ~~$2.7~~$0.8 million in the ~~third~~second quarter of 2023 compared to $3.8 million in the second quarter of 2022, ~~compared to $1.5 million in the third quarter of 2021,~~ and was ~~$9.9~~$2.5 million in the first ~~nine~~six months of ~~2022~~2023 compared to ~~$3.5~~$6.4 million in the first ~~nine~~six months of ~~2021.~~2022. The margin on this relatively small block of business is sensitive to annuitant mortality related to contracts with life contingencies. An increase in mortality in this block will result in a decrease in insurance liabilities and insurance policy benefits. Such mortality was ~~higher~~lower in the ~~2022~~2023 periods compared to the same periods in 2021. We believe the margin from other annuities reflected favorable (unfavorable) COVID-19 impacts of approximately $1 million and $2 million in the three and nine months ended September 30, 2022, respectively, and approximately $(1) million and $(4) million in the three and nine months ended September 30, 2021, respectively.

2022.

6788

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Margin from Health Products (dollars in millions):


		Three months ended						Nine months ended							Three months ended						Six months ended
		September 30,						September 30,							June 30,						June 30,
		2022			2021			2022			2021				2023			2022			2023			2022
Health margin:	Health margin:													Health margin:
Supplemental health	Supplemental health													Supplemental health
Insurance policy income	Insurance policy income	$	173.5		$	171.2		$	519.0		$	511.0		Insurance policy income	$	176.2		$	172.0		$	355.2		$	345.5
Net investment income	Net investment income	38.0			36.9			113.3			109.3			Net investment income	38.9			37.6			77.5			75.0
Insurance policy benefits	Insurance policy benefits	(117.7)			(127.8)			(370.6)			(385.0)			Insurance policy benefits	(128.9)			(128.1)			(257.1)			(257.4)
Amortization and non-deferred commissions	Amortization and non-deferred commissions	(30.5)			(29.4)			(88.9)			(86.5)			Amortization and non-deferred commissions	(26.3)			(25.5)			(52.4)			(51.0)
Margin from supplemental health	Margin from supplemental health	$	63.3		$	50.9		$	172.8		$	148.8		Margin from supplemental health	$	59.9		$	56.0		$	123.2		$	112.1
Margin/insurance policy income	Margin/insurance policy income	36		%	30		%	33		%	29		%	Margin/insurance policy income	34		%	33		%	35		%	32		%
Medicare supplement	Medicare supplement													Medicare supplement
Insurance policy income	Insurance policy income	$	163.6		$	177.4		$	495.5		$	538.1		Insurance policy income	$	155.3		$	165.1		$	311.8		$	331.9
Net investment income	Net investment income	1.3			1.3			4.0			3.9			Net investment income	1.2			1.4			2.5			2.7
Insurance policy benefits	Insurance policy benefits	(115.9)			(129.7)			(341.6)			(372.7)			Insurance policy benefits	(113.4)			(114.1)			(233.9)			(234.6)
Amortization and non-deferred commissions	Amortization and non-deferred commissions	(10.8)			(11.7)			(47.1)			(48.1)			Amortization and non-deferred commissions	(10.8)			(12.6)			(22.0)			(25.6)
Margin from Medicare supplement	Margin from Medicare supplement	$	38.2		$	37.3		$	110.8		$	121.2		Margin from Medicare supplement	$	32.3		$	39.8		$	58.4		$	74.4
Margin/insurance policy income	Margin/insurance policy income	23		%	21		%	22		%	23		%	Margin/insurance policy income	21		%	24		%	19		%	22		%
Long-term care	Long-term care													Long-term care
Insurance policy income	Insurance policy income	$	66.4		$	65.8		$	199.2		$	197.2		Insurance policy income	$	65.6		$	66.4		$	131.5		$	132.8
Net investment income	Net investment income	32.6			34.0			98.0			102.1			Net investment income	34.2			34.0			68.3			68.6
Insurance policy benefits	Insurance policy benefits	(74.2)			(67.9)			(212.6)			(197.6)			Insurance policy benefits	(80.4)			(67.7)			(149.8)			(141.0)
Amortization and non-deferred commissions	Amortization and non-deferred commissions	(2.2)			(2.2)			(5.9)			(8.2)			Amortization and non-deferred commissions	(3.4)			(3.1)			(6.9)			(6.2)
Margin from long-term care	Margin from long-term care	$	22.6		$	29.7		$	78.7		$	93.5		Margin from long-term care	$	16.0		$	29.6		$	43.1		$	54.2
Margin/insurance policy income	Margin/insurance policy income	34		%	45		%	40		%	47		%	Margin/insurance policy income	24		%	45		%	33		%	41		%
Total health margin	Total health margin	$	124.1		$	117.9		$	362.3		$	363.5		Total health margin	$	108.2		$	125.4		$	224.7		$	240.7
Margin/insurance policy income	Margin/insurance policy income	31		%	28		%	30		%	29		%	Margin/insurance policy income	27		%	31		%	28		%	30		%

Margin from supplemental health business was ~~$63.3~~$59.9 million in the ~~third~~second quarter of 2023 compared to $56.0 million in the second quarter of 2022, ~~up 24 percent from the third quarter of 2021,~~ and was ~~$172.8~~$123.2 million in the first ~~nine~~six months of ~~2022, up 16 percent from~~2023 compared to $112.1 million in the first ~~nine~~six months of ~~2021,~~2022, reflecting growth in the ~~block and favorable claim experience.~~block. The margin as a percentage of insurance policy income was 3634 percent in the ~~third~~second quarter of ~~2022~~2023 compared to 3033 percent in the prior year period, and was 3335 percent in the first ~~nine~~six months of ~~2022~~2023 compared to 2932 percent in the first ~~nine~~six months of 2021. The supplemental health margin continues to compare favorably to the margins experienced prior to the COVID-19 pandemic. We estimate the favorable impacts due to COVID-19 on the supplemental health margin in the three and nine months ended September 30, 2022 were approximately $14 million and $29 million, respectively, and approximately $8 million and $16 million in the three and nine months ended September 30, 2021, respectively, relative to our expectations and previous experience prior to COVID-19. Claim experience will fluctuate from period to period and there is no assurance that such favorable impacts will continue. The supplemental health margin was also favorably impacted by $3 million in the third quarter of 2022 due to a refinement to our claim reserve loss adjustment expense assumption as a result of a recently completed loss adjustment expense study.2022.

Our supplemental health products (including specified disease, accident and hospital indemnity products) generally provide fixed or limited benefits. For example, payments under cancer insurance policies are generally made directly to, or at the direction of, the policyholder following diagnosis of, or treatment for, a covered type of cancer. Approximately three-fourths of our supplemental health policies inforce (based on policy count) are sold with return of premium or cash value riders. The return of premium rider generally provides that after a policy has been inforce for a specified number of years or upon the policyholder reaching a specified age, we will pay to the policyholder, or a beneficiary under the policy, the aggregate amount of all premiums paid under the policy, without interest, less the aggregate amount of all claims incurred under the policy. The cash value rider is similar to the return of premium rider, but also provides for payment of a graded portion of the return of

~~CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES~~

~~___________________~~

premium benefit if the policy terminates before the return of premium benefit is earned. Accordingly, the net cash flows from these products generally result in the accumulation of amounts in the early years of a policy (reflected in our earnings as reserve increases which is a component of insurance policy benefits) which will be paid out as benefits in later policy years (reflected in our earnings as reserve decreases which offset the recording of benefit payments). As the policies age, insurance policy benefits will typically increase, but the increase in benefits will be partially offset by investment income earned on the accumulated assets.

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Margin from Medicare supplement business was ~~$38.2~~$32.3 million and ~~$37.3~~$39.8 million in the ~~third~~second quarters of ~~2022~~2023 and ~~2021,~~2022, respectively, and ~~$110.8~~$58.4 million and ~~$121.2~~$74.4 million in the first ~~nine~~six months of ~~2022~~2023 and ~~2021,~~2022, respectively. The decrease in margin on the Medicare supplement business is primarily due to a reduction in the ~~2022~~size of the block and ~~2021 periods continued to compare favorably to the margins experienced prior to the COVID-19 pandemic. We estimate that the favorable impacts due to COVID-19 (based on actual~~unfavorable claims incurred and persistency relative to our expectations and previous experience prior to COVID-19) on the Medicare supplement margin were approximately $3 million and $14 million in the three and nine months ended September 30, 2022, respectively, and $3 million and $23 million in the three and nine months ended September 30, 2021, respectively.experience. Claim experience will fluctuate from period to ~~period and there is no assurance that such favorable impacts will continue.~~period. Insurance policy income was ~~$163.6~~$155.3 million in the ~~third~~second quarter of 2023, down 5.9 percent from the second quarter of 2022, ~~down 7.8 percent from the third quarter of 2021,~~ and was ~~$495.5~~$311.8 million in the first ~~nine~~six months of ~~2022,~~2023 down ~~7.9~~6.1 percent from the first ~~nine~~six months of ~~2021,~~2022, reflecting lower sales in recent periods partially offset by premium rate increases. WeOver the last several years, we have experienced a shift in the sale of Medicare supplement policies to the sale of Medicare Advantage policies. We receive fee income when Medicare Advantage policies of other providers are sold, which is recorded in our Fee income segment. We continue to invest in both our Medicare supplement products and Medicare Advantage distribution to meet our customers' needs and preferences. For example, we launched a new competitive Medicare supplement product in ~~the second quarter of~~ 2022.

Medicare supplement business consists of both individual and group policies. Government regulations generally require we attain and maintain a ratio of total benefits incurred to total premiums earned (excluding changes in policy benefits reserves which is a component of Insurance policy benefits) of not less than 65 percent on individual products and not less than 75 percent on group products. The ratio is determined after three years from the original issuance of the policy and over the lifetime of the policy and measured in accordance with statutory accounting principles. Since the insurance product liabilities we establish for Medicare supplement business are subject to significant estimates, the ultimate claim liability we incur for a particular period is likely to be different than our initial estimate. Changes to our estimates are reflected in insurance policy benefits in the period the change is determined.

Margin from Long-term care products was ~~$22.6~~$16.0 million and $29.6 million in the ~~third quarter~~second quarters of 2023 and 2022, ~~down 24 percent from the third quarter of 2021,~~respectively, and ~~was $78.7~~$43.1 million and $54.2 million in the first ~~nine~~six months of 2023 and 2022, ~~down 16 percent from the first nine months of 2021.~~respectively. The margin as a percentage of insurance policy income was 3424 percent in the ~~third~~second quarter of ~~2022~~2023 compared to 45 percent in the ~~third~~second quarter of ~~2021,~~2022, and was 4033 percent in the first ~~nine~~six months of ~~2022~~2023 compared to 4741 percent in the first ~~nine~~six months of ~~2021.~~2022. The ~~margin~~decrease in ~~both~~margins in the ~~2022 and 2021~~2023 periods ~~continued~~is primarily due to ~~compare favorably~~unfavorable claims experience as compared to the ~~margins experienced~~ prior year periods. The unfavorable experience in this block is expected to ~~the COVID-19 pandemic. In addition, an increase~~moderate in policyholder deaths attributable to the pandemic resulted in higher than expected reserve releases in the first quarter of 2021. We estimate the favorable impacts due to COVID-19 (based on actual claims incurred and persistency relative to our expectations and previous experience prior to COVID-19) on the long-term care margin were approximately $9 million and $36 million in the three and nine months ended September 30, 2022, respectively, and by approximately $14 million and $56 million in the three and nine months ended September 30, 2021, respectively. Claimfuture periods, however claim experience will fluctuate from ~~period~~quarter to period and there is no assurance that such favorable impacts will continue. In addition, the margin has been favorably impacted by the more profitable business currently being sold and the run-off of less profitable older long-term care business.quarter.

6990

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Margin from Life Products (dollars in millions):


		Three months ended						Nine months ended							Three months ended						Six months ended
		September 30,						September 30,							June 30,						June 30,
		2022			2021			2022			2021				2023			2022			2023			2022
Life margin:	Life margin:													Life margin:
Interest-sensitive life	Interest-sensitive life													Interest-sensitive life
Insurance policy income	Insurance policy income	$	43.5		$	42.3		$	130.4		$	124.5		Insurance policy income	$	45.3		$	43.8		$	89.8		$	86.9
Net investment income	Net investment income	13.0			12.6			38.9			37.4			Net investment income	12.7			12.8			25.8			25.8
Insurance policy benefits	Insurance policy benefits	(20.5)			(17.4)			(57.5)			(60.1)			Insurance policy benefits	(17.1)			(15.8)			(35.3)			(37.0)
Interest credited	Interest credited	(12.0)			(10.9)			(34.6)			(32.2)			Interest credited	(12.0)			(11.5)			(24.0)			(23.4)
Amortization and non-deferred commissions	Amortization and non-deferred commissions	(7.7)			(6.6)			(22.2)			(18.6)			Amortization and non-deferred commissions	(4.8)			(5.9)			(9.4)			(11.6)
Margin from interest-sensitive life	Margin from interest-sensitive life	$	16.3		$	20.0		$	55.0		$	51.0		Margin from interest-sensitive life	$	24.1		$	23.4		$	46.9		$	40.7
Average net insurance liabilities	Average net insurance liabilities	$	1,025.0		$	983.8		$	1,019.1		$	969.5		Average net insurance liabilities	$	1,035.4		$	1,016.4		$	1,033.7		$	1,012.9
Interest margin	Interest margin	$	1.0		$	1.7		$	4.3		$	5.2		Interest margin	$	.7		$	1.3		$	1.8		$	2.4
Interest margin/average net insurance liabilities	Interest margin/average net insurance liabilities	.39		%	.69		%	.56		%	.72		%	Interest margin/average net insurance liabilities	.27		%	.51		%	.35		%	.47		%
Underwriting margin	Underwriting margin	$	15.3		$	18.3		$	50.7		$	45.8		Underwriting margin	$	23.4		$	22.1		$	45.1		$	38.3
Underwriting margin/insurance policy income	Underwriting margin/insurance policy income	35		%	43		%	39		%	37		%	Underwriting margin/insurance policy income	52		%	50		%	50		%	44		%
Traditional life	Traditional life													Traditional life
Insurance policy income	Insurance policy income	$	169.9		$	168.1		$	512.6		$	507.2		Insurance policy income	$	177.8		$	172.5		$	352.3		$	342.7
Net investment income	Net investment income	23.6			23.8			70.2			70.9			Net investment income	23.4			22.4			46.6			44.9
Insurance policy benefits	Insurance policy benefits	(122.1)			(123.9)			(387.1)			(394.3)			Insurance policy benefits	(125.7)			(111.9)			(254.7)			(243.8)
Interest credited	Interest credited	(.2)			(.2)			(.5)			(.5)			Interest credited	(.2)			(.2)			(.3)			(.3)
Amortization and non-deferred commissions	Amortization and non-deferred commissions	(22.0)			(14.9)			(56.2)			(46.3)			Amortization and non-deferred commissions	(16.0)			(13.4)			(31.3)			(26.1)
Advertising expense	Advertising expense	(22.1)			(19.7)			(74.0)			(68.0)			Advertising expense	(25.5)			(22.6)			(54.2)			(51.9)
Margin from traditional life	Margin from traditional life	$	27.1		$	33.2		$	65.0		$	69.0		Margin from traditional life	$	33.8		$	46.8		$	58.4		$	65.5
Margin/insurance policy income	Margin/insurance policy income	16		%	20		%	13		%	14		%	Margin/insurance policy income	19		%	27		%	17		%	19		%
Margin excluding advertising expense/insurance policy income	Margin excluding advertising expense/insurance policy income	29		%	31		%	27		%	27		%	Margin excluding advertising expense/insurance policy income	33		%	40		%	32		%	34		%
Total life margin	Total life margin	$	43.4		$	53.2		$	120.0		$	120.0		Total life margin	$	57.9		$	70.2		$	105.3		$	106.2

Margin from interest-sensitive life business was ~~$16.3~~$24.1 million in the ~~third~~second quarter of 2023, up 3.0 percent from the second quarter of 2022, ~~down 19 percent from the third quarter of 2021,~~ and was ~~$55.0~~$46.9 million in the first ~~nine~~six months of ~~2022,~~2023, up ~~7.8~~15 percent from the first ~~nine~~six months of ~~2021. The change in margin reflects the~~2022, reflecting favorable mortality, ~~experienced related to COVID-19 in the 2022 periods,~~as compared to the ~~2021~~2022 periods, and growth in the block due to sales in recent periods. We estimate that the unfavorable impact from death claims related to COVID-19 on the margin of this block of business was approximately $3 million and $6 million in the three and nine months ended September 30, 2022, respectively, and approximately $1 million and $12 million in the three and nine months ended September 30, 2021, respectively.

The interest margin was ~~$1.0~~$0.7 million and ~~$1.7~~$1.3 million in the ~~third~~second quarters of ~~2022~~2023 and ~~2021,~~2022, respectively, and was ~~$4.3~~$1.8 million and ~~$5.2~~$2.4 million in the first ~~nine~~six months of ~~2022~~2023 and ~~2021,~~2022, respectively. Net investment income in the ~~2022~~2023 periods was ~~slightly higher than~~comparable to the ~~2021~~2022 periods. The increase in average net insurance liabilities results in higher net investment income allocated, which is partially offset by lower earned yields. The earned yield was ~~5.07~~4.91 percent and ~~5.12~~5.04 percent in the ~~third~~second quarters of ~~2022~~2023 and ~~2021,~~2022, respectively, and was ~~5.09~~4.99 percent and ~~5.14~~5.09 percent in the first ~~nine~~six months of 2023 and 2022, ~~and 2021,~~ respectively. The decrease in earned yields is due to the sale or maturity of higher yielding investments. Interest credited to policyholders may be changed annually but is subject to minimum guaranteed rates and, as a result, any reduction in our earned rate may not be fully reflected in the rate credited to policyholders.

Net investment income and interest credited exclude the change in market values of the underlying options supporting the fixed ~~index~~indexed life products and corresponding offsetting amount credited to policyholder account balances. Such amounts were ~~$(4.0)~~$6.2 million and ~~$.9~~$(12.3) million in the ~~third~~second quarters of ~~2022~~2023 and ~~2021,~~2022, respectively, and were ~~$(23.9)~~$8.3 million and ~~$13.5~~$(19.9) million in the first ~~nine~~six months of ~~2022~~2023 and ~~2021,~~2022, respectively.

Margin from traditional life business was $33.8 million and $46.8 million in the second quarters of 2023 and 2022, respectively, and was $58.4 million and $65.5 million in the first six months of 2023 and 2022, respectively. In the second

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

~~Margin from traditional life~~ business was $27.1 million and $33.2 million in the third quarters of 2022 and 2021, respectively, and was $65.0 million and $69.0 million in the first nine months of 2022 and 2021, respectively. Insurance policy benefits were $122.1 million in the third quarter of 2022, there was a larger than typical reduction in traditional life claim liabilities due to the work down ~~1.5 percent from~~of a backlog of claims that were in-the-course-of-settlement. The claim payments also had a favorable impact (of approximately $10 million) on the ~~same period in 2021, and were $387.1 million~~change in the ~~first nine months of 2022, down 1.8 percent from the same period in 2021. We estimate that the impact from death claims related to COVID-19 increased insurance~~liability for future policy benefits, ~~by approximately $2 million and $15 million~~as calculated under the new LDTI standard, which is the primary driver of the decrease in the ~~three and nine months ended September 30, 2022, respectively, and by approximately $2 million and $21 million~~traditional life margin in the ~~three and nine months ended September 30, 2021, respectively. In addition, amortization is higher in the 2022~~2023 periods as compared to the same periods in ~~2021, primarily related to higher deferred acquisition costs in recent periods due to strong sales, including sales of our direct-to-consumer products through third party distributors.~~2022.

Allocated net investment income was higher in the ~~2022~~2023 periods, ~~was down slightly,~~ as compared to the ~~2021~~2022 periods, ~~as lower average investment yields more than offset the~~primarily due to growth in the ~~block.~~block and higher investment yields. The earned yield was 4.74 percent and 4.59 percent in the second quarters of 2023 and 2022, respectively and was 4.72 percent and 4.60 percent in the first six months of 2023 and 2022, respectively.

Advertising expense was ~~$22.1~~$25.5 million in the ~~third~~second quarter of ~~2022,~~2023, up 1213 percent from the comparable period in ~~2021,~~2022, and was ~~$74.0~~$54.2 million in the first ~~nine~~six months of ~~2022,~~2023, up ~~8.8~~4.4 percent from the comparable period in ~~2021.~~2022. The demand and cost of television advertising can fluctuate from period to period. We are disciplined with our marketing expenditures and will increase or decrease our marketing spend depending on ~~prices~~the current economics of the purchase or other factors.

Collected Premiums From Annuity and Interest-Sensitive Life Products (dollars in millions):

Three months ended Nine months ended
September 30, September 30,
2022 2021 2022 2021
Collected premiums from annuity and interest-sensitive life products:
Annuities $ 370.0 $ 333.3 $ 1,173.6 $ 1,003.0
Interest-sensitive life 56.6 54.4 169.8 163.5
Total collected premiums from annuity and interest-sensitive life products $ 426.6 $ 387.7 $ 1,343.4 $ 1,166.5


	Three months ended				Six months ended
	June 30,				June 30,
	2023		2022		2023		2022
Collected premiums from annuity and interest-sensitive life products:
Annuities	$	401.8	$	435.0	$	772.7	$	803.6
Interest-sensitive life	60.3		56.6		118.5		113.2
Total collected premiums from annuity and interest-sensitive life products	$	462.1	$	491.6	$	891.2	$	916.8

Collected premiums from annuity and interest-sensitive products ~~increased 10~~decreased 6.0 percent in the ~~third~~second quarter of 2023 compared to the second quarter of 2022, ~~compared to the third quarter of 2021,~~ and 152.8 percent in the first ~~nine~~six months of ~~2022~~2023 compared to the first ~~nine~~six months of ~~2021, primarily due to higher premium~~2022. Premium collections from fixed ~~index annuity products.~~

indexed annuities decreased 15 percent to $351.6 million in the second quarter of 2023 compared to the same period of 2022, and 12 percent to $674.9 million in the first six months of 2023 compared to the first six months of 2022. Premium collections from fixed interest annuities increased 121 percent to $46.6 million in the second quarter of 2023 compared to the same period in 2022, and 183 percent to $92.7 million in the first six months of 2023 compared to the first six months of 2022, resulting from increased consumer preference for these products in the current interest rate environment.

7192

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Investment Income Not Allocated to Product Lines (dollars in millions):


		Three months ended				Nine months ended					Three months ended				Six months ended
		September 30,				September 30,					June 30,				June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Net investment income	Net investment income	$	268.1	$	308.2	$	700.2	$	1,025.6	Net investment income	$	399.7	$	223.9	$	742.7	$	432.1
Allocated to product lines:	Allocated to product lines:									Allocated to product lines:
Annuity	Annuity	(117.3)		(115.5)		(347.2)		(346.1)		Annuity	(127.7)		(117.8)		(253.1)		(235.3)
Health	Health	(71.9)		(72.2)		(215.3)		(215.3)		Health	(74.3)		(73.0)		(148.3)		(146.3)
Life	Life	(36.6)		(36.4)		(109.1)		(108.3)		Life	(36.1)		(35.2)		(72.4)		(70.7)
Equity returns credited to policyholder account balances	Equity returns credited to policyholder account balances	34.9		(7.2)		199.2		(125.8)		Equity returns credited to policyholder account balances	(62.3)		92.4		(80.9)		164.3
Amounts allocated to product lines and credited to policyholder account balances	Amounts allocated to product lines and credited to policyholder account balances	(190.9)		(231.3)		(472.4)		(795.5)		Amounts allocated to product lines and credited to policyholder account balances	(300.4)		(133.6)		(554.7)		(288.0)
Impact of annual option forfeitures related to fixed indexed annuity surrenders										Impact of annual option forfeitures related to fixed indexed annuity surrenders	1.4		(.5)		1.4		1.1
Amount related to variable interest entities and other non-operating items	Amount related to variable interest entities and other non-operating items	(13.6)		(7.1)		(29.9)		(22.9)		Amount related to variable interest entities and other non-operating items	(19.0)		(9.1)		(39.9)		(16.3)
Interest expense on debt	Interest expense on debt	(15.6)		(15.6)		(46.9)		(46.7)		Interest expense on debt	(15.6)		(15.6)		(31.3)		(31.3)
Interest expense on investment borrowings from FHLB	Interest expense on investment borrowings from FHLB	(10.3)		(2.3)		(17.4)		(7.5)		Interest expense on investment borrowings from FHLB	(24.2)		(4.7)		(45.9)		(7.1)
Expenses related to FABN program	Expenses related to FABN program	(7.5)		—		(22.4)		—		Expenses related to FABN program	(7.6)		(7.6)		(15.2)		(14.9)
Less amounts credited to deferred compensation plans (offsetting investment income)	Less amounts credited to deferred compensation plans (offsetting investment income)	2.0		(1.0)		18.0		(11.3)		Less amounts credited to deferred compensation plans (offsetting investment income)	(6.3)		11.8		(13.6)		16.0
Total adjustments	Total adjustments	(45.0)		(26.0)		(98.6)		(88.4)		Total adjustments	(71.3)		(25.7)		(144.5)		(52.5)
Investment income not allocated to product lines	Investment income not allocated to product lines	$	32.2	$	50.9	$	129.2	$	141.7	Investment income not allocated to product lines	$	28.0	$	64.6	$	43.5	$	91.6

The above table reconciles net investment income to investment income not allocated to product lines. Such amount will generally fluctuate from period to period based on the level of prepayment income (including call premiums) and trading account income; the performance of our alternative investments (which are typically reported a quarter in arrears); the earnings related to the investments underlying our COLI; and the spread we earn from our FHLB investment borrowing and FABN programs.

Net Non-Operating Income:

The following summarizes our net non-operating income (loss) for the three and ~~nine~~six months ending ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022 (dollars in millions):


		Three months ended				Nine months ended					Three months ended				Six months ended
		September 30,				September 30,					June 30,				June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Net realized investment gains (losses) from sales, impairments and change in allowance for credit losses (net of related amortization)		$	(.1)	$	2.2	$	(33.3)	$	30.1
Net realized investment losses from sales and change in allowance for credit losses										Net realized investment losses from sales and change in allowance for credit losses	$	(31.3)	$	(27.1)	$	(44.0)	$	(34.3)
Net change in market value of investments recognized in earnings	Net change in market value of investments recognized in earnings	(17.0)		(4.6)		(64.2)		(5.3)		Net change in market value of investments recognized in earnings	(4.0)		(21.7)		(5.9)		(47.2)
Fair value changes related to agent deferred compensation plan	Fair value changes related to agent deferred compensation plan	12.0		—		48.7		13.2		Fair value changes related to agent deferred compensation plan	—		14.0		—		36.7
Fair value changes in embedded derivative liabilities (net of related amortization)		66.0		10.9		236.5		48.1
Changes in fair value of embedded derivative liabilities and market risk benefits										Changes in fair value of embedded derivative liabilities and market risk benefits	50.4		160.6		(14.7)		326.0

Other	Other	2.0		.2		2.2		1.7		Other	(.2)		(.2)		2.1		.2
Net non-operating income before taxes		$	62.9	$	8.7	$	189.9	$	87.8
Net non-operating income (loss) before taxes										Net non-operating income (loss) before taxes	$	14.9	$	125.6	$	(62.5)	$	281.4

Net realized investment losses ~~net of related amortization,~~ in the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, were ~~$0.1~~$31.3 million and ~~$33.3~~$44.0 million, respectively, including the ~~favorable (unfavorable)~~unfavorable change in the allowance for credit losses of ~~$7.5~~$9.9 million and $(46.9) million, respectively, which was recorded in earnings. Net realized investment gains, net of related amortization, in the three and nine months ended September 30, 2021, were $2.2 million and $30.1$11.4 million, respectively,

7293

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

which was recorded in earnings. Net realized investment losses in the three and six months ended June 30, 2022, were $27.1 million and $34.3 million, respectively, including the ~~favorable (unfavorable)~~unfavorable change in the allowance for credit losses of ~~$(1.4)~~$23.7 million and ~~$13.9~~$54.4 million, respectively, which was recorded in earnings.

The change in market value of investments recognized in earnings was a decrease of ~~$17.0~~$4.0 million and ~~$4.6~~$21.7 million in the ~~third~~second quarters of ~~2022~~2023 and ~~2021,~~2022, respectively, and ~~$64.2~~$5.9 million and ~~$5.3~~$47.2 million in the first ~~nine~~six months of ~~2022~~2023 and ~~2021,~~2022, respectively. The change in value will fluctuate from period to period based on market conditions.

During the first ~~nine~~six months of 2022, ~~and 2021,~~ we recognized an increase in earnings of ~~$48.7~~$36.7 million ~~and $13.2 million, respectively,~~ for the mark-to-market change in the agent deferred compensation plan liability which was impacted by changes in the underlying actuarial assumptions used to value the liability. We recognize the mark-to-market change in the estimated value of this liability through earnings as assumptions change.

~~The fair value changes~~We recognized an increase (decrease) in ~~embedded derivative liabilities related to our fixed index annuities (net~~earnings of ~~related amortization) increased earnings by $236.5~~$(14.7) million and ~~$48.1~~$326.0 million in the first ~~nine~~six months of ~~2022~~2023 and ~~2021,~~2022, respectively, resulting from changes in the ~~estimated~~ fair value of embedded derivative liabilities and MRBs related to our fixed ~~index annuities, net of related amortization.~~indexed annuities. Such amounts include the impacts of changes in market interest rates and equity impacts used to determine the ~~derivative's~~ estimated fair value. The discount rate is based on risk-free rates (U.S. Treasury rates for similar durations) adjusted for our non-performance risk and risk margins for non-capital market inputs. The increase in U.S. Treasury rates in 2022 was the primary factor in the change in estimated fair valuevalues of the embedded ~~derivative liabilities.~~derivatives and MRBs.

Other non-operating items primarily include earnings attributable to VIEs that we are required to consolidate, net of affiliated amounts. Such earnings are not indicative of, and are unrelated to, the Company's underlying fundamentals.

7394

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

LIQUIDITY AND CAPITAL RESOURCES

~~2022~~2023 Outlook

~~Market volatility adversely impacted our results~~Prior to the sharp rise in interest rates in the ~~first nine months~~United States in 2022, interest rates had been at or near historically low levels. We expect that a continued level of ~~2022 (specifically~~higher interest rates will benefit our operating results over time. We continuously monitor current market conditions and the ~~decrease~~impact to our business from potential changes in overall economic growth. We are also subject to financial impacts associated with changes in the equity markets and the higher equity market volatility and increase in interest rates), decreasing our fixed index annuity margin by approximately $48 million. If such market volatility persists in future periods, we expect it would have directionally similar adverse impacts on our results in those periods.

~~In the fourth quarter of 2022, we expect:~~

•~~continued positive sales momentum with respect to new annualized premiums, collected premiums and fee revenue;~~

•~~continued net favorable COVID-19 impacts on insurance product margin, but lower than recent periods;~~

•~~investment income allocated to product lines to be slightly higher due to growth in our insurance inforce and leveling yields, as compared to the fourth quarter of 2021;~~

•~~net investment income not allocated to product lines to be lower in the fourth quarter of 2022, as compared to the same period in 2021, due to lower expected yields on alternative investments;~~

•~~earnings from our fee income segment to be seasonally higher in the fourth quarter due to: (i) the Medicare annual enrollment period; and (ii) employer benefit enrollments;~~

•total expenses allocated and not allocated to product lines in the fourth quarter of 2022 to be higher than the fourth quarter of 2021, reflecting a trend similar to the first nine months of 2022, as compared to the same period in 2021, as we capture operating efficiencies, while also investing in growth; and

•~~effective tax rate in 2022 to be higher than 2021 primarily due to higher state income taxes.~~

In the aggregate, our consolidated RBC capital level and excess holding company liquidity were approximately $12 million above our target capital levels at September 30, 2022 (see "—Liquidity for Insurance Operations" below).credit cycle.

We are in the process of seeking approval for the formation of a wholly-owned Bermuda captive reinsurance company for the purpose of ceding a portion of our inforce fixed indexed annuity business and all of the new fixed indexed annuity business written after the inception of the reinsurance agreement. We do not anticipate assuming any unaffiliated business or seeking any third party capital for our wholly-owned Bermuda captive reinsurance company.

For 2023, we currently expect ~~free~~operating earnings per diluted share to be in the range of $2.65 to $2.85, excluding any significant items in the year (down from our previous guidance of $2.80 to $3.00 per diluted share). Our current guidance reflects the lower alternative investment income and elevated claims experience in our long-term care and Medicare supplement blocks of business that we recognized in the first half of 2023.

With respect to excess cash flow in 2023, we currently expect cash flow to the holding company to be ~~less than~~in the ~~$380~~range of $180 million ~~generated in 2021, reflecting moderating yield on alternative investments and tapering of net favorable COVID-19 impacts, capital strain from new business, and~~to $200 million (assuming our ~~decision in 2021 to reduce~~current capital and ~~excess holding company liquidity~~reinsurance structure), as compared to ~~target levels which contributed~~our previous guidance of $170 million to ~~higher levels of free cash flow in 2021.~~

Our expectations are based on our financial model, which reflects our best estimate assumptions of various key variables. Given the unprecedented nature of the COVID-19 pandemic and the current macro-economic and geopolitical environment, the assumptions used in our modeling are based on variables that are inherently unpredictable, are subject to change, and have been difficult to predict accurately in prior periods. There are many plausible assumptions which could result in materially different projected outcomes from those used in our modeling which could affect our business, results of operations, financial condition and liquidity. The outcome generated by the application of updated assumptions may be materially different from those described above.

$200 million.

7495

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Our capital structure as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 was as follows (dollars in millions):


		September 30, 2022		December 31, 2021			June 30, 2023		December 31, 2022
Total capital:	Total capital:					Total capital:
Corporate notes payable	Corporate notes payable	$	1,138.4	$	1,137.3	Corporate notes payable	$	1,139.7	$	1,138.8
Shareholders’ equity:	Shareholders’ equity:					Shareholders’ equity:
Common stock	Common stock	1.1		1.2		Common stock	1.1		1.1
Additional paid-in capital	Additional paid-in capital	2,030.6		2,184.2		Additional paid-in capital	1,997.9		2,033.8
Accumulated other comprehensive income (loss)		(2,165.7)		1,947.1
Accumulated other comprehensive loss						Accumulated other comprehensive loss	(1,733.5)		(1,957.3)
Retained earnings	Retained earnings	1,431.9		1,127.2		Retained earnings	1,730.3		1,691.2
Total shareholders’ equity	Total shareholders’ equity	1,297.9		5,259.7		Total shareholders’ equity	1,995.8		1,768.8
Total capital	Total capital	$	2,436.3	$	6,397.0	Total capital	$	3,135.5	$	2,907.6

The following table summarizes certain financial ratios as of and for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and as of and for the year ended December 31, ~~2021:~~2022:


		September 30, 2022			December 31, 2021				June 30, 2023			December 31, 2022
Book value per common share	Book value per common share	$	11.35		$	43.69		Book value per common share	$	17.56		$	15.47
Book value per common share, excluding accumulated other comprehensive income (loss) (a)	Book value per common share, excluding accumulated other comprehensive income (loss) (a)	30.28			27.52			Book value per common share, excluding accumulated other comprehensive income (loss) (a)	32.81			32.59
Debt to total capital ratios:	Debt to total capital ratios:							Debt to total capital ratios:
Corporate debt to total capital	Corporate debt to total capital	46.7		%	17.8		%	Corporate debt to total capital	36.3		%	39.2		%
Corporate debt to total capital, excluding accumulated other comprehensive income (loss) (a)		24.7		%	25.6		%
Corporate debt to total capital, excluding accumulated other comprehensive income (loss) (a) (b)								Corporate debt to total capital, excluding accumulated other comprehensive income (loss) (a) (b)	23.4		%	23.4		%

_____________________

(a)This non-GAAP measure differs from the corresponding GAAP measure presented immediately above, because accumulated other comprehensive income (loss) has been excluded from the value of capital used to determine this measure. Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in accumulated other comprehensive income (loss). Such volatility is often caused by changes in the estimated fair value of our investment portfolio resulting from changes in general market interest rates rather than the business decisions made by management. However, this measure does not replace the corresponding GAAP measure.

(b)Our targeted ratio is in the range of 25.0 percent to 28.0 percent.

Liquidity for Insurance Operations

Our insurance companies generally receive adequate cash flows from premium collections and investment income to meet their obligations. Life insurance, long-term care and supplemental health insurance and annuity liabilities are generally long-term in nature. Life and annuity policyholders may, however, withdraw funds or surrender their policies, subject to any applicable penalty provisions; there are generally no withdrawal or surrender benefits for long-term care insurance. We actively manage the relationship between the duration of our invested assets and the estimated duration of benefit payments arising from contract liabilities.

Three of the Company's insurance subsidiaries (Bankers Life, Washington National and Colonial Penn) are members of the FHLB. As members of the FHLB, our insurance subsidiaries have the ability to borrow on a collateralized basis from the FHLB. We are required to hold certain minimum amounts of FHLB common stock as a condition of membership in the FHLB, and additional amounts based on the amount of the borrowings. At ~~September~~June 30, ~~2022,~~2023, the carrying value of the FHLB common stock was ~~$75.2~~$79.7 million. As of ~~September~~June 30, ~~2022,~~2023, collateralized borrowings from the FHLB totaled ~~$1.6~~$1.8 billion and the proceeds were used to purchase matched variable rate fixed maturity securities. The borrowings are classified as investment borrowings in the accompanying consolidated balance sheet. The borrowings are collateralized by investments with an estimated fair value of ~~$2.1~~$2.3 billion at ~~September~~June 30, ~~2022,~~2023, which are maintained in custodial accounts for the benefit of the FHLB.

7596

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

In the third quarter of 2021, Bankers Life established a FABN program pursuant to which Bankers Life may issue funding agreements to a Delaware statutory trust organized in series (the "Trust") to generate spread-based earnings. The maximum aggregate principal amount of funding agreements permitted to be outstanding at any one time under the FABN program is $3 billion. In October 2021, Bankers Life issued a funding agreement to a series of the Trust in an aggregate principal amount of $500 million. In January 2022, Bankers Life issued two additional funding agreements, each to a series of the Trust, totaling $900 million. We expect the FABN program to provide approximately 100 basis points of annualized pre-tax spread income on the notional amount of the funding agreements outstanding, net of the expense associated with the program. The activity related to the funding agreements is reported in investment income not allocated to product lines.

State laws generally give state insurance regulatory agencies broad authority to protect policyholders in their jurisdictions. Regulators have used this authority in the past to restrict the ability of our insurance subsidiaries to pay any dividends or other amounts without prior approval. We cannot be assured that the regulators will not seek to assert greater supervision and control over our insurance subsidiaries' businesses and financial affairs.

Our estimated consolidated statutory RBC ratio was ~~375 percent at September 30, 2022, compared to 360~~386 percent at June 30, ~~2022, and 386~~2023, compared to 384 percent at December 31, ~~2021.~~2022. In the first ~~nine~~six months of ~~2022,~~2023, the RBC ratio reflected our estimated consolidated statutory operating earnings of ~~$189~~$76 million and insurance company dividends (net of capital contributions) of ~~$95.0~~$74.7 million that were paid to the holding company. Our RBC ratio at ~~September~~June 30, ~~2022, was equal to~~2023, exceeded our targeted ~~statutory~~ RBC ratio of 375 percent and ~~above~~ the minimum 350 percent that is reflected in our risk appetite statement that we share and discuss with rating agencies and insurance regulators. Our targeted RBC ratio of 375 percent allows for a reduction in the ratio toward our minimum threshold of 350 percent in stressed market conditions such as we have experienced this year. Our holding company liquidity at September 30, 2022, was $162 million which was above our minimum target level of $150 million (see "—Liquidity of the Holding Companies" below). In the aggregate, our RBC capital level and excess holding company liquidity were approximately $12 million above our target capital levels. In the event we are below our target levels (such as we experienced in the first half of 2022), we would expect to manage back to $150 million of holding company liquidity and the 375 percent targeted consolidated statutory RBC ratio over time. We believe that the 375 percent RBC ratio target continues to adequately support our financial strength and credit ~~ratings~~ratings.

In June 2023, we began a sale-leaseback program resulting in a $43 million reduction in non-admitted assets and ~~is aligned with~~a corresponding increase in total adjusted capital which favorably impacted our ~~risk appetite.~~consolidated RBC ratio. Such sale-leaseback transactions are accounted for as operating leases pursuant to statutory accounting principles. Pursuant to GAAP, the sale-leaseback transactions do not meet the criteria for a sale. Accordingly, we account for these transactions as financing arrangements which are classified as other liabilities in our consolidated balance sheet.

Our insurance subsidiaries transfer exposure to certain risk to others through reinsurance arrangements. When we obtain reinsurance, we are still liable for those transferred risks in the event the reinsurer defaults on its obligations. The failure, insolvency, inability or unwillingness of one or more of the Company's reinsurers to perform in accordance with the terms of its reinsurance agreement could negatively impact our earnings or financial position and our consolidated statutory RBC ratio.

Financial Strength Ratings of our Insurance Subsidiaries

Financial strength ratings provided by AM Best Company ("AM Best"), Fitch Ratings ("Fitch"), Moody's Investor Services, Inc. ("Moody's") and S&P are the rating agency's opinions of the ability of our insurance subsidiaries to pay policyholder claims and obligations when due.

~~On January 26, 2022, AM Best upgraded the~~S&P most recently reviewed its "A-" financial strength ratings of our primary insurance subsidiaries on June 23, 2023. The outlook for these ratings is stable. S&P financial strength ratings range from "AAA" to "R" and some companies are not rated. An insurer rated "A", in S&P's opinion, has strong financial security characteristics, but is somewhat more likely to be affected by adverse business conditions than are insurers with higher ratings. Pluses and minuses show the relative standing within a category. S&P has twenty-one possible ratings. There are six ratings above the "A-" rating of our primary insurance subsidiaries and fourteen ratings that are below that rating.

Moody's most recently reviewed its "A3" financial strength ratings of our primary insurance subsidiaries on May 12, 2023. The outlook for these ratings remains stable. Moody’s financial strength ratings range from "Aaa" to "C". These ratings may be supplemented with numbers "1", "2", or "3" to show relative standing within a category. In Moody's view, an insurer rated "A" ~~from "A-"~~offers good financial security, however, certain elements may be present which suggest a susceptibility to impairment sometime in the future. Moody's has twenty-one possible ratings. There are six ratings above the "A3" rating of our primary insurance subsidiaries and fourteen ratings that are below that rating.

On February 1, 2023, AM Best affirmed its "A" financial strength ratings of our primary insurance subsidiaries and the outlook for these ratings is stable. The "A" rating is assigned to companies that have an excellent ability, in AM Best's opinion, to meet their ongoing obligations to policyholders. AM Best ratings for the industry currently range from "A++ (Superior)" to "F (In Liquidation)" and some companies are not rated. An "A++" rating indicates a superior ability to meet ongoing obligations to policyholders. AM Best has sixteen possible ratings. There are two ratings above the "A" rating of our primary insurance subsidiaries and thirteen ratings that are below that rating.

On ~~December 2, 2021,~~November 21, 2022, Fitch affirmed its "A-" financial strength ratings of our primary insurance ~~subsidiaries. The~~subsidiaries and revised the outlook for these ratings ~~remain~~to positive from stable. An insurer rated "A", in Fitch's opinion, indicates a low expectation of ceased or interrupted payments and indicates strong capacity to meet policyholder and contract obligations. This capacity may, nonetheless, be more vulnerable to changes in circumstances or in economic conditions than is the case for higher

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

ratings. Fitch ratings for the industry range from "AAA Exceptionally Strong" to "C Distressed" and some companies are not rated. Pluses and minuses show the relative standing within a category. Fitch has nineteen possible ratings. There are six ratings above the "A-" rating of our primary insurance subsidiaries and twelve ratings that are below that rating.

~~CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES~~

~~___________________~~

On September 28, 2021, Moody's affirmed its "A3" financial strength ratings of our primary insurance subsidiaries. The outlook for these ratings remains stable. Moody’s financial strength ratings range from "Aaa" to "C". These ratings may be supplemented with numbers "1", "2", or "3" to show relative standing within a category. In Moody's view, an insurer rated "A" offers good financial security, however, certain elements may be present which suggests a susceptibility to impairment sometime in the future. Moody's has twenty-one possible ratings. There are six ratings above the "A3" rating of our primary insurance subsidiaries and fourteen ratings that are below that rating.

~~On June 21, 2019, S&P upgraded the financial strength ratings of our primary insurance subsidiaries to "A-" from~~

"BBB+" and the outlook for these ratings is stable. S&P financial strength ratings range from "AAA" to "R" and some companies are not rated. An insurer rated "A", in S&P's opinion, has strong financial security characteristics, but is somewhat more likely to be affected by adverse business conditions than are insurers with higher ratings. Pluses and minuses show the relative standing within a category. S&P has twenty-one possible ratings. There are six ratings above the "A-" rating of our primary insurance subsidiaries and fourteen ratings that are below that rating.

Rating agencies have increased the frequency and scope of their credit reviews and requested additional information from the companies that they rate, including us. They may also adjust upward the capital and other requirements employed in ~~the~~their rating ~~agency~~ models for maintenance of certain ratings levels. We cannot predict what actions rating agencies may take, or what actions we may take in response. Accordingly, downgrades and outlook revisions related to us or the life insurance industry may occur in the future at any time and without notice by any rating agency. These could increase policy surrenders and withdrawals, adversely affect relationships with our distribution channels, reduce new sales, reduce our ability to borrow and increase our future borrowing costs.

Liquidity of the Holding Companies

Availability and Sources and Uses of Holding Company Liquidity; Limitations on Ability of Insurance Subsidiaries to Make Dividend and Surplus Debenture Interest Payments to the Holding Companies; Limitations on Holding Company Activities

At ~~September~~June 30, ~~2022,~~2023, CNO, CDOC, Inc. ("CDOC", our wholly owned subsidiary and the immediate parent of Washington National and Conseco Life Insurance Company of Texas ("CLTX")) and our other non-insurance subsidiaries held ~~$162.3~~$176 million of ~~cash and investments which was comprised of: (i)~~ unrestricted cash and cash equivalents of $125.8 million; and (ii) exchange-traded funds that invest in fixed income securities of $36.5 million. Our holding company liquidity of $162.3 million increased $21.4 million from June 30, 2022, andwhich was above our minimum target level of $150 million. ~~Refer to "—Liquidity for Insurance Operations" above regarding our aggregate capital levels relative to our consolidated statutory RBC ratio target and minimum holding company liquidity target.~~

CNO and CDOC are holding companies with no business operations of their own; they depend on their operating subsidiaries for cash to make principal and interest payments on debt, and to pay administrative expenses and income taxes. CNO and CDOC receive cash from insurance subsidiaries, consisting of dividends and distributions, interest payments on surplus debentures and tax-sharing payments, as well as cash from non-insurance subsidiaries consisting of dividends, distributions, loans and advances. The principal non-insurance subsidiaries that provide cash to CNO and CDOC are 40|86 Advisors, Inc., which receives fees from the insurance subsidiaries for investment services, and CNO Services, LLC which receives fees from the insurance subsidiaries for providing administrative services. The agreements between our insurance subsidiaries and CNO Services, LLC and 40|86 Advisors, Inc., respectively, were previously approved by the domestic insurance regulator for each insurance company, and any payments thereunder do not require further regulatory approval.

The ability of our insurance subsidiaries to pay dividends is subject to state insurance department regulations and is based on the financial statements of our insurance subsidiaries prepared in accordance with statutory accounting practices prescribed or permitted by regulatory authorities, which differ from GAAP. These regulations generally permit dividends to be paid from statutory earned surplus of the insurance company without regulatory approval for any 12-month period in amounts equal to the greater of (or in some states, the lesser of): (i) statutory net gain from operations or net income for the prior year; or (ii) 10 percent of statutory capital and surplus as of the end of the preceding year. However, as each of the immediate insurance subsidiaries of CDOC has significant negative earned surplus, any dividend payments from the insurance subsidiaries require the prior approval of the director or commissioner of the applicable state insurance department. In the first ~~nine~~six months of ~~2022,~~2023, our insurance subsidiaries paid dividends to CDOC totaling ~~$109.6~~$82.2 million. We expect to receive regulatory approval for

~~CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES~~

~~___________________~~

future dividends from our subsidiaries, but there can be no assurance that such payments will be approved or that the financial condition of our insurance subsidiaries will not change, making future approvals less likely.

CDOC holds surplus debentures from CLTX with an aggregate principal amount of $749.6 million. Interest payments on those surplus debentures do not require additional approval provided the RBC ratio of CLTX exceeds 100 percent (but do require prior written notice to the Texas ~~state insurance department)~~Department of Insurance). The estimated RBC ratio of CLTX was ~~323~~339 percent at ~~September~~June 30, ~~2022.~~2023. CDOC also holds a surplus debenture from Colonial Penn with a principal balance of $160.0 million. Interest payments on that surplus debenture require prior approval by the Pennsylvania ~~state insurance department.~~Insurance Department. Dividends and other payments from our non-insurance subsidiaries, including 40|86 Advisors, Inc. and CNO Services, LLC, to CNO or CDOC do not require approval by any regulatory authority or other third party. However, insurance regulators may prohibit payments by our insurance subsidiaries to parent companies if they determine that such payments could be adverse to our policyholders or contractholders.

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

The insurance subsidiaries of CDOC receive funds to pay dividends primarily from: (i) the earnings of their direct businesses; (ii) tax sharing payments received from subsidiaries (if applicable); and (iii) with respect to CLTX, dividends received from subsidiaries. At ~~September~~June 30, ~~2022,~~2023, the subsidiaries of CLTX had earned surplus (deficit) as summarized below (dollars in millions):

Subsidiaries of CLTX

Earned surplus (deficit)

Additional information

Bankers Life

~~346.0~~367.0

(a)

Colonial Penn

~~(452.9)~~(488.4)

(b)

____________________

(a)Bankers Life paid dividends of ~~$45.0~~$55.0 million to CLTX in the first ~~nine~~six months of ~~2022.~~2023. Bankers Life may pay dividends without regulatory approval or prior notice for any 12-month period if such dividends are less than the greater of: (i) statutory net income for the prior year; or (ii) 10 percent of statutory capital and surplus as of the end of the preceding year. Dividends in excess of these levels require 30 days prior notice.

(b)The deficit is primarily due to transactions which occurred several years ago, including a tax planning transaction and the fee paid to recapture a block of business previously ceded to an unaffiliated insurer.

A significant deterioration in the financial condition, earnings or cash flow of the material subsidiaries of CNO or CDOC for any reason could hinder such subsidiaries' ability to pay cash dividends or other disbursements to CNO and/or CDOC, which, in turn, could limit CNO's ability to meet debt service requirements and satisfy other financial obligations. In addition, we may choose to retain capital in our insurance subsidiaries or to contribute additional capital to our insurance subsidiaries to maintain or strengthen their surplus or fund reinsurance transactions, and these decisions could limit the amount available at our top tier insurance subsidiaries to pay dividends to the holding companies. In the first ~~nine~~six months of ~~2022,~~2023, CDOC made a capital contribution of ~~$14.6~~$7.5 million to CLTX.

At ~~September~~June 30, ~~2022,~~2023, there are no amounts outstanding under our $250 million Revolving Credit Agreement and there are no scheduled repayments of our direct corporate obligations until May 2025.

Free cash flow is a measure of holding company liquidity and is calculated as: (i) dividends, management fees and surplus debenture interest payments received from our subsidiaries; plus (ii) earnings on corporate investments; less (iii) interest expense, corporate expenses and net tax payments. In the first ~~nine~~six months of ~~2022,~~2023, we generated ~~$132~~$88 million of such free cash flow. The Company ~~is committed~~expects to ~~deploying 100 percent of~~deploy its free cash flow into investments to accelerate profitable growth, common stock dividends and share repurchases. The amount and timing of future share repurchases (if any) will be based on business and market conditions and other factors including, but not limited to, available free cash flow, the current price of our common stock and investment opportunities. In the first ~~nine~~six months of ~~2022,~~2023, we repurchased ~~7.2~~2.0 million shares of common stock for ~~$170.0~~$45.1 million under our securities repurchase ~~program.~~program (including $0.9 million of repurchases settled in the third quarter of 2023). In May 2023, the Company's Board of Directors approved an additional $500.0 million to repurchase the Company's outstanding shares of common stock. The Company had remaining repurchase authority of ~~$196.9~~$641.8 million as of ~~September~~June 30, ~~2022.~~2023.

In the first ~~nine~~six months of ~~2022,~~2023, dividends declared on common stock totaled ~~$48.7~~$33.8 million ($~~0.41~~0.29 per common share). In May ~~2022,~~2023, the Company increased its quarterly common stock dividend to ~~$0.14~~$0.15 per share from ~~$0.13~~$0.14 per share.

~~CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES~~

~~___________________~~

On January 26, 2022, AM Best upgraded our issuer credit and senior unsecured debt ratings to "bbb" from "bbb-" and the outlook for these ratings is stable. In AM Best's view, a company rated "bbb" has an adequate ability to meet the terms of its obligations; however, the issuer is more susceptible to changes in economic or other conditions. Pluses and minuses show the relative standing within a category. AM Best has a total of 22 possible ratings ranging from "aaa (Exceptional)" to "d (In default)". There are eight ratings above CNO's "bbb" rating and thirteen ratings that are below its rating.

~~On December 2, 2021, Fitch affirmed~~S&P most recently reviewed its "BBB-" rating on our senior unsecured ~~debt.~~debt on June 23, 2023. The outlook for these ratings remain stable. In Fitch's view, an obligation rated "BBB" indicates that expectations of default risk are currently low. The capacity for payment of financial commitments is considered adequate but adverse business or economic conditions are more likely to impair this capacity. Pluses and minuses show the relative standing within a category. Fitch has a total of 21 possible ratings ranging from "AAA" to "D". There are nine ratings above CNO's "BBB-" rating and eleven ratings that are below its rating.

On September 28, 2021, Moody's affirmed its "Baa3" rating on our senior unsecured debt. The outlook for these ratings remains stable. In Moody's view, obligations rated "Baa" are subject to moderate credit risk and may possess certain speculative characteristics. A rating is supplemented with numerical modifiers "1", "2" or "3" to show the relative standing within a category. Moody's has a total of 21 possible ratings ranging from "Aaa" to "C". There are nine ratings above CNO's "Baa3" rating and eleven ratings that are below its rating.

~~On June 21, 2019, S&P upgraded our senior unsecured debt rating to "BBB-" from "BB+" and the~~ outlook for these ratings is stable. In S&P's view, an obligation rated "BBB" exhibits adequate protection parameters. However, adverse economic conditions or changing circumstances are more likely to lead to a weakened capacity of the obligor to meet its financial commitment on the obligation. Pluses and minuses show the relative standing within a category. S&P has a total of 22twenty-two possible ratings ranging from "AAA (Extremely Strong)" to "D (Payment Default)". There are nine ratings above CNO's "BBB-" rating and twelve ratings that are below its rating.

Moody's most recently reviewed its "Baa3" rating on our senior unsecured debt on May 12, 2023. The outlook for these ratings remains stable. In Moody's view, obligations rated "Baa" are subject to moderate credit risk and may possess certain speculative characteristics. A rating is supplemented with numerical modifiers "1", "2" or "3" to show the relative standing within a category. Moody's has a total of twenty-one possible ratings ranging from "Aaa" to "C". There are nine ratings above CNO's "Baa3" rating and eleven ratings that are below its rating.

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

On February 1, 2023, AM Best affirmed its "bbb" rating on our issuer credit and senior unsecured debt and the outlook for these ratings is stable. In AM Best's view, a company rated "bbb" has an adequate ability to meet the terms of its obligations; however, the issuer is more susceptible to changes in economic or other conditions. Pluses and minuses show the relative standing within a category. AM Best has a total of twenty-two possible ratings ranging from "aaa (Exceptional)" to "d (In default)". There are eight ratings above CNO's "bbb" rating and thirteen ratings that are below its rating.

On November 21, 2022, Fitch affirmed its "BBB-" rating on our senior unsecured debt. Fitch also affirmed CNO's long term issue default rating of "BBB" and revised the outlook for this rating to positive from stable. In Fitch's view, an obligation rated "BBB" indicates that expectations of default risk are currently low. The capacity for payment of financial commitments is considered adequate but adverse business or economic conditions are more likely to impair this capacity. Pluses and minuses show the relative standing within a category. Fitch has a total of twenty-one possible ratings ranging from "AAA" to "D". There are nine ratings above CNO's "BBB-" rating and eleven ratings that are below its rating.

We believe that the existing cash available to the holding company, the cash flows to be generated from operations and other transactions will be sufficient to allow us to meet our debt service obligations, pay corporate expenses and satisfy other financial obligations. However, our cash flow is affected by a variety of factors, many of which are outside of our control, including insurance regulatory issues, competition, financial markets and other general business conditions. We cannot provide assurance that we will possess sufficient income and liquidity to meet all of our debt service requirements and other holding company obligations.

79100

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

INVESTMENTS

At ~~September~~June 30, ~~2022,~~2023, the amortized cost, gross unrealized gains, gross unrealized losses, allowance for credit losses and estimated fair value of fixed maturities, available for sale, were as follows (dollars in millions):

Amortized
cost Gross
unrealized
gains Gross
unrealized
losses Allowance for credit losses Estimated
fair
value
Investment grade (a):
Corporate securities $ 13,242.8 $ 21.3 $ (2,062.1) $ (35.9) $ 11,166.1
United States Treasury securities and obligations of United States government corporations and agencies 169.5 — (11.7) — 157.8
States and political subdivisions 2,807.2 20.9 (437.0) (1.5) 2,389.6
Foreign governments 84.5 — (14.4) (.8) 69.3
Asset-backed securities 1,266.5 .2 (114.6) (.3) 1,151.8
Agency residential mortgage-backed securities 39.0 — (.5) — 38.5
Non-agency residential mortgage-backed securities 1,168.2 6.1 (156.8) — 1,017.5
Collateralized loan obligations 778.3 — (45.1) — 733.2
Commercial mortgage-backed securities 2,368.6 — (225.0) — 2,143.6
Total investment grade fixed maturities, available for sale 21,924.6 48.5 (3,067.2) (38.5) 18,867.4
Below-investment grade (a) (b):
Corporate securities 699.4 .9 (74.5) (13.3) 612.5
States and political subdivisions 11.6 — (.8) (.2) 10.6
Asset-backed securities 135.5 — (17.2) — 118.3
Non-agency residential mortgage-backed securities 587.3 44.6 (10.5) — 621.4
Commercial mortgage-backed securities 84.1 — (13.2) — 70.9
Total below-investment grade fixed maturities, available for sale 1,517.9 45.5 (116.2) (13.5) 1,433.7
Total fixed maturities, available for sale $ 23,442.5 $ 94.0 $ (3,183.4) $ (52.0) $ 20,301.1


	Amortized cost		Gross unrealized gains		Gross unrealized losses		Allowance for credit losses		Estimated fair value
Investment grade (a):
Corporate securities	$	12,862.5	$	36.6	$	(1,627.5)	$	(38.1)	$	11,233.5
United States Treasury securities and obligations of United States government corporations and agencies	174.2		—		(10.1)		—		164.1
States and political subdivisions	2,804.6		27.6		(387.5)		(.8)		2,443.9
Foreign governments	93.9		.6		(10.2)		(.5)		83.8
Asset-backed securities	1,365.7		1.0		(118.1)		(.2)		1,248.4
Agency residential mortgage-backed securities	351.4		.4		(3.0)		—		348.8
Non-agency residential mortgage-backed securities	1,218.8		5.9		(161.1)		—		1,063.6
Collateralized loan obligations	961.1		.9		(28.1)		—		933.9
Commercial mortgage-backed securities	2,471.1		.3		(266.8)		—		2,204.6
Total investment grade fixed maturities, available for sale	22,303.3		73.3		(2,612.4)		(39.6)		19,724.6
Below-investment grade (a) (b):
Corporate securities	573.8		.9		(42.6)		(26.3)		505.8
States and political subdivisions	10.6		—		(.7)		(.2)		9.7

Asset-backed securities	119.8		—		(18.7)		—		101.1
Non-agency residential mortgage-backed securities	539.3		31.9		(17.2)		—		554.0

Commercial mortgage-backed securities	83.7		—		(19.2)		—		64.5
Total below-investment grade fixed maturities, available for sale	1,327.2		32.8		(98.4)		(26.5)		1,235.1
Total fixed maturities, available for sale	$	23,630.5	$	106.1	$	(2,710.8)	$	(66.1)	$	20,959.7

_______________

(a)Investment ratings are assigned the second lowest rating by Nationally Recognized Statistical Rating Organizations ("NRSROs") (Moody's, S&P or Fitch), or if not rated by such firms, the rating assigned by the National Association of Insurance Commissioners (the "NAIC"). NAIC designations of "1" or "2" include fixed maturities generally rated investment grade (rated "Baa3" or higher by Moody's or rated "BBB-" or higher by S&P and Fitch). NAIC designations of "3" through "6" are referred to as below-investment grade (which generally are rated "Ba1" or lower by Moody's or rated "BB+" or lower by S&P and Fitch). References to investment grade or below-investment grade throughout our consolidated financial statements are determined as described above.

(b) Certain structured securities rated below-investment grade by NRSROs may be assigned a NAIC 1 or NAIC 2 designation based on the cost basis of the security relative to estimated recoverable amounts as determined by the NAIC. Refer to the table below for a summary of our fixed maturity securities, available for sale, by NAIC designations.

80101

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

The NAIC evaluates the fixed maturity investments of insurers for regulatory and capital assessment purposes and assigns securities to one of six credit quality categories called NAIC designations, which are used by insurers when preparing their annual statements based on statutory accounting principles. The NAIC designations are generally similar to the credit quality designations of the NRSROs for marketable fixed maturity securities, except for certain structured securities. However, certain structured securities rated below investment grade by the NRSROs can be assigned NAIC 1 or NAIC 2 designations depending on the cost basis of the holding relative to estimated recoverable amounts as determined by the NAIC. The following summarizes the NAIC designations and NRSRO equivalent ratings:


NAIC Designation						NRSRO Equivalent Rating
1						AAA/AA/A
2						BBB
3						BB
4						B
5						CCC and lower
6						In or near default

A summary of our fixed maturity securities, available for sale, by NAIC designations (or for fixed maturity securities held by non-regulated entities, based on NRSRO ratings) as of ~~September~~June 30, ~~2022~~2023 is as follows (dollars in millions):


NAIC designation	NAIC designation	Amortized cost		Estimated fair value		Percentage of total estimated fair value		NAIC designation	Amortized cost		Estimated fair value		Percentage of total estimated fair value
1	1	$	13,913.9	$	12,147.2	59.9	%	1	$	14,824.4	$	13,200.6	63.0	%
2	2	8,586.8		7,335.5		36.1		2	8,074.2		7,124.9		34.0
Total NAIC 1 and 2 (investment grade)	Total NAIC 1 and 2 (investment grade)	22,500.7		19,482.7		96.0		Total NAIC 1 and 2 (investment grade)	22,898.6		20,325.5		97.0
3	3	681.6		592.9		2.9		3	561.3		496.1		2.4
4	4	241.3		208.3		1.0		4	143.5		127.2		.6
5	5	17.9		17.2		.1		5	18.1		10.8		—
6	6	1.0		—		—		6	9.0		.1		—
Total NAIC 3, 4, 5 and 6 (below-investment grade)	Total NAIC 3, 4, 5 and 6 (below-investment grade)	941.8		818.4		4.0		Total NAIC 3, 4, 5 and 6 (below-investment grade)	731.9		634.2		3.0
Total	Total	$	23,442.5	$	20,301.1	100.0	%	Total	$	23,630.5	$	20,959.7	100.0	%

81102

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Fixed Maturity Securities, Available for Sale

The following table summarizes the carrying values and gross unrealized losses of our fixed maturity securities, available for sale, by category as of ~~September~~June 30, ~~2022~~2023 (dollars in millions):


		Carrying value		Percent of fixed maturities		Gross unrealized losses		Percent of gross unrealized losses			Carrying value		Percent of fixed maturities		Gross unrealized losses		Percent of gross unrealized losses
States and political subdivisions	States and political subdivisions	$	2,400.2	11.8	%	$	437.8	13.8	%	States and political subdivisions	$	2,453.6	11.7	%	$	388.2	14.3	%
Commercial mortgage-backed securities	Commercial mortgage-backed securities	2,214.5		10.9		238.2		7.5		Commercial mortgage-backed securities	2,269.1		10.8		286.0		10.6
Banks	Banks	1,740.1		8.6		303.9		9.6		Banks	1,776.3		8.5		241.7		8.9
Non-agency residential mortgage-backed securities	Non-agency residential mortgage-backed securities	1,638.9		8.1		167.3		5.3		Non-agency residential mortgage-backed securities	1,617.6		7.7		178.3		6.6
Asset-backed securities	Asset-backed securities	1,270.1		6.3		131.8		4.1		Asset-backed securities	1,349.5		6.4		136.8		5.0
Insurance	Insurance	1,191.5		5.9		220.4		6.9		Insurance	1,136.7		5.4		193.7		7.2
Utilities	Utilities	1,176.6		5.8		198.9		6.2		Utilities	1,098.3		5.2		159.4		5.9
Healthcare/pharmaceuticals	Healthcare/pharmaceuticals	1,052.9		5.2		235.3		7.4		Healthcare/pharmaceuticals	1,045.4		5.0		187.8		6.9
Brokerage	Brokerage	990.9		4.9		164.5		5.2		Brokerage	940.1		4.5		138.3		5.1
Collateralized loan obligations										Collateralized loan obligations	933.9		4.5		28.1		1.0
Technology	Technology	767.8		3.8		192.2		6.0		Technology	793.7		3.8		136.0		5.0
Collateralized loan obligations		733.2		3.6		45.1		1.4
Food/beverage	Food/beverage	677.5		3.3		108.6		3.4		Food/beverage	665.1		3.2		72.3		2.7
Energy	Energy	506.9		2.5		66.5		2.1		Energy	507.0		2.4		46.4		1.7
Cable/media	Cable/media	444.8		2.2		101.3		3.2		Cable/media	458.3		2.2		75.0		2.8
Real estate/REITs	Real estate/REITs	395.8		1.9		52.6		1.7		Real estate/REITs	371.7		1.8		49.1		1.8
Agency residential mortgage-backed securities										Agency residential mortgage-backed securities	348.8		1.7		3.0		.1
Transportation	Transportation	383.5		1.9		51.7		1.6		Transportation	342.5		1.6		38.1		1.4
Telecom	Telecom	322.4		1.6		45.5		1.4		Telecom	331.6		1.6		28.0		1.0
Capital goods	Capital goods	282.4		1.4		44.1		1.4		Capital goods	273.3		1.3		31.9		1.2
Chemicals	Chemicals	271.2		1.3		48.8		1.5		Chemicals	262.5		1.2		35.8		1.3

Other	Other	1,839.9		9.0		328.9		10.3		Other	1,984.7		9.5		256.9		9.5
Total fixed maturities, available for sale	Total fixed maturities, available for sale	$	20,301.1	100.0	%	$	3,183.4	100.0	%	Total fixed maturities, available for sale	$	20,959.7	100.0	%	$	2,710.8	100.0	%

Below-Investment Grade Securities

At ~~September~~June 30, ~~2022,~~2023, the amortized cost of the Company's below-investment grade fixed maturity securities, available for sale, was ~~$1,517.9~~$1,327.2 million, or ~~6.5~~5.6 percent of the Company's fixed maturity portfolio (or ~~$941.8~~$731.9 million, or ~~4.0~~3.1 percent, of the Company's fixed maturity portfolio measured on credit quality ratings assigned by the NAIC). The estimated fair value of the below-investment grade portfolio was ~~$1,433.7~~$1,235.1 million, or 9493 percent of the amortized cost.

Below-investment grade corporate debt securities typically have different characteristics than investment grade corporate debt securities. Based on historical performance, probability of default by the borrower is significantly greater for below-investment grade corporate debt securities and in many cases severity of loss is relatively greater as such securities are generally unsecured and often subordinated to other indebtedness of the issuer. Also, issuers of below-investment grade corporate debt securities frequently have higher levels of debt relative to investment-grade issuers, hence, all other things being equal, are generally more sensitive to adverse economic conditions. The Company attempts to reduce the overall risk related to its investment in below-investment grade securities, as in all investments, through careful credit analysis, strict investment policy guidelines, and diversification by issuer and/or guarantor and by industry.

82103

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Net Realized and Unrealized Investment Losses

During the first ~~nine~~six months of ~~2022,~~2023, we recognized ~~$81.3~~$36.0 million of realized losses on sales of ~~$1,321.7~~$388.8 million of fixed maturity securities, available for sale, including: (i) ~~$54.3~~$29.8 million related to various corporate securities; (ii) ~~$14.0~~$4.3 million related to ~~non-agency residential~~commercial mortgage-backed securities; and (iii) ~~$7.3 million related to states and political subdivisions; and (iv) $5.7~~$1.9 million related to various other investments. Securities are generally sold at a loss following unforeseen issuer-specific events or conditions or shifts in perceived relative values. These reasons include but are not limited to: (i) changes in the investment environment; (ii) expectation that the market value could deteriorate; (iii) our desire to reduce our exposure to an asset class, an issuer or an industry; (iv) prospective or actual changes in credit quality; (v) better match certain characteristics of our investment portfolio with the corresponding characteristics of our insurance liabilities; or (vi) changes in expected portfolio cash flows.

During the first ~~nine~~six months of ~~2021,~~2022, we recognized ~~$18.4~~$56.9 million of realized losses on sales of ~~$350.3~~$1,106.0 million of fixed maturity securities, available for sale, ~~primarily~~including: (i) $37.6 million related to various corporate ~~securities.~~securities; (ii) $10.2 million related to non-agency residential mortgage-backed securities; (iii) $4.2 million related to states and political subdivisions; and (iv) $4.9 million related to various other investments.

The following summarizes the investments sold at a loss during the first ~~nine~~six months of ~~2022~~2023 which had been

continuously in an unrealized loss position exceeding 20 percent of the amortized cost basis prior to the sale for the period

indicated (dollars in millions):

At date of sale
Number
of issuers Amortized cost Fair value
Less than 6 months prior to sale 16 $ 64.0 $ 34.7


		At date of sale
	Number of issuers	Amortized cost		Fair value
Less than 6 months prior to sale	2	$	40.6	$	20.1
Greater than or equal to 6 months and less than 12 months prior to sale	1	2.6		.1
Greater than 12 months prior to sale	1	.9		.2
		$	44.1	$	20.4

The following table sets forth the amortized cost and estimated fair value of those fixed maturities, available for sale, with unrealized losses at ~~September~~June 30, ~~2022,~~2023, by contractual maturity. Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties. Structured securities frequently include provisions for periodic principal payments and permit periodic unscheduled payments.


		Amortized cost		Estimated fair value			Amortized cost		Estimated fair value
		(Dollars in millions)					(Dollars in millions)
Due in one year or less	Due in one year or less	$	62.9	$	61.7	Due in one year or less	$	110.0	$	107.8
Due after one year through five years	Due after one year through five years	1,776.6		1,643.4		Due after one year through five years	2,076.7		1,926.8
Due after five years through ten years	Due after five years through ten years	1,962.2		1,726.0		Due after five years through ten years	1,507.9		1,348.6
Due after ten years	Due after ten years	11,838.6		9,557.0		Due after ten years	11,131.8		9,298.7
Subtotal	Subtotal	15,640.3		12,988.1		Subtotal	14,826.4		12,681.9
Structured securities	Structured securities	5,937.3		5,354.1		Structured securities	6,436.6		5,804.2
Total	Total	$	21,577.6	$	18,342.2	Total	$	21,263.0	$	18,486.1

83104

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

The following summarizes the investments in our portfolio rated below-investment grade not deemed to have credit losses which have been continuously in an unrealized loss position exceeding 20 percent of the cost basis for the period indicated as of ~~September~~June 30, ~~2022~~2023 (dollars in millions):


		Number of issuers	Cost basis		Unrealized loss		Estimated fair value			Number of issuers	Cost basis		Unrealized loss		Estimated fair value
Less than 6 months	Less than 6 months	15	$	49.2	$	(12.6)	$	36.6	Less than 6 months	12	$	74.9	$	(17.3)	$	57.6
Greater than or equal to 6 months and less than 12 months	Greater than or equal to 6 months and less than 12 months	1	5.0		(1.8)		3.2		Greater than or equal to 6 months and less than 12 months	1	15.4		(4.6)		10.8

Greater than 12 months									Greater than 12 months	3	20.1		(7.2)		12.9
Total	Total		$	54.2	$	(14.4)	$	39.8	Total		$	110.4	$	(29.1)	$	81.3

84105

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

The following table summarizes the gross unrealized losses of our fixed maturity securities, available for sale, by category and ratings category as of ~~September~~June 30, ~~2022~~2023 (dollars in millions):


		Investment grade				Below-investment grade							Investment grade				Below-investment grade
		AAA/AA/A		BBB		BB		B+ and below		Total gross unrealized losses			AAA/AA/A		BBB		BB		B+ and below		Total gross unrealized losses
States and political subdivisions	States and political subdivisions	$	426.9	$	10.1	$	—	$	.8	$	437.8	States and political subdivisions	$	379.0	$	8.5	$	—	$	.7	$	388.2
Commercial mortgage-backed securities												Commercial mortgage-backed securities	217.3		49.5		16.7		2.5		286.0
Banks	Banks	168.5		134.5		.9		—		303.9		Banks	126.9		111.5		3.3		—		241.7
Commercial mortgage-backed securities		181.5		43.5		11.2		2.0		238.2
Insurance												Insurance	94.5		95.5		3.3		.4		193.7
Healthcare/pharmaceuticals	Healthcare/pharmaceuticals	152.6		78.2		3.1		1.4		235.3		Healthcare/pharmaceuticals	132.9		51.7		2.2		1.0		187.8
Insurance		107.4		108.9		3.1		1.0		220.4
Non-agency residential mortgage-backed securities												Non-agency residential mortgage-backed securities	103.2		57.9		1.4		15.8		178.3
Utilities	Utilities	104.8		90.8		2.7		.6		198.9		Utilities	88.3		69.1		1.9		.1		159.4
Technology		103.7		77.9		7.6		3.0		192.2
Non-agency residential mortgage-backed securities		92.1		64.7		.9		9.6		167.3
Brokerage	Brokerage	75.2		85.5		3.1		.7		164.5		Brokerage	66.2		70.1		1.6		.4		138.3
Asset-backed securities	Asset-backed securities	41.4		73.2		15.6		1.6		131.8		Asset-backed securities	46.3		71.8		17.8		.9		136.8
Technology												Technology	82.2		49.1		4.4		.3		136.0
Cable/media												Cable/media	9.1		60.3		2.8		2.8		75.0
Food/beverage	Food/beverage	22.0		83.3		1.2		2.1		108.6		Food/beverage	23.4		47.2		1.2		.5		72.3
Cable/media		14.7		76.7		4.3		5.6		101.3
Real estate/REITs												Real estate/REITs	26.9		21.5		.7		—		49.1
Energy	Energy	10.7		51.4		4.4		—		66.5		Energy	6.8		39.4		.2		—		46.4
Real estate/REITs		29.7		21.8		1.1		—		52.6
Transportation	Transportation	18.1		32.8		.1		.7		51.7		Transportation	14.0		23.9		—		.2		38.1
Chemicals	Chemicals	5.4		41.6		1.0		.8		48.8		Chemicals	2.6		32.0		.7		.5		35.8
Consumer products												Consumer products	20.6		11.7		2.4		.9		35.6
Retail												Retail	19.7		10.1		1.3		1.4		32.5
Capital goods												Capital goods	15.7		13.8		2.4		—		31.9
Collateralized loan obligations												Collateralized loan obligations	24.7		3.4		—		—		28.1
Telecom	Telecom	.4		45.1		—		—		45.5		Telecom	.1		27.9		—		—		28.0
Collateralized loan obligations		38.3		6.8		—		—		45.1
Consumer products		22.2		15.8		3.0		3.5		44.5
Capital goods		21.6		20.4		1.5		.6		44.1
Retail		24.2		13.6		3.2		—		41.0
Aerospace/defense		7.0		24.4		.1		1.2		32.7
Autos	Autos	5.0		24.0		2.3		.3		31.6		Autos	4.6		17.9		1.2		.1		23.8
Building materials	Building materials	5.4		23.5		1.1		.8		30.8		Building materials	4.6		16.8		.6		.2		22.2
Aerospace/defense												Aerospace/defense	5.3		15.5		—		.3		21.1
Metals and mining	Metals and mining	3.8		18.7		1.1		—		23.6		Metals and mining	4.8		9.5		.6		—		14.9
Paper	Paper	.8		15.5		—		.5		16.8		Paper	.7		10.6		.1		.5		11.9
Foreign governments	Foreign governments	5.8		8.6		—		—		14.4		Foreign governments	4.6		5.6		—		—		10.2
United States Treasury securities and obligations of United States government corporations and agencies												United States Treasury securities and obligations of United States government corporations and agencies	10.1		—		—		—		10.1
Entertainment/hotels	Entertainment/hotels	5.8		5.1		1.0		2.0		13.9		Entertainment/hotels	5.3		3.9		.4		—		9.6
United States Treasury securities and obligations of United States government corporations and agencies		11.7		—		—		—		11.7
Agency residential mortgage-backed securities												Agency residential mortgage-backed securities	3.0		—		—		—		3.0
Business services	Business services	—		2.0		1.1		.8		3.9		Business services	—		1.0		.6		.3		1.9
Packaging		—		—		1.1		.3		1.4

Other	Other	55.8		6.3		.5		—		62.6		Other	57.2		5.1		.5		.3		63.1
Total fixed maturities, available for sale	Total fixed maturities, available for sale	$	1,762.5	$	1,304.7	$	76.3	$	39.9	$	3,183.4	Total fixed maturities, available for sale	$	1,600.6	$	1,011.8	$	68.3	$	30.1	$	2,710.8

85106

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

opportunities change, to reflect changing perceptions of risk, or to better match certain characteristics of our investment portfolio with the corresponding characteristics of our insurance liabilities.

Structured Securities

At ~~September~~June 30, ~~2022,~~2023, fixed maturity investments included structured securities with an estimated fair value of ~~$5.9~~$6.5 billion (or ~~29.0~~31.1 percent of all fixed maturity securities). The yield characteristics of structured securities generally differ in some respects from those of traditional corporate fixed-income securities or government securities. For example, interest and principal payments on structured securities may occur more frequently, often monthly. In many instances, we are subject to variability in the amount and timing of principal and interest payments. For example, in many cases, partial prepayments may occur at the option of the issuer and prepayment rates are influenced by a number of factors that cannot be predicted with certainty, including: the relative sensitivity of prepayments on the underlying assets backing the security to changes in interest rates and asset values; the availability of alternative financing; a variety of economic, geographic and other factors; the timing, pace and proceeds of liquidations of defaulted collateral; and various security-specific structural considerations (for example, the repayment priority of a given security in a securitization structure). In addition, the total amount of payments for non-agency structured securities may be affected by changes to cumulative default rates or loss severities of the related collateral.

The amortized cost and estimated fair value of structured securities at ~~September~~June 30, ~~2022,~~2023, summarized by type of security, were as follows (dollars in millions):


				Estimated fair value							Estimated fair value
Type	Type	Amortized cost		Amount		Percent of fixed maturities		Type	Amortized cost		Amount		Percent of fixed maturities
Asset-backed securities	Asset-backed securities	$	1,402.0	$	1,270.1	6.2	%	Asset-backed securities	$	1,485.5	$	1,349.5	6.4	%
Agency residential mortgage-backed securities	Agency residential mortgage-backed securities	39.0		38.5		.2		Agency residential mortgage-backed securities	351.4		348.8		1.7
Non-agency residential mortgage-backed securities	Non-agency residential mortgage-backed securities	1,755.5		1,638.9		8.1		Non-agency residential mortgage-backed securities	1,758.1		1,617.6		7.7
Collateralized loan obligations	Collateralized loan obligations	778.3		733.2		3.6		Collateralized loan obligations	961.1		933.9		4.5
Commercial mortgage-backed securities	Commercial mortgage-backed securities	2,452.7		2,214.5		10.9		Commercial mortgage-backed securities	2,554.8		2,269.1		10.8

Total structured securities	Total structured securities	$	6,427.5	$	5,895.2	29.0	%	Total structured securities	$	7,110.9	$	6,518.9	31.1	%

Residential mortgage-backed securities ("RMBS") include transactions collateralized by agency-guaranteed and non-agency mortgage obligations. Non-agency RMBS investments are primarily categorized by underlying borrower credit quality: Prime, Alt-A, Non-Qualified Mortgage ("Non-QM"), and Subprime. Prime borrowers typically default with the lowest frequency, Alt-A and Non-QM default at higher rates, and Subprime borrowers default with the highest frequency. In addition to borrower credit categories, RMBS investments include Re-Performing Loan ("RPL") and Credit Risk Transfer ("CRT") transactions. RPL transactions include borrowers with prior difficulty meeting the original mortgage terms and were subsequently modified, resulting in a sustainable payback arrangement. CRT securities are collateralized by Government-Sponsored Enterprise ("GSE") conforming mortgages and Prime borrowers, but without an agency guarantee against default losses.

Commercial mortgage-backed securities ("CMBS") are secured by commercial real estate mortgages, generally income producing properties that are managed for profit. Property types include, but are not limited to, multi-family dwellings including apartments, retail centers, hotels, restaurants, hospitals, nursing homes, warehouses, and office buildings. While most CMBS have call protection features whereby underlying borrowers may not prepay their mortgages for stated periods of time without incurring prepayment penalties, recoveries on defaulted collateral may result in involuntary prepayments.

86107

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

INVESTMENTS IN VARIABLE INTEREST ENTITIES

The following table provides supplemental information about the revenues and expenses of the VIEs which have been consolidated in accordance with authoritative guidance, after giving effect to the elimination of our investment in the VIEs and investment management fees earned by a subsidiary of the Company (dollars in millions):


		Three months ended				Nine months ended					Three months ended				Six months ended
		September 30,				September 30,					June 30,				June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Revenues:	Revenues:									Revenues:
Net investment income – policyholder and other special-purpose portfolios	Net investment income – policyholder and other special-purpose portfolios	$	16.0	$	10.9	$	39.6	$	34.4	Net investment income – policyholder and other special-purpose portfolios	$	22.0	$	12.8	$	44.4	$	23.6
Fee revenue and other income	Fee revenue and other income	1.4		1.3		3.9		4.0		Fee revenue and other income	1.2		1.1		2.5		2.5
Total revenues	Total revenues	17.4		12.2		43.5		38.4		Total revenues	23.2		13.9		46.9		26.1
Expenses:	Expenses:									Expenses:
Interest expense	Interest expense	11.7		5.8		24.9		17.6		Interest expense	17.8		7.5		35.1		13.2
Other operating expenses	Other operating expenses	.2		.2		1.3		1.0		Other operating expenses	.6		.7		1.1		1.1
Total expenses	Total expenses	11.9		6.0		26.2		18.6		Total expenses	18.4		8.2		36.2		14.3
Income before net investment gains (losses) and income taxes		5.5		6.2		17.3		19.8
Net investment gains (losses)		3.5		—		(6.7)		5.1
Income before net investment losses and income taxes										Income before net investment losses and income taxes	4.8		5.7		10.7		11.8
Net investment losses										Net investment losses	(3.4)		(7.0)		(4.0)		(10.2)

Income before income taxes		$	9.0	$	6.2	$	10.6	$	24.9
Income (loss) before income taxes										Income (loss) before income taxes	$	1.4	$	(1.3)	$	6.7	$	1.6

87108

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

Supplemental Information on Investments Held by VIEs

The following table summarizes the carrying values and gross unrealized losses of the investments held by the VIEs by category as of ~~September~~June 30, ~~2022~~2023 (dollars in millions):


		Carrying value		Percent of fixed maturities		Gross unrealized losses		Percent of gross unrealized losses			Carrying value		Percent of fixed maturities		Gross unrealized losses		Percent of gross unrealized losses
Cable/media										Cable/media	$	116.8	12.3	%	$	3.9	12.7	%
Technology	Technology	$	143.1	13.0	%	$	10.4	16.9	%	Technology	115.1		12.1		7.6		24.5
Cable/media		128.6		11.7		6.1		9.9
Healthcare/pharmaceuticals	Healthcare/pharmaceuticals	118.6		10.8		8.0		13.0		Healthcare/pharmaceuticals	103.1		10.9		5.8		18.7
Food/beverage	Food/beverage	82.3		7.5		5.2		8.5		Food/beverage	66.7		7.0		2.0		6.4
Brokerage	Brokerage	61.3		5.6		2.5		4.1		Brokerage	59.7		6.3		.7		2.3
Building materials										Building materials	52.6		5.6		.6		2.0
Chemicals	Chemicals	58.5		5.3		2.5		4.1		Chemicals	52.1		5.5		.6		1.8
Capital goods	Capital goods	52.5		4.8		3.1		5.0		Capital goods	41.4		4.4		1.0		3.1
Building materials		51.6		4.7		2.5		4.1
Transportation										Transportation	41.4		4.4		.3		1.1
Paper										Paper	41.2		4.3		.6		2.0
Utilities										Utilities	40.8		4.3		1.0		3.1
Consumer products	Consumer products	47.1		4.3		3.6		5.9		Consumer products	33.1		3.5		1.2		3.8
Paper		42.2		3.8		2.3		3.8
Transportation		40.7		3.7		1.7		2.7
Utilities		38.5		3.5		2.0		3.2
Autos	Autos	34.5		3.1		1.6		2.7		Autos	28.5		3.0		.4		1.1
Insurance	Insurance	33.5		3.0		1.7		2.8		Insurance	27.7		2.9		.2		.8
Business services										Business services	26.5		2.8		.3		1.1
Aerospace/defense	Aerospace/defense	32.6		3.0		1.7		2.8		Aerospace/defense	21.3		2.3		1.3		4.1
Business services		23.3		2.1		1.6		2.7
Banks	Banks	18.9		1.7		.6		1.1		Banks	16.4		1.7		.3		.9
Retail	Retail	18.1		1.7		.7		1.1		Retail	11.6		1.2		.1		.4
Environmental		11.7		1.1		.3		.4

Other	Other	61.6		5.6		3.2		5.2		Other	52.2		5.5		3.2		10.1
Total	Total	$	1,099.2	100.0	%	$	61.3	100.0	%	Total	$	948.2	100.0	%	$	31.1	100.0	%

The following table sets forth the amortized cost and estimated fair value of those investments held by the VIEs with unrealized losses at ~~September~~June 30, ~~2022,~~2023, by contractual maturity. Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.


		Amortized cost		Estimated fair value			Amortized cost		Estimated fair value
		(Dollars in millions)					(Dollars in millions)
Due in one year or less	Due in one year or less	$	4.6	$	4.4	Due in one year or less	$	6.6	$	5.9
Due after one year through five years	Due after one year through five years	670.9		636.0		Due after one year through five years	667.1		637.3
Due after five years through ten years	Due after five years through ten years	470.2		437.5		Due after five years through ten years	143.4		138.4

Total	Total	$	1,145.7	$	1,077.9	Total	$	817.1	$	781.6

88109

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

The following summarizes the investments held by the VIEs sold at a loss during the first ~~nine~~six months of ~~2022~~2023 which had been continuously in an unrealized loss position exceeding 20 percent of the amortized cost basis prior to the sale for the period indicated (dollars in millions):


			At date of sale						At date of sale
		Number of issuers	Amortized cost		Fair value			Number of issuers	Amortized cost		Fair value
Less than 6 months prior to sale	Less than 6 months prior to sale	2	$	3.5	$	1.9	Less than 6 months prior to sale	1	$	1.7	$	1.2
Greater than or equal to 6 months and less than 12 months prior to sale	Greater than or equal to 6 months and less than 12 months prior to sale	1	.4		—		Greater than or equal to 6 months and less than 12 months prior to sale	1	2.7		.8
Greater than 12 months prior to sale							Greater than 12 months prior to sale	1	3.5		1.0
									$	7.9	$	3.0
			$	3.9	$	1.9

The following summarizes the investments held by the VIEs rated below-investment grade not deemed to have credit losses which have been continuously in an unrealized loss position exceeding 20 percent of the cost basis for the period indicated as of ~~September~~June 30, ~~2022~~2023 (dollars in millions):

Number
of issuers Cost
basis Unrealized
loss Estimated
fair value
Less than 6 months 1 $ 5.3 $ (1.2) $ 4.1


	Number of issuers	Cost basis		Unrealized loss		Estimated fair value
Less than 6 months	1	$	3.6	$	(1.1)	$	2.5
Greater than or equal to 6 months and less than 12 months	1	2.9		(.8)		2.1

Total		$	6.5	$	(1.9)	$	4.6

89110

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

NEW ACCOUNTING STANDARDS

See "Recently ~~Issued~~Adopted Accounting Standards" in the notes to consolidated financial statements for a discussion of recently ~~issued~~adopted accounting standards.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Our market risks, and the ways we manage them, are summarized in "Management's Discussion and Analysis of Financial Condition and Results of Operations", included in our Annual Report on Form 10-K for the year ended December 31, ~~2021.~~2022. There have been no material changes in the first ~~nine~~six months of ~~2022~~2023 to such risks or our management of such risks.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures. CNO's management, under the supervision and with the participation of the Chief Executive Officer and the Chief Financial Officer, evaluated the effectiveness of CNO's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as ~~amended)~~amended, (the "Exchange Act")). Based on its evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of ~~September~~June 30, ~~2022,~~2023, CNO's disclosure controls and procedures were effective to ensure that information required to be disclosed by CNO in reports that it files or submits under the ~~Securities~~ Exchange Act ~~of 1934~~ is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures are also designed to reasonably assure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes to Internal Control Over Financial Reporting. There were no changes in the Company's internal control over financial reporting (as defined in Rule 13a-15(f) under the ~~Securities~~ Exchange ~~Act of 1934)~~Act) during the three months ended ~~September~~June 30, ~~2022,~~2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

90111

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

Information required for Part II, Item 1 is incorporated by reference to the discussion under the heading "Litigation and Other Legal Proceedings" in the footnotes to our consolidated financial statements included in Part I, Item 1 of this Form 10-Q.

ITEM 1A. RISK FACTORS.

CNO and its businesses are subject to a number of risks including general business and financial risk. Any or all of such risks could have a material adverse effect on the business, financial condition or results of operations of CNO. Refer to "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, ~~2021,~~2022, for further discussion of such risk factors. There have been no material changes from such previously disclosed risk factors.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Issuer Purchases of Equity Securities

Period (in 2022) Total number of shares (or units) purchased Average price paid per share (or unit) Total number of shares (or units) purchased as part of publicly announced plans or programs Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs (a)
(dollars in millions)
July 1 through July 31 560,664 $ 17.84 560,449 $ 196.9
August 1 through August 31 867 19.82 25 196.9
September 1 through September 30 2,819 18.10 — 196.9
Total 564,350 17.85 560,474 196.9


Period (in 2023)	Total number of shares (or units) purchased	Average price paid per share (or unit)		Total number of shares (or units) purchased as part of publicly announced plans or programs	Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs (a)
					(dollars in millions)
April 1 through April 30	419,718	$	22.03	418,310	$	162.6
May 1 through May 31	490,459	21.78		489,907	651.9
June 1 through June 30	441,542	23.07		438,451	641.8
Total	1,351,719	22.28		1,346,668	641.8

_________________

(a) ~~In May 2011, the Company announced a securities repurchase program. Since that date, the~~The Company's Board of Directors has authorized additional repurchases from time to time, most recently in May ~~2021~~2023 when it authorized the repurchase of an additional $500.0 million of the Company's outstanding shares of common stock.

91112

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

ITEM 5. OTHER INFORMATION.

During the second quarter of 2023, a director and certain officers (as defined in Rule 16a-1(f) of the Exchange Act) (the "Section 16 officers") of the Company adopted separate Rule 10b5-1 trading arrangements (as defined in Item 408(a) of Regulation S-K) for the sale of the Company’s common stock. The following summarizes the material terms of such Rule 10b5-1 trading arrangements:

Name and title of officer

Date of trading arrangement

Duration of trading arrangement (a)

Aggregate shares of common stock to be sold pursuant to the trading arrangement

Gary C. Bhojwani

June 9, 2023

March 8, 2024

42,572

–Director and Chief Executive Officer

Karen J. DeToro

May 12, 2023

May 13, 2024

18,071

–Chief Actuary

Scott L. Goldberg

June 8, 2023

March 11, 2024

7,768

–President, Consumer Division

Matthew J. Zimpfer

June 9, 2023

August 20, 2024

13,001

–General Counsel

_________

(a) Or such earlier date that the aggregate amount of shares has been sold.

During the second quarter of 2023, no other of the Company's directors or Section 16 officers has adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as defined in Item 408(a) of Regulation S-K).

113

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

ITEM 6. EXHIBITS.


3.1			Amended and Restated Certificate of Incorporation of CNO Financial Group, Inc., incorporated by reference to Exhibit 3.1 of our Current Report o n on Form 8-K filed August 1,, 2022.

3.2			Amended and Restated Bylaws of CNO Financial Group, Inc., incorporated by reference to Exhibit ~~3.2~~3.1 of our ~~Annual~~Current Report on Form ~~10-K for the year ended~~8-K filed December ~~31, 2018.~~14, 2022.

10.1			Fourth Amendment and Restatement Agreement, dated as of May 4, 2023, among CNO Financial Group, Inc., the lenders party thereto, and KeyBank National Association, as administrative agent for the lenders, in respect of the Credit Agreement, dated as of May 19, 2015, among CNO Financial Group, Inc., the lenders party thereto, and KeyBank National Association, as administrative agent for the lenders.

31.1			Certification Pursuant to the Securities Exchange Act Rule 13a-14(a)/15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2			Certification Pursuant to the Securities Exchange Act Rule 13a-14(a)/15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1			Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2			Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS			XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH			XBRL Taxonomy Extension Schema Document.

101.CAL			XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF			XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB			XBRL Taxonomy Extension Label Linkbase Document.

101.PRE			XBRL Taxonomy Extension Presentation Linkbase Document.

104			Cover Page Interactive Data File (embedded within the Inline XBRL document).

92114

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

CNO FINANCIAL GROUP, INC.

Dated: ~~November 4, 2022~~August 9, 2023


			By:			/s/ John R. Kline
						John R. Kline
						Senior Vice President and Chief Accounting Officer
						(authorized officer and principal accounting officer)

93115


	September 30, 2022		December 31, 2021
Net unrealized gains (losses) on investments having no allowance for credit losses	$	(1,222.1)	$	2,963.3
Unrealized losses on investments with an allowance for credit losses	(1,929.9)		(23.1)
Adjustment to present value of future profits (a)	8.7		(8.3)
Adjustment to deferred acquisition costs	367.1		(420.2)
Adjustment to insurance liabilities	—		(25.5)
Deferred income tax assets (liabilities)	610.5		(539.1)
Accumulated other comprehensive income (loss)	$	(2,165.7)	$	1,947.1


Period (in 2022)	Total number of shares (or units) purchased	Average price paid per share (or unit)		Total number of shares (or units) purchased as part of publicly announced plans or programs	Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs (a)
					(dollars in millions)
July 1 through July 31	560,664	$	17.84	560,449	$	196.9
August 1 through August 31	867	19.82		25	196.9
September 1 through September 30	2,819	18.10		—	196.9
Total	564,350	17.85		560,474	196.9